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Abstract
It has been previously described that antibiotic-resistant bacteria can be found in the
guts of insects feeding on a variety of plants and not exposed to significant levels of
antibiotics. Such naturally-occurring resistance has implications for clinically-relevant
antibiotic resistance, which is a worldwide problem, and for using plants as a source of
potential  novel  antibiotics.  We  investigated  this  phenomenon  further.  Firstly,  we
searched for antibiotic resistance in different insects’ guts and explored its origin, using
two  lepidopteran  hosts  feeding  on  artificial  food  containing  either  ciprofloxacin  or
oxytetracycline.  We discovered that  these antibiotics  have a diverse  impact on the
insect gut microbiome, beyond simply inducing antibiotic resistance. Secondly, we used
the insect gut bacteria to identify plant extracts with antibacterial activity, and purified
their active fractions. We found that vindoline, from leaf extract, and serpentine, from
root  extract,  are  the most  abundant  metabolites  in  active  fractions  of  Madagascar
periwinkle extracts. Finally, we developed one of the insect species we used, Galleria
mellonella, into a laboratory model for antibiotic efficacy testing, toxicity testing and as
a model for human baby gut. In summary, in this project we explored different aspects
of the antibiotic resistance that can be found in the insect gut and used it to guide us
towards plant metabolites with antibacterial properties.
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Introduction
1 Introduction
In  this  project  I  investigated  the  gut  microbiota  of  insects  feeding  on  plants.  We
explored the origin of antibiotic resistance in the insect gut, examined the antibiotic
properties of plant secondary metabolites and developed greater wax moth larvae into
a laboratory animal model. 
I will open this chapter with a description of plant secondary metabolites, their uses
and  environmental  roles.  I  will  follow  with  an  introduction  about  insects,  their
relationship  with  plants  and  the  bacterial  communities  associated  with  them.  The
following section will focus on antibiotics, antibiotic resistance and the current crisis in
antibiotic discovery and will lead to a part about using insects for research purposes. I
will summarize with presenting the aims and objectives of each part of the project.
1.1 Plant secondary metabolites
1.1.1 Classes of plant secondary metabolites
Plant secondary metabolites (also referred to as phytochemicals) are compounds that
are not directly involved in the normal growth, development, or reproduction of the
plant  and  their  absence  does  not  result  in  immediate  death.  They  used  to  be
considered by-products of plant metabolism with no role in the plant fitness [1]. More
recently  secondary  metabolites  have  been  indicated  in  plant  defence  (against
herbivores,  microbial  pathogens,  and  other  plants),  signalling  and  attraction  (for
pollination,  seed  dispersal,  and  symbiosis),  and  abiotic  stress  response.  Secondary
metabolites can be specific to plant families or species. For example flavonoids from
Ginkgo biloba,  ginkgolides A, B, C and J,  commonly used to treat impaired cerebral
circulation, have not been found in any other living species [2]. Phytochemicals have
beneficial role to the plant under stress conditions, but their production is costly and
needs to be tightly regulated.
Secondary metabolites derive from primary metabolism and can be divided into four
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classes: 1) phenolics and polyphenols, 2) alkaloids, 3) terpenoids and essential oils, and
4) lectins with polypeptides. 
Firstly,  phenolics  and  polyphenols  are  a  diverse  class,  consisting  of  aromatic
compounds,  including  flavonoids,  quinones,  tannins,  and  coumarins.  Phenolics  and
polyphenols are characterised by the presence of phenol groups and their derivatives,
when the double bonds of the phenol groups are rearranged. 
Polyphenols are often considered the component responsible for the health benefits of
fruit and vegetables. Pomegranate (Punica granatum), which was used in traditional
medicine  for  the  treatment  of  cough  and  sore  throat,  diarrhea,  dysentery,  dental
plaque, bleeding noses and ulcers (see review by Ismail et al., 2012 [3]), contains high
amounts  of  polyphenols.  Punicalagin  (Figure  1-1a)  is  one  of  the  most  abundant,
reaching levels  of  11–20 g/kg in  the peel  powder.  Punicalagin  is  a  reactive oxygen
species  scavenger  and  a  metal  chelator  and  was  described  to  have  antioxidant,
antiproliferative,  apoptotic,  anti-inflammatory,  and hepatoprotective  properties  (see
review Faria and Calhau, 2011 [4]).  Similarly,  tea (Camelia sinensis) polyphenols are
considered beneficial for a number of conditions. Epigallocatechin-3-gallate (Figure 1-
1b)  is  an  abundant  tea  polyphenol,  constituting  up  to  7%  dried  tea  leaves.
Epigallocatechin-3-gallate  has  antiviral  [5],  anticancer  [6],  and  neuroprotective
activities  [7],  but  also  suffers  from  poor  bioavailability  with  relatively  high  doses
leading to mild side effects [8].
The  second  class,  alkaloids,  are  a  group  of  heterocyclic  nitrogen-containing
compounds. These compounds are derived from amino acids. The nitrogen-containing
groups in alkaloids often carry positive charge, but can also carry neutral or negative
charge.
2
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Figure  1.1:   Examples  of  phytochemicals  with  medicinal  properties.  Punicalagin  (a)  from
pomegranate  and  epigallocatechin-3-gallate  (b)  from  tea  are  examples  of  polyphenols.
Morphine (c) and quinine (d) are alkaloids with high economic value. Artemisinin (e) and taxol
(f) are economically and medically important terpenes. Components of tea tree oil γ-terpinene,
α-terpined and terpinen-4-ol (g) are examples of terpenes in essential oils used for medicinal
purposes. h) Tertiary structure of ricin. Subunit A is shown in orange and subunit B in green
(PDB file 2AAI).
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Alkaloids, like painkiller morphine and antimalarial  drug quinine, have been used in
both  traditional  and  modern  medicine  and  are  often  of  high  commercial  value.
Morphine (Figure 1-1c), isolated from the straw of opium poppy (Papaver somniferum),
is  an analgesic (pain-relieving compound) used to treat mild to severe cancer pain.
Morphine and its metabolites, morphine-3-glucuronide and morphine-6-glucuronide,
bind with different affinities to subclasses of opioid receptors in the central nervous
system to exert their analgesic action [9]. Another high value alkaloid is antimalarial
quinine  (Figure  1-1d)  isolated  from  the  bark  of  Cinchona  trees.  The  extracts  of
Cinchona bark have been used since the 17th century to treat malaria, but since 2006
the active component of the extracts, the drug quinine, is no longer recommended as
first-line  treatment  due  to  drug  resistance  issues.  Quinine  is  toxic  to  Plasmodium
falciparum parasite  by  interfering  with  the  haemoglobin  metabolism,  but  the
mechanism of action is not well understood [10]. 
The third class, terpenes and essential oils, consist of five-carbon isoprene structural
units linked in various configurations. Terpenes and essential oils are derived from the
hydrocarbon metabolism.
Artemisinin (Figure 1-1e) is one of the most recognizable terpenoids, with the 2015
Nobel Prize in Physiology or Medicine being awarded for its discovery [11]. Artemisinin
can be isolated from  Artemisia annua and kills  Plasmodium falciparum parasites by
inducing reactive oxygen species formation in their mitochondria [12]. Another notable
example of plant-produced terpene is the anticancer drug taxol  (Figure 1-1f).  Taxol,
isolated  from  the  bark  of  the  Pacific  yew  Taxus  brevifolia,  stabilizes  microtubule
filaments,  preventing their  disassembly,  blocking progression through cell  cycle and
leading to cell death. Examples of bioactive essential oils are clove oil and tea tree oil.
The active ingredient of clove oil is eugenol, which is used in dentistry as an antiseptic
and  anaesthetic,  but  in  large  doses  is  cytotoxic  [13].  Tea  tree  oil,  containing  γ-
terpinene,  α-terpined  and  terpinen-4-ol  (Figure  1-1g),  has  been  used  as  an
antimicrobial and anti-inflammatory agent in traditional and complementary medicine
[14].
Finally,  lectins  and polypeptides  are  amino acid  chains.  Unlike  alkaloids,  which  are
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derived from amino acids and are often heavily modified, the general structure of the
amino acid units in lectins and polypeptides is preserved.
Ricin (Figure 1-1h) is an example of plant-produced lectin. It occurs naturally in castor
oil plant (Ricinus communis). Ricin is extremely toxic with LD50 of 22 µg/kg body weight
by inhalation or injection. Ricin’s extreme cytotoxicity is due to the inactivation of the
eukaryotic ribosome by catalytic cleavage of N-glycosidic bond of adenine 4324 of 28S
rRNA within the ribosomal 60S subunit [15]. 
These examples highlight how plants and their extracts have been used for medical
purposes for centuries. Ayurveda, traditional Chinese and African medicines depend on
plants with medicinal properties as sources of treatments.
1.1.2 The use of plants in traditional medicine
Traditional  medicine is  defined by the WHO as the knowledge,  skills,  and practices
based on the theories, beliefs, and experiences indigenous to different cultures used in
the maintenance of health as well  as in the prevention, diagnosis,  improvement or
treatment  of  physical  and mental  illness  [16].  Adopting these practices  by  modern
societies  outside of  their  traditional  context  is  complimentary,  non-conventional  or
alternative medicine. Before the rise of modern, evidence-based medicine, traditional
medicine was the only option offering treatment for disease. Many empirically-tested
traditional treatments are still in use today and in some African countries up to 80% of
the population depend on traditional medicine for their primary healthcare, while 50 –
90% Europeans declare having used complimentary or alternative treatments at least
once [16]. 
Plant extracts  are used for  numerous purposes,  compounds are sometimes crudely
purified and often complex mixtures are used. Some mixtures are surprisingly complex
considering their  narrow specificity.  A medieval  eye infection remedy composed of
garlic, oxgall,  wine, leek or onion, and copper salts was shown to be active against
methicillin-resistant  S.  aureus (MRSA)  but  not  vancomycin-resistant  enterobacteria
(VREs), Acinetobacter baumanni or Pseudomonas aeruginosa [17].
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Traditional  medicine  treatments  are  sometimes  criticised  over  the  insufficient
knowledge  of  their  composition  and  the  lack  of  data  on  their  efficacy  and  safety.
Normally the long history of popular use is accepted as a proof that a treatment is safe
to  use.  Even  though  there  is  no  scientific  basis  to  the  belief  that  plant-based
treatments are by their nature beneficial  and safe,  they require fewer clinical  trials
before being accepted for use that conventional medicines, and are commonly used
even in the absence of data suggesting superiority over placebo in clinical trials (see
review by Moreira et al.,  2014 [18]).  Moreover, for many traditional treatments the
only  toxicity data are from lack of observed adverse effects during short-term use,
sometimes  leading  to  the  use  of  formulations  that  are  carcinogenic,  hepatotoxic,
nephrotoxic or teratogenic in long term. 
Additionally, misidentification and mislabelling of traditional treatments is a common
issue. A genetic survey of 15 traditional Chinese medicines revealed some preparations
were lacking the main ingredient listed on the ingredient list, but also the presence of
ingredients  from  vulnerable  and  endangered  plant  and  animal  species  [19].  More
importantly, sometimes misidentification leads to serious toxicity issues. Chinese star
anise (Illicium verum) is used not only for culinary purposes but also as an antiviral [20],
as  it  contains  high  amounts  of  shikimic  acid.  Shikimic  acid  is  a  precursor  in  the
production  of  oseltamivir  phosphate,  known  better  under  its  commercial  name
Tamiflu, used as a treatment for influenza virus A [21]. Chinese star anise can be easily
mistaken with a similarly looking poisonous Japanese star anise (Illicium anisatum) [22]
causing neurological symptoms in infants treated with star anise tea for infant colic.
Interestingly, some herbal treatments used in self-medication can gain popularity even
when they are ineffective [23]. Such treatments often lack clinical data on safety and
efficacy, and have no history of use in traditional medicine. Their ineffectiveness leads
to longer use by the original users, who demonstrate the treatment and spread it to a
larger number of converts. Even though the treatment is abandoned by the original
users due to the lack of efficacy, the large number of converts keeps spreading the use
of such ineffective treatments.
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1.1.3 The biological roles of plant secondary metabolites
Plants and their preparations are often toxic to humans, but limited data are available
about the biological  roles of  many plant metabolites.  The non-essential  function of
plant secondary metabolites makes them difficult to study in the native context. Some
compounds are reported to be poisonous, but the testing is often conducted above
physiologically relevant concentrations. 
For  example,  when  bees  feed  on  caffeine-rich  nectar  of  Citrus species,  the  bitter
caffeine can act as a feeding deterrent.  However, it is not detectable by bees at the
levels  present  in  nectar  and  instead  it  enhances  learning  and  memory  [24].  The
caffeine acts on adenosine receptors of Kenyon cells in bee brains to form a “memory
trace”  for  the  scent  associated  with  reward  during  and  after  the  conditioning.  A
number of studies automatically propose anti-herbivory role for secondary metabolites
without strict testing of the hypothesis, while mediating plant insect interactions can
be more nuanced.
1.2 Insects
1.2.1 Insect anatomy
Insects are a class of invertebrates characterized by three part body consisting of head,
thorax and abdomen, a periodically-molted exoskeleton composed of α-chitin, three
pairs of legs with joints, compound eyes and antennae. Apart from primitive wingless
insect  orders  (Archaeognatha – bristletails  and Thysanura –  silverfish),  insects  have
wings. Insects are extremely diverse and numerous group of animals with over a 1.5
million already described species, out of a predicted 5 to 30 million [25].
Generally  speaking,  the external  anatomy of  an insect consists  of  three body parts
(Figure  1-2a):  head,  thorax  and  abdomen.  Internally,  nearly  the  entire  body  cavity
(haemocoel) is filled with the digestive tract (Figure 1-2b). The digestive tract can be
divided into foregut, midgut and hindgut, all composed of a single epithelial cell layer
surrounded by muscles. The midgut is of endodermal origin, while foregut and hindgut
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are of ectodermal origin and are therefore lined with cuticle that molts. The haemocoel
is filled with hemolymph, a fluid analogous to blood in vertebrates. The nervous system
can  be  located  either  dorsally  or  ventrally  depending  on  the  insect  species.  Other
important  organs  are  the malphigian  tubule  system,  responsible  for  excretion,  and
fatbody, biosynthetic and storage organ analogous to vertebrate liver.  
1.2.2 The role of insects
Insects have important ecological roles, including herbivory, predation, pollination and
nutrient  recycling.  In  tropical  forests  ants  are  not  only  a  major  herbivore,  with
herbivorous ants consuming 12-15% total leaf area, but also an important carnivore,
with carnivorous ants  making up to 25% total  animal  biomass  in  some areas  [25].
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Figure 1.2: The generalized anatomy of an insect on an example of a larva.
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Insects are responsible for the pollination of most flowering plants. Importantly, insects
have an economic role, as domesticated pollinators bees alone contribute between
$1.6 and $5.7 billion to US agriculture alone [26].
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Figure 1.3: An overview of insect phylogeny (adapted from Misof et al., 2014 [27]).
Order common name
Archaeognatha jumping brisetails
Zygnetoma silverfish, firebrats
Odonata dragonflies, damselflies
Ephemeroptera mayflies
Dermaptera earwigs
Zoraptera angel insects
Plecoptera stoneflies
Orthoptera crickets, wetas, grasshoppers, locusts
Mantophasmatod
ea
gladiators
Grylloblattodea ice crawlers, icebugs
Embioptera webspinners
Phasmatodea stick and leaf insects
Mantodea mantises
Blattodea cockroaches
Isoptera termites
Thysanoptera thrips
Hemiptera cicads, aphids, true bugs
Psocodea barklice, lice
Hymenoptera sawflies, wasps, ants, bees
Raphidioptera snakeflies
Megaloptera alderflies, dobsonflies, fishflies
Neuroptera net-winged insects, mantidflies, antlions
Strepsiptera twisted-winged parasites
Coleoptera beetles
Trichoptera caddisflies
Lepidoptera moths, butterflies
Mecoptera scorpionflies
Siphonaptera fleas
Diptera gnats, mosquitoes, flies
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1.2.3 Insect diversity
Insects  are  extremely  diverse  group,  with  0.2  mm  long  parasitic  wasps  Alaptus
magnanimus and 35 cm long stick  insects  Phobaeticus chani,  but are most likely  a
monophyletic group [25]. Even though fossil record suggests insects originated in Late
Silurian, phylogenomic data suggest Early Ordovician [27]. The clade is divided into 27
orders, with Coleoptera (beetles), Diptera (gnats, mosquitoes and flies), Hymenoptera
(sawflies,  wasps,  ants  and bees) and Lepidoptera (moths and butterflies)  being the
largest groups [27]. Phylogenetic relationships between different insect groups were
only clarified by an extensive survey of 1478 single-copy nuclear genes from different
insect  taxa  and  other  arthropods  in  combination  with  validated  set  of  fossils.  The
phylogenetic relationships resulting from this analysis is presented in Figure 1-3.
1.2.4 Insect immunity
Insect immune system consists of cellular response and systemic (humoral) response
[25]. Specialized cells, hemocytes, are the components of cellular response system and
include  cells  capable  of  phagocytosis,  encapsulation  of  pathogens,  and  storing  of
antimicrobial peptides [28, 29]. These cells circulate in the hemolymph of a healthy
insect. Systemic immune response is activated in response to wounding or infection
and involves the fat body and gut epithelium producing large amounts of antimicrobial
peptides [30]. 
Cellular  responses  are  mediated  by  six  types  of  hemocytes:  adipohemocytes,
granulocytes,  oenocytoids,  plasmatocytes,  prohemocytes,  and  spherule  cells  [25].
Adipohemocytes  are  tissue-bound and have  a  secretory  function.  Granulocytes  are
involved  in  the  early  stages  of  capsule  formation  around  pathogens  and  attract
phagocytic  plasmatocytes  to  the  infection  site.  Spherule  cells  are  involved  in
encapsulation  of  pathogens  that  are  too  big  to  be  neutralised  by  phagocytosis.
Oenocytoids  have  a  role  in  melanisation  associated  with  wound  healing  and
encapsulation.  Prohemocytes  are  considered hemocyte  stem cells,  they  divide  and
differentiate  into  other  hemocyte  types.  Generally,  these  six  types  are  the  most
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common, but additional hemocyte types exits in some insects [29]. The number and
types of hemocytes vary between different developmental stages.
Systemic or humoral responses are induced by the detection of a pathogen [30, 31].
The  response  is  mediated  by  soluble  effector  molecules:  antimicrobial  peptides,
melanin,  and proteolytic  cascades.  Antimicrobial  peptides kill  bacteria and fungi  by
forming pores and depolarising their cell  membrane [32].  Melanin is produced and
deposited around the invading pathogen as a part of the encapsulation process [33].
Proteolytic  cascades  are  induced  by  the  pathogen  recognition  and  they  initiate
encapsulation and melanisation processes, as well as other cellular responses [31].
The insect immune responses are not only inducible but also specific against the type
of invading pathogen [32]. The genes encoding receptors responsible for the pathogen
recognition can be alternatively spliced into a large variety of isoforms. Depending on
pathogen  recognition  different  proteolytic  cascades  activate  a  different  arsenal  of
immune defences.
1.2.5 Similarities between insect and human immunity
Innate, not inducible, immune response is the more ancient part of immune system.
Many parts of innate immune responses are conserved between different animals, for
example insects and humans. Both structural and functional similarities can be found.
Often the receptors and pathways from different animals carry conserved molecular
patterns. For example, there is structural homology between Drosophila Toll receptors
and  human  TLR4  (Toll-like  receptor  4)  [34].  The  family  of  receptors  was  originally
discovered in insects and only later the structural homology between the insect Toll
receptors and human interleukin 1 receptors was discovered.
Insects  and  mammals  are  distantly  related  and  structural  homology  is  rare,  but
functional homology is more common. The most striking similarities between insect
and human immunity are between their  cellular  responses [29]. The central  role is
played by  phagocytic  cells,  which  use  lectin-mediated phagocytosis.  Lectins  on  the
surface of phagocytic cells directly recognize pathogen-associated molecular patterns
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on the surface of the bacteria or fungi and that interaction initiates phagocytosis. For
both insects and mammals the ingested pathogen cells are neutralised by the same
reactive oxygens species: O2-,  H2O2,  NO-.  Degranulation,  the release of antimicrobial
molecules  from  the  granules  in  immune  cells,  and  certain  antimicrobial  peptides
(peroxynectin,  transferrin,  lysozyme,  defensin)  are  shared  between  insects  and
mammals.  These similarities  between insect  and human immunity  makes insects  a
suitable model used in immunology research, virulence and antibiotic efficacy studies.
1.3 Insects in research context
1.3.1 Insect species used in immunity studies
The majority of studies in insect immunity have been conducted in drosophila. More
recently, some studies on insect immunity have been conducted in greater wax moth,
Galleria mellonella. For example, the inducible immune response was described in G.
mellonella larvae.  Inducible immune responses are not constitutively expressed and
were thought to be absent in insects. The pre-exposure of G. mellonella larvae to non-
lethal doses of  Aspergillus fumigatus conidia increased resistance to a second, lethal
dose [35]. The immune response comprised of increased hemocyte and antimicrobial
peptide concentration in the hemolymph 24 hours after the initial exposure. 
Apart from providing insight into the functional basis of animal immunity, the biggest
impact of  insect immunity studies have been on understanding the colony collapse
disorder in bees (Apis mellifera). Colony collapse disorder occurs when the majority of
worker  bees  disappear  from the beehive  leaving  behind  the food,  immature  bees,
queen and only a few nurse bees to take care of them. No single factor has been found
to be solely responsible for the disorder, but rather an interaction between pathogens
and other stress factors. More prone colonies have higher pathogen loads, are more
likely to be co-infected with different pathogens and have accumulation of coumaphos,
a pesticide used for mite control [36]. 
A  likely  factor  in  colony  collapse  disorder  is  the  extensive  use  of  antibiotics  in
apiculture.  Bee  colonies  in  the  US  have  been  prophylactically  treated  with
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oxytetracycline  for  control  of  larval  foulbrood  pathogens  Melissococcus  pluton and
Paenibacillus larvae for the last 50 years. Those colonies have accumulated antibiotic
resistance  genes  in  their  gut  microbiomes  at  high  frequencies  [37,  38].  Eight
tetracycline/oxytetracycline resistance loci,  conferring high levels of resistance, were
identified:  efflux  pump  genes  tetB,  tetC,  tetD,  tetH,  tetL,  and  tetY,  and  ribosome
protection genes tetM and tetW. The genes were rarely present in wild bee colonies
and colonies not exposed to antibiotics for at least 25 years. This demonstrates the
impact  of  long-term  antibiotic  exposure  on  an  organism  with  highly  stable,  well-
defined microbiota.
1.3.2 Using insects as scientific tools
Bees are not the only insect species exposed to antibiotics over prolonged periods of
time. The impact of dietary antibiotics on insect survival and development has been
investigated  in  the  greater  wax  moth  (Galleria  mellonella)  [35],  as  antibiotics  are
routinely added to insect culture media. Diets with penicillin, streptomycin, fluconazole
and griseofluvin decreased larval survival and increased development time between
50% and 80%. Interestingly, high concentrations of penicillin and low concentrations of
streptomycin,  fluconazole  and griseofluvin  increased the  wet  weight  of  the  larvae,
either  by  promoting  growth  or  increasing  water  retention.  The  authors  did  not
investigate the impact of the dietary antibiotics on the wax moth gut microbiota, but
nonetheless  they  demonstrated  a  significant  effect  of  these  compounds  on  insect
health. 
Insects are interesting not only in their ecological context and through their role in
agriculture but also as models for more complex organisms. Because of their small size
and  high  reproductive  rate,  insects  have  been  used  in  many  molecular,  cellular,
ecological and evolutionary studies. The fruit fly Drosophila melanogaster has been an
irreplaceable  model  in  genetics  (see review by  Bier,  2005 [39]).  Silkworm (Bombyx
mori)  and greater wax moth (Galleria mellonella) have been used for  acute toxicity
testing in vivo [40, 41]. Greater wax moth is also commonly used in virulence [42] and
antimicrobial efficacy studies [43]. The main benefit of using insects in place of other
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laboratory animals is  the reduced cost  and relatively  uncomplicated procedures.  In
many cases using insects is a more ethical way of obtaining larger datasets.
1.3.3 Interactions between plants and insects
Herbivorous insects have a close ecological  relationship with their  plant-food. Food
plants can drive speciation of insect species. For example two host plants of the stick
insect Timema cristinae have repeatedly driven speciation between the insect ecotypes
[44].  The  insects  are  endemic  to  California  and  different  ecotypes  are  adapted  to
feeding on either Adenostoma fasciculatum or Ceanothus spinosus. Genetic analysis of
the stick insects’ genome revealed repeated evolution of partial reproductive isolation
between different ecotype pairs from the same geographical locations. Plants can also
drive insect extinction events, especially through biodiversity loss [45]. Habitat loss has
been driving insect extinction in biodiversity hotspots around the world, especially that
conservation efforts are rarely aimed at preservation of insect species. 
As  mentioned  before,  insects  have  important  ecological  roles.  These  roles  are
sometimes mediated by microbes and include aiding digestion and providing essential
nutrients, detoxification of food, use of novel hosts, pathogen resistance, mediating
fertility  and temperature  tolerance,  invasiveness  and adaptive  body coloration (see
review by Feldhaar, 2011 [46]).
1.3.4 Bacteria can mediate interactions between insects and plants
The  relationship  between  herbivores  and  their  food  plants  cannot  be  considered
without  the  digestive  tract  of  microbial  symbionts.  The  symbionts  are  often  the
component  responsible  for  the  digestion  of  the  complex  plant  material.  Cellulose-
degrading microbes are responsible for 75% of the cellulose digestion in lower termites
such  as  Mastotermes  darwiniensis and  Coptotermes  lacteus [47].  The  vertically-
transmitted bacteriocyte symbiont Buchnera aphidicola of sap-feeding aphids increases
the nitrogen utilization from the insect food by synthesizing essential amino acids and
riboflavin [25]. 
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Interestingly,  bacteria  can  drive  insect  behaviour.  The  life  cycle  of  Aster  Yellows
phytoplasma strain Witches’ Broom depends on the transmission between two of its
hosts: the leafhopper  Macrosteles quadrilineatus and the plant  Arabidopsis thaliana.
The pathogen modifies  the plant  development,  inducing conversion of  flowers into
leaf-like structures [48]. This conversion attracts insect colonisation. The insects feed
on plant sap, become infected with the phytoplasma and transmit the pathogen to the
next plant they feed on. It has been demonstrated that one of phytoplasma’s virulence
proteins SAP54 selectively destabilizes transcription factors of the MADS-domain family
which  regulate  flower  development  [49].  Disturbing  the  plant  development  the
pathogen creates sterile plants and that increases insect feeding.
Other  roles  of  insect  microbiota  include  protection  from  potential  pathogens.
Fungiculture-practicing  ants  Acromyrmex  octospinosus carry  an  antibiotic-producing
actinomycete on their cuticle [50]. The actinomycete specifically supports the growth
of the fungal garden, while inhibiting the growth of fungus  Escovopsis,  a specialized
parasite of the fungus/ant symbiosis. Interestingly, fungiculture-practicing ants, beetles
and  termites  from  different  habitats  and  continents  share  similar  microbiota  [51].
Culture-independent bacteria identification techniques demonstrated that microbiota
from  these  insects  converge  not  only  functionally,  but  also  structurally.  The
microbiomes  are  primarily  compromised  of  genera  Enterobacter,  Rahnella and
Pseudomonas and  the  species  within  them  exhibit  high  degree  of  whole-genome
similarity. Such investigations into bacterial communities are only possible thanks to
recent developments in culture-independent methods in microbiology.
1.4 Microbiome diversity
1.4.1 Studying  bacteria:  from  culturing  single  isolates  to  population
studies
Microbiology was developed as a scientific discipline due to the possibility to cultivate
bacteria, which biased the studies towards culturable isolates of organisms capable of
causing disease. Only later did it become apparent that bacteria behave differently in
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vitro and in their natural habitats, where different species and ecotypes co-exist and
the  cell  density  is  much lower  [52].  An  interesting  example  is  bacteria  growing in
biofilms  –  genetically  antibiotic-susceptible  cells  are  often antibiotic-resistant  when
growing in a biofilm [53]. The extracellular matrix secreted by the bacteria forming the
biofilm protects the cells from toxic concentrations of antibiotics,  the host immune
response and other external factors. 
Developments in molecular biology techniques and sequencing technology allowed for
detailed studies of bacterial populations as they occur in nature, without the need to
culture these organisms. These developments allowed for a better understanding of
the microbiota as the interactive community of microorganisms sharing an ecological
niche. 
1.4.2 Microbiome composition and function
Cheaper sequencing and more robust data analysis allows the microbiome research to
move from simple composition studies to analysing functional data. Even though most
microbiomes are complex and spatially and temporally variable, some organisms, such
as  honey bees,  host sets  of  bacteria  that  are small  and consistent  across  different
populations. 
Worker  honey  bee  gut  hosts  nine  core  phylotypes  (defined  as  strains  with  ≥97%
sequence identity in 16S gene): two Gammaproteobacteria (Gamma-1, also known as
Gilliamella apicola, and Gamma-2), one Betaproteobacterium (Snodgrassella alvi), two
Firmicutes,  one  Bifidobacterium,  two  Alphaproteobacteria,  and  one  Bacteroidetes
(Apibacter adventoris)  [54, 55]. Genes from these core species constitute between
95% and 99% of all reads in the bee gut, but the frequencies of each phylotype in an
individual gut vary to a large extent. On an individual gut level most communities are
dominated by the two Firmicutes phylotypes, constituting over a half of reads in 80%
of the guts. Each gut also contains Gamma-1 and Snodgrassella alvi at frequencies of
up to 40%. The occurrence of Gamma-2, Alpha-2 and Bifidobacterium is high, but their
frequency  is  low.  Alpha-1  is  present  in  35%  guts  at  low  frequencies.  Apibacter
adventoris is also present rarely at low frequencies. 
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Such highly  defined and conserved composition of  a  bacterial  community  suggests
functional  specialization  of  the  microbiota.  It  was  demonstrated  that  normal
microbiota  correlates  with  the  protection  against  bacterial  [56]  and  protozoan
pathogens [57]. Shotgun metagenomic analyses of the bee microbiome revealed that
the community  is  enriched in  carbohydrate-related functions  (such as  sugar-uptake
systems), fitting to the carbohydrate-rich diet of nectar [58]. Mannose uptake systems
(mannose  phosphotransferase  systems)  were  abundant,  even  though  mannose  is
present in trace amounts in nectar. Mannose is toxic to bees suggesting a detoxifying
role of microbiota. An arabinose efflux permease gene family was also enriched and
the genes were diverse. Some of the enriched genes have homology to known drug
efflux  pumps,  including  close  homologs  to  tetracycline  efflux  pumps.  Gilliamella
apicola (Gamma-1  phylotype)  was  indicated  in  pectin  metabolism [58].  Pectin  is  a
component of the pollen primary cell wall and bees lack enzymes capable of digesting
it. The metagenomics study predicted G. apicola to be the only isolate in the bee gut
capable  of  digesting  pectin,  however  in  vitro experiments  showed  that  not  all  G.
apicola clades are capable of digesting pectin. PCR screening of the G. apicola isolates
revealed that clades lacking pectinase genes also lack the ability to degrade pectin, and
that the isolates belong to two separate phylogenetic clades.
Research into the function of non-core bee microbiota revealed that Fructobacillus and
Lactobacillus species that colonize beehives (brood cells, bee bread, and nectar), but
not bees, facilitate the colonization of bee gut by core microbiota, namely Firmicutes
and  Bifidobacteria  [58].  In  co-culture  assays  Fructobacillus isolates  facilitated  the
growth of core phylotypes above the expected cell density. Cell-free supernatant of the
Fructobacillus isolates had the same effect, suggesting that the metabolic by-products
or excretions of the culture were responsible for the effect, but the chemical nature of
the signal is not yet known.
1.4.3 Functional verification of the roles of microbiome
Metagenomic analyses allow some insight into the role of the microbiome for  host
health. The genomic approach has been applied to the study of microbial communities
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in insects but the interactions between the members have rarely been validated by
other  methods.  To  confirm  such  functional  data  an  in  vivo mechanism  of  the
interaction has to be shown. Even in simple communities the number of interactions
between the host and members of the microbial community and within the community
itself is large. 
An example of the role of bacteria in host health is Wolbachia infection of the fruitfly
Drosophila  melanogaster [59].  Wolbachia are  endosymbiotic  bacteria  that  reduce
aggressive  behaviour  in  male  fruitflies,  without  affecting  the  ability  to  fly  or  fight.
Transcriptional  analysis  revealed  that  the  bacteria  downregulate  the  octopamine
biosynthesis  pathway.  Octopamine  is  a  neurotransmitter  responsible  for  energy-
expensive behaviours, such as flying, egg-laying and jumping, and has been previously
shown to be able to alone regulate aggressive behaviour in drosophila [60]. As well as
different  levels  of  transcripts  of  octopamine  pathway  biosynthesis  genes,  different
levels of the neurotransmitter were detected in the insect heads by chromatographic
methods  [59].  However  to  fully  explain  how  the  bacteria  control  insect  gene
expression,  a  molecule  secreted by  Wolbachia would  have to be identified and its
interaction with host would have to be shown. Transcriptomic data alone only imply
correlation of Wolbachia infection and male fruitfly aggression.
Similarly, the speciation of a parasitic wasp genus Nasonia was thought to be driven by
genetic  loci  within  the  wasp  genome,  associated  with  hybrid  lethality.  It  was
demonstrated that the hybrids between different Nasonia species have higher lethality
when their microbiome is not similar to either of the parent species [61]. The lethal
phenotype  was  rescued  when  the  wasps  were  bred  in  germ-free  conditions  and
transcriptomic  data  showed  that  nearly  40%  of  the  immune  genes  were
underexpressed in  these germ-free hybrids.  This  suggests  hybrid  lethality  might  be
caused by the breakdown of host-symbiont network.
These examples demonstrate how bacteria play an important role in insect life, but the
exact mechanisms mediating the interactions are rarely known. Microbial communities
are an interesting subject to study from the ecological point, especially that bacteria
have been mostly studied as pathogens. 
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1.5 Microbiology
1.5.1 Antibiotics and antibiotic resistance
1.5.1.1 The history of antibiotics
Bacteria used to be studied primarily as the causative agent of human disease. Before
the discovery of antibiotics, bacterial diseases used to be the major cause of death,
with pneumonia, tuberculosis and enteritis responsible for nearly 40% of deaths [62].
In the 19th century infectious diseases, both bacterial and viral, used to kill 800 people
out of 100,000 per year. Advances in microbiology, especially Pasteur’s invalidation of
the theory of spontaneous generation [63] and Koch’s germ theory of disease [64],
allowed for a better understanding of  the spread of infections.  The introduction of
better  hygiene,  especially  in  hospitals,  lowered  the  incidence  of  infections.  Joseph
Lister pioneered hospital hygiene and antiseptic technique, using solutions of phenol
for  sterilisation,  in  Glasgow  Royal  Infirmary  in  1867  [65].  However,  only  the
development  of  arsphenamine  in  1909,  the  discovery  of  penicillin  in  1928  and
development of sulpha drugs in 1932 gave doctors tools to clear bacterial infections. 
These advances paved the way to what is now known as the golden era of antibiotic
discovery. Penicillin was introduced to the market in 1940s and many more antibiotics
were to follow (Figure  1-4).  All  currently  used broad-spectrum antibiotic  classes  in
primary healthcare were first brought to the market between 1940s and 1970s [66].
Importantly,  most antibiotic classes that were brought to the market recently were
discovered before the 1970s. An example of an antibiotic that was recently approved
for treatment but has been discovered in the last century is fidaxomycin. Fidaxomycin,
which  is  a  macrocyclic  antibiotic  used  to  treat  Clostridium  difficile infections,  was
discovered in 1948 and introduced to the market in 2011 [67]. 
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Figure 1.4:  Timeline of antibiotic discovery. Antibiotic classes and an example of
each class  are shown on a  timeline.  Most  antibiotic  classes  were  discovered
between  1940s  and  1960s.  Antibiotic  classes  highlighted  in  red  are  ones
reserved for second line therapies against resistant bacteria.
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Recently  developed  antibiotics  are  either  narrow  spectrum  topical  treatments  like
retapamulin, indicated for the treatment of impetigo caused by Staphylococcus aureus,
or are not available in primary health care, reserved for the treatment of the most
resistant infections, like daptomycin and linezolid. Both antibiotics are indicated for the
treatment  of  infections  caused  by  multi-drug  resistant  Gram-positive  organisms.
Interestingly, both daptomycin and linezolid are also examples of antibiotics that were
approved  for  treatment  much  later  than  they  were  discovered.  Daptomycin  was
discovered in 1986 and first marketed in 2003 and linezolid was discovered in 1955 and
first marketed in 2000 [67].
1.5.1.2 The emergence of antibiotic resistance
Whenever a new antibiotic was discovered, resistance to it would be observed soon
after  [68].  Resistance to penicillin,  introduced for  clinical  use  in  1943,  was  already
observed in 1946. Antibiotic resistance arises even to antibiotics like vancomycin that
were shown not to cause any significant resistance in vitro. Vancomycin resistance of
clinical significance was observed 31 years after the introduction of the antibiotic to
the market [69]. 
Antibacterial resistance is manifested by the ability of bacteria to grow and multiply in
the presence of an antibiotic that would normally kill them or limit their growth. It can
be caused by three different mechanisms: a target mutation where the antibiotic target
changes so that it is no longer sensitive to the compound, efflux pump which removes
the antibiotic or toxin from the bacterial cell or an antibiotic-modifying enzyme where
a  separate  protein  capable  of  deactivating  the  antibiotic  is  present.  Resistance  by
target mutation requires point mutations to arise spontaneously, while efflux pumps
and modifying enzymes are normally acquired via horizontal gene transfer.
The sequencing of bacterial genomes revealed features of bacteria that readily allow
the acquisition and spread of resistance [70]. The genomes of MRSA and VRSA revealed
antibiotic  resistance  gene  clusters  on  pathogenicity  islands  and  mobile  genetic
elements, indicating readiness to pick up resistance elements from the environment.
On  the  other  hand  P.  aerugionosa PA01  genome  revealed  many  two-component
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regulatory systems, numerous porins, and efflux pumps, suggesting extreme plasticity
of environmental responses.
1.5.1.3 Factors contributing to antibiotic resistance
Antibiotic  resistance genes are often associated with mobile  genetic  elements.  The
fitness cost of resistance genes is often surpassed by the host organism and without
that cost the antibiotic-resistant phenotype readily replaces the susceptible phenotype
(see review by Aminov and Mackie, 2007 [71]). In cases like that the bottleneck for
antibiotic  resistance spread is  the original  release of  the resistance genes which is
triggered by  a  selection  by  a  high  use  of  antibiotics.  Therefore  environments  with
historically low use of antibiotics have relatively low level of antibiotic resistance.
Apart from the intrinsic ability of antibiotic resistance genes to spread, the main factors
contributing  to  the  rise  in  antibiotic  resistance  are  overprescription  by  doctors
combined with misuse by patients, and antibiotic use in agriculture, horticulture and
animal husbandry. Antibiotic misuse in healthcare is often a result of using antibiotics
to treat viral  infections that present themselves with similar  symptoms to bacterial
disease [70]. In case of viral infections, a response to antibiotic is not mechanistically
possible.  The  only  outcome  of  such  treatment  is  deterioration  of  normal  host
microbiota. Doctors are sometimes prone to sub-optimal dosing and patients are prone
to not using prescribed antibiotics correctly, for example by not following the dosing
regimen or terminating the treatment early [70]. Furthermore some official medical
practice guidelines recommend treatments that have been shown to promote bacterial
resistance. Persistent urinary tract infections are treated with sub-inhibitory doses of
ciprofloxacin over 7 to 9 days, even though it has been demonstrated such treatment is
not  effective  and  it  selects  for  antibiotic-resistant  populations  [72].  Similarly,
cephalosporins  are  frequently  administered  to  patients  before  surgeries  for
antibacterial  prophylaxis,  resulting  in  some  patients  acquiring  coagulase-negative
staphylococci within hours of admission to the hospital [73].
In animal husbandry antibiotics are used to raise the weight and fat content of farm
animals and prevent infections, but they contribute to the spread of microbes with
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antibiotic resistance [70]. In many countries the use of antibiotics in animal husbandry
continues even after an extensive body of evidence confirmed a link between antibiotic
use and the spread of antibiotic resistance from animal farms to clinical settings [74]. In
1994 in Denmark 1000 times less vancomycin was used as a human therapeutic than
avoparcin,  a  vancomycin analog  used in  animal  feed [70].  Even though the  use of
antibiotics  for  growth promotion was banned in  the European Union in 2006 [75],
other countries still allow antibiotic use for non-medical purposes. In the US, out of
14.9 million kilograms of antibiotic sold for animal use, only 28% were used solely for
therapeutic indications [76].
1.5.2 Antibiotic resistance in the ecological context
1.5.2.1 The origin of antibiotic resistance
Interestingly, antibiotics and antibiotic resistance are not phenomena specific to the
20th and  21st centuries  and  human  antibiotic  use.  Antibiotic  resistance  pre-dates
modern  antibiotic  era.  Tetracycline  resistance  genes  were  present  in  2%  of
enterobacteria before the widespread clinical use of tetracycline [77]. It demonstrates
how antibiotic resistance was present in bacteria before the strong selective pressure
imposed by human antibiotic use was present, but also how the level was low and only
became of significance due to human activity. The primary role of antibiotic resistance
is the protection of the producing organism. Modifications of the antibiotic target or
increased efflux are necessary for  the survival  of  the antibiotic producing organism
[78]. Without the protection from the antibiotic action, the host bacteria would be
killed. 
Modern day antibiotic resistance genes have been shown to originate from ancient
genes with similar function [71, 79]. The diversity found in the gene pool originates
from an ancient diversification event. The genes only spread from the environmental
antibiotic-producing bacteria to pathogens recently in the evolutionary history. Diverse
resistance  genes  conferring  resistance  to  β-lactams,  tetracyclines  and  glycopeptide
antibiotics have been found in 30,000 years old permafrost sediments [80]. Studies on
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a vancomycin resistance gene from the sediment indicated a high level of similarity to
modern variants, suggesting that rapid emergence of clinical antibiotic resistance after
the discovery of antibiotics was caused by the selection for pre-existing genes.
1.5.2.2 The role of antibiotic resistance in ecosystems
In bacterial communities antibiotics are defence compounds and signalling molecules.
It has been shown that in Streptomyces antibiotics have a role mediating interactions
between competing strains  [81].  Antibiotics  are  present in  the environment at  low
concentrations, below their minimal inhibitory concentrations, at which they induce
transcriptional changes, such as increased virulence and biofilm formation. In response
to  cues  from  their  competitors,  Streptomyces  activate  or  increase  their  antibiotic
production and supress the antibiotic production in their competitors. Such behaviour
prevents  resource-expensive  strategy  of  constitutive  antibiotic  production  while
minimising the threat from the competitors.
Another possible origin of antibiotic resistance genes is the co-selection for antibiotic
resistant  phenotypes  by  other  factors  such  as  the  presence  of  heavy  metals.  An
example of an antibiotic resistance gene associated with a gene conferring resistance
to heavy metals is genetic element Tn21 (see review by Liebert et al., 1999 [82]). The
element  consists  of  mercury-resistance  operon,  genes  conferring  resistance  to
streptomycin, spectinomycin and sulphonamides, and is transposable. Interestingly it
was found in Japan in enterobacteria isolated in the 1950s.
Resistance phenotypes can be pleiotrophic – naturally-occurring amino acid variation
in the GyrA subunit of gyrase selected for by fluoroquinolone exposure confers the
ability to use different carbon, nitrogen and phosphate sources for growth [83]. Gyrase
is responsible for maintaining the topology of bacterial chromosome and mutations in
gyrase genes have been shown to affect transcription levels of supercoiling-sensitive
genes, many of which are stress-response genes. Specifically a substitution at position
87  of  Salmonella  enterica GyrA  lowers  antibiotic  susceptibility  to  quinolones,  β-
lactams,  folate  synthesis  inhibitors  and  aminoglycosides  [84].  The  mutation  alters
global  supercoiling  levels,  resulting  in  changes  in  transcription  of  stress-responsive
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sigma factors  rpoS,  rpoE and  rpoN.  Such response explains  why mutants  are  more
evolutionarily  successful,  because  the  mutation  is  beneficial  under  a  range  of
conditions.
1.5.3 Antibiotic resistance in the context of human antibiotic use
1.5.3.1 Significance of antibiotic resistance
As the antibiotic development pipeline dries out, antibiotic resistance becomes more
widespread.  Antimicrobial  resistance  is  a  burden  both  in  clinical  settings  and  in
everyday life. Overall first line (initial) antibiotic treatment failure in primary healthcare
increased by 12% between 1991 and 2012 [85]. Antibiotic treatment failure can be
defined  as  inefficacy  of  the  antibiotic  against  infections  it  is  indicated  for.  While
treatment  failure  stays  under  20%  for  most  commonly  prescribed  antibiotics,  the
current failure rates for trimethoprim, ciprofloxacin and cefalexin are 70.1%, 30.8% and
30.8% respectively. The economic burden (defined as a cost to the health service, the
labour market and the individual) of infectious disease in England is estimated at £30
billion each year [86].
1.5.3.2 Antibiotic discovery gap
The effectiveness of antibiotic treatment of bacterial disease diminishes as antibiotic
resistance  is  on  the  rise  both  in  incidence  and  spectrum and the  number  of  new
antibiotics  in the discovery pipeline  declines.  The last  time a broad spectrum drug
against a novel target was introduced was in 1986 when daptomycin was shown to
depolarize the cell membrane by inserting itself into the cell membrane, altering the
cell surface curvature and creating leaks. Daptomycin was only brought to market in
2003 [67]. More recently,  teixobactin has been shown to inhibit cell wall synthesis by
binding to precursors of teichoic acid, which is a novel target in antibiotic discovery
[87]. However, teixobactin has not been approved for clinical use.
This  decline  is  sometimes attributed to the shortage  of  commercial  funding  as  big
pharmaceutical companies close down their antibiotic development programs [88, 89].
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The investment in antibiotic development is rarely economically viable without private-
public partnerships and financial incentives from national governments, especially for
smaller biotechnology companies. Apart from promoting and funding collaborations,
governments  encourage  re-investment  in  antibiotic  discovery  by  extending  patent
lifetimes and guaranteeing purchase of a defined stockpile of the ready antibiotic, as is
the case with some vaccines.
Economic  incentives  might  not  be  enough  to  stimulate  re-investment  in  antibiotic
discovery.  The antibiotic  development programs were often closed as  a  result  of  a
shortage of hits from the discovery platforms over decades of research. The golden era
of  antibiotic  discovery  was  a  consequence  of  the  discovery  of  common classes  of
broad-spectrum antibiotics  that are often found in large quantities in the producer
organism  [67].  Such  compounds  are  frequently  re-discovered  in  high-throughput
screens  of  bacterial  strain  libraries  and  novel  chemical  scaffolds  are  scarcely
discovered.  As  the  antibiotic  discovery  platforms  stopped  delivering  new  hits,  the
programs were deemed unsuccessful and closed down. Hardly any information about
the closed down programs is publicly available and no definite conclusions can easily
be  drawn  from  them.  Current  antibiotic  development  programs  require  more
innovative  approaches  and  are  significantly  more  difficult  [90].  Most  common
strategies involve screening large collections of bacterial strains and screening chemical
libraries.
1.5.3.3 Reasons behind the discovery void
Antibiotics  have  a  finite  therapeutic  lifetime  due  to  antibiotic  resistance  potential
present in bacteria. Antibiotic production and the development of antibiotic resistance
are parts of evolutionary arms race between bacteria. Both antibiotic production and
resistance are under constant evolutionary pressure and lead to an effect known as
“The red queen effect” [91]. This phenomenon can be observed when an organism
needs  to  continually  evolve  just  to  keep  pace  with  its  evolving  competitors,  even
though on average their fitness remains the same [92]. The antibiotic resistance genes
evolve not only in response to changes in antibiotic production genes in other bacteria,
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but also in response to human antibiotic use. There is a constant need for discovery
and development cycles of new antibiotics if human antibiotic use is to keep pace with
bacteria and  antibiotic resistance. 
Not only have few new antibiotic classes been brought to the market since the 1970s,
but the number of companies researching them steadily declined [88]. At the moment
there are only a handful of large pharmaceutical companies researching antibiotics:
GlaxoSmithKline,  Novartis,  Allergan/AstraZeneca,  and  Merck.  Fewer  resources  are
being  devoted  to  antibiotic  research  and  development  because  they  are  not  as
profitable as other medicines. 
Antibacterials  are  as  expensive  as  other  drugs  to  develop,  yet  their  clinical  use  is
discouraged to aid antibiotic efficacy conservation. Especially in developing countries
antibiotics have to affordable. Novel drugs are often much more expensive than old
antibiotics.  A  single  course  of  fidaxomicin,  approved  for  treatment  of  Clostridium
difficile,  costs  over  £1350 while  a  more standard  treatment with vancomycin costs
about  £35 [93].  The decrease in  resources  devoted to antibiotic  discovery and the
pressure  to  keep  the  price  of  new  drugs  low  make  for  an  extremely  unattractive
economic model for antibiotic discovery programs.
Apart from the economic reasons the discovery void arises from screening libraries that
fail  to  bring  the  expected  hits  and  leads  [94],  especially  against  Gram-negative
pathogens [95]. Standard chemical libraries, most commonly used for screening against
human targets, are rarely optimised for antibiotics – they often follow the Lipinski’s
rule of five [96]. The rule is a set of guidelines for pharmacologically-active molecules
that are suitable for oral treatment in humans. The rule states a compound should
have a molecular mass of less than 500 Da, fewer than 5 hydrogen bond donors (the
total  number  of  nitrogen–hydrogen  and  oxygen–hydrogen  bonds),  fewer  than  10
hydrogen bond acceptors (all nitrogen or oxygen atoms) and the log P value (octanol-
water partition coefficient; an indication of the hydrophobicity of the compound) not
greater than 5. Antibiotics often do not fit within the rule. For example aminoglycoside
streptomycin  is  581  Da,  has  16  hydrogen  donor  bonds  and  18  hydrogen  acceptor
bonds. Even though streptomycin is readily water-soluble, it is relatively toxic at 430
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mg/kg . 
It  was  also suggested that  not  enough chemical  space is  probed to discover  novel
molecules with antibacterial activity [97]. When compared to other drugs, for example
used to treat diseases of the central nervous system, antibiotics have relatively similar
structures and properties. In theory it should be possible to identify novel chemical
scaffolds,  dissimilar  to  currently  used  ones,  with  antibiotic  properties.  However,
chemical libraries with novel scaffolds that have not been screened for antibacterial
activity are scarce.  To yield useful  new leads,  chemical  libraries need to mimic the
variety found in natural product libraries and natural product libraries need to be fused
with  combinatorial  chemistry  to  accommodate  the  human  drug  requirements  (see
Lipinski rule discussed above).
Another important aspect of the development gap in antibiotic discovery is the lack of
novel  targets  and  mechanisms  of  action  [70].  Only  a  few  processes  in  bacterial
physiology are utilised as drug targets: inhibition of cell wall synthesis and inhibition of
folate synthesis in Gram-positive bacteria, and in Gram-negative bacteria inhibition of
protein synthesis and inhibition of DNA or RNA synthesis. 
Historically cell wall synthesis inhibition and protein synthesis inhibition were the most
common strategies for antibiotic development, because they are multi-step processes
and offer many opportunities for disrupting bacterial cells. Physiological processes can
be targeted in various ways, for example protein synthesis can be interfered with at
initiation step by linezolid or at elongation step by disruption of either the 50S complex
(by  macrolides,  chloramphenicol  and  clindamycin)  or  the  30S  complex  (by
aminoglycosides  and tetracyclines)  [70].  Each of  the classes  mentioned works  by  a
different mechanism. For example macrolides inhibit peptidyl transferase by sterically
blocking  the  elongation  of  the  polypeptide  chain,  while  chloramphenicol  inhibits
peptidyl transferase by binding to it and preventing substrate binding.
1.5.3.4 Potential solutions
The scale of the resistance crisis has prompted World Health Organization (WHO) and
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local governments to action. WHO released a report in 2012 that outlined options for
action  against  antibiotic  resistance  [96]:  improved  surveillance  of  antimicrobial
resistance, measures to ensure better antibiotic stewardship, reducing antibiotic use in
animal husbandry, infection prevention and fostering innovation in antibiotic discovery.
Another  WHO  report  on  global  resistance  surveillance  in  2014  [97]  summarized
available data on the prevalence of antibiotic resistance and its health and economic
burden,  identifying  gaps  in  data  from  low  income  countries.  In  the  UK  the  Chief
Medical Officer made antibiotic resistance the focal point of the annual report in 2011
[86]. A number of recommendations for policy makers have been made, summarised in
four areas: prioritising antimicrobial resistance as a national  security risk, improving
education  and  awareness  of  appropriate  antibiotic  use,  developing  surveillance
systems for monitoring infections and antibiotic stewardship, and developing better
diagnostic  technologies  for  rapid  identification  of  the  pathogen  allowing  narrow-
spectrum treatment.
A number of consortia have been set up to tackle the problem on antibiotic resistance.
Europe’s largest public-private partnership the Innovative Medicines Initiative, a joint
project  between  European  Union  and  the  European  Federation  of  Pharmaceutical
Industries and Associations, funded a project aiming to tackle the antibiotic resistance
problem.  The  project  is  called  New  Drugs  for  Bad  Bugs
(http://www.imi.europa.eu/content/nd4bb)  and  has  a  number  of  sub-sections
spanning  a  number  of  subjects:  COMBACTE  (Combatting  Bacterial  Resistance  in
Europe)  (https://www.imi.europa.eu/content/combacte),  DRIVE-AB  (Driving  re-
investment  in  research  and  development  and  responsible  antibiotic  use)
(https://www.imi.europa.eu/content/drive-ab),  ENABLE  (European  Gram-negative
Antibacterial  Engine)  (https://www.imi.europa.eu/content/enable),  and
TRANSLOCATION  (Molecular  basis  of  the  bacterial  cell  wall  permeability)
(https://www.imi.europa.eu/content/translocation). 
Another initiative is University of Queensland’s Community of Open Antimicrobial Drug
Discovery  (CO-ADD)  which  specializes  in  screening  of  compounds  that  would  not
normally  be  screened  for  antimicrobial  activity.  The  initiative  is  funded  by  the
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Wellcome Trust and free of change for academic groups. Importantly, the results of all
screens are open-access and the ownership of the compound screened remains with
the original owner of the compound.
The  efforts  to  develop  more  antibiotics  are  not  limited  to  screening  for  novel
molecules.  A number of  alternative therapies and antibiotic  resistance breakers are
being researched, but so far there has been little success. An interesting approach has
been  targeting  bacterial  virulence  as  a  way  to  target  a  process  necessary  for
pathogenicity but non-essential to survival. To some extent the combination therapy of
clindamycin  and  penicillin  in  the  treatment  of  streptococcal  shock  syndrome is  an
example of such treatment [98] – penicillin kills the cells by inhibiting cell wall synthesis
and clindamycin prevents bacterial virulence by inhibiting protein synthesis and toxin
production.
1.5.3.5 Rational approach to plant screening for antibiotic discovery
Plants have been proposed as a potential source of novel antibiotics [99]. A number of
commercial high-throughput screens have failed to identify potent, non-toxic, broad
spectrum antimicrobials from plants [100]. They were undertaken by pharmaceutical
companies  Merck  and  Pfizer,  and  by  two  biotech  firms  Phytera  and  Shaman
Pharmaceuticals. Unfortunately the outcomes of the screens have not been published.
Only a few reports have been published as a result of medicinal plant screens. Over 60
Indian medicinal plants were screened for antibacterial activity against four bacterial
strains (E. coli,  B. subtilis,  P. aeruginosa and MRSA) with a method employing the dye
resazurin  as  an  indicator  of  bacterial  growth  [101].  Two  plant  species,  Celastrus
paniculatus and  Lobelia  nicotianifolia,  were  identified  by  the  authors  as  having
antimicrobial  activity  at  concentrations  similar  to  the  reference  antibiotics:
streptomycin and tetracycline (10-25 μg/ml), but a closer look at the data reveals that
the plant extracts were at least an order of magnitude less active than the reference
antibiotics. In another screen 1,220 Brazilian plant extracts have been tested against
Staphylococcus  aureus,  Enterococcus  faecalis,  Pseudomonas  aeruginosa and
Escherichia coli [102]. 50 plant extracts showed antibacterial  activity against one or
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more bacteria at the initial concentration of 100 μg/mL and those extracts have been
fractionated. A follow-up screen identified three anti-E. fecalis compounds lupeol, α-
amyrin and 3β-hydroxyglutin-5-ene from Symphonia globulifera [103]. 
The scarcity of data from past screens and especially the reasons for lack of commercial
success of plant-derived compounds makes it difficult to rationally design new screens.
1.5.3.6 Successful plant-derived medicines
Almost a half of drugs approved for human use between 1994 and 2007 were plant-
derived [104], yet there are no plant-derived antibiotics in clinical use. An example of a
plant-derived medicine is camptothecin, a potent inhibitor of human topoisomerase I,
used in anticancer therapy. Camptothecin is a quinoline alkaloid isolated from the stem
tissue and bark of Camptotheca acuminata, happy tree [105]. The compound binds to
topoisomerase I and DNA complex, stabilising it and leading to the formation of single
strand DNA breaks [106]. Camptothecin induces cell death when the single strand DNA
breaks  are  converted  into  lethal  double  strand  DNA  breaks  as  the  transcription
machinery collides with the topoisomerase I covalently bound to the nicked DNA [107].
Many plants  are reported to have antibacterial  activity but  only in some cases the
compound responsible for the activity has been identified, and even less frequently a
specific mechanism of action has been identified. Garlic has antimicrobial activity and
the component responsible for the activity is allicin (diallylthiosulfinate) [108] which
reacts  with  thiol  groups  of  various  enzymes  in  bacterial,  protozoan,  plant  and
mammalian cells.  Allicin is  reactive sulphur species and it  unspecifically reacts with
glutathione and cysteine residues in proteins, disrupting the cell’s redox state. Its lack
of specificity makes it unsuitable as a drug and any of the health claims are difficult to
prove.
A number of phytochemicals reported to have antibiotic activity are compounds known
as pan assay interference compounds (PAINs) [109]. They are artefacts of the screening
procedure and their activity is due to unspecific interaction between the molecule and
proteins. PAINs can interfere with the redox state of the cell,  covalently modify the
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target protein, disrupt cell membranes, sequester metal ions from target proteins, or
be chemically unstable themselves. An example is resveratrol which is listed to have a
wide impact on human health: having anticancer [110, 111] and antidiabetic properties
[112],  suppressing  angiogenesis  [113],  improving  memory  [114],  protecting  against
coronary  heart  disease  [115]  and  Alzheimer’s  disease  [116],   but  also  has  been
described as a PAIN [117].
The  lack  of  plant-derived  antibiotics  is  not  due  to  plants  lacking  antimicrobial
compounds.  An  example  of  a  successful  antimicrobial  drug  in  clinical  use  is  the
antimalarial  artemisinin  is  isolated  from  Artemisia  annua herb.  The  example  of
arteminisin illustrates a number of issues in drug discovery from plant sources. Firstly
phytochemicals  are  notoriously  difficult  to  purify.  The  purification  of  the  active
component  from  the  infusion  of  A.  annua,  used  in  traditional  medicine  for  the
treatment of malarial  fever,  was not possible. Only after ethyl  ether extraction was
utilised, the component was purified, but even then it was not identified until seven
years later [118]. The compounds are present in small quantities, often in mixtures
with other similar compounds. A hectare of  A. annua plants produces between 3.39
and 24.39 kg artemisinin [119].  Plant extracts are much more difficult to prepare and
purify  on  high  throughput  platforms,  because  of  the  small  proportion  of  active
ingredient. 
Plants grow much slower than bacteria and their genomes are less dynamic. However,
plant  genomes  are  extremely  large  with  a  proportion  devoted  to  fast-evolving
secondary  metabolism.  In  a  study  of  the  natural  variation  of  Arabidopsis  thaliana
metabolome only 13.4% metabolites were shared between different accessions [120]
revealing a diversity of phytochemicals even within single plant species. Such diversity
makes the metabolome an ideal resource for novel chemical scaffolds. 
1.6 What can we learn from the insect gut bacteria?
Interestingly, insects feeding on plants can harbour antibiotic resistant bacteria in their
guts [121].  The authors  developed a method to identify novel  antibiotic  resistance
elements by screening the metagenomic sequencing library from gypsy moth larvae
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(Lepidoptera,  Lymantia  diaspar)  for  resistance  to  antibiotics  when  plated  on  solid
media. Normally genes are identified in silico by homology to known genes and novel
genes, but such approach undersamples novel or unusual genes. 
The functional metagenomics of cultured bacteria from the gypsy moth larvae revealed
a reservoir of antibiotic resistant genes. Six different isolates were selected: two were
resistant to penicillin-type β-lactam antibiotics, another two were moderately resistant
to erythromycin and the last two were moderately resistant to a panel of antibiotics
(erythromycin, carbenicillin and chloramphenicol).   The resistance was produced by
varied  mechanisms:  efflux  pump,  extended-spectrum  β-lactamase,  and  a
transcriptional factor. Worryingly the levels of antibiotic resistance in the gypsy moth
guts were clinically relevant and readily transferable.
The  authors  hypothesised  that  the  resistance  in  the  insect  guts  could  have  been
selected for by the toxins in the insects’ food. The insect diets compromised a variety
of plant species: larch, white oak, willow, and aspen. The phenomena described in this
paper inspired us to investigate further the insect gut. Among our aims, stemming out
of this research, was to test if the antibiotic resistance observed in the gypsy moth guts
is a universal property and to test if it is correlated or linked to phytotoxins present in
the insect food.
1.7 Summary and aims
In  summary,  this  chapter  introduced  the  diversity  of  plant  secondary  metabolites,
insects  and  their  microbiomes.  I  closed  the  chapter  introducing  antibiotics  and
antibiotic resistance. It is intended as a background for three following results chapters:
“The impact of antibiotics on the gut microbiota of two lepidopteran hosts:  Plutella
xylostella and Galleria mellonella”, “Investigating antibiotic resistance in the insect gut
bacteria: the search for novel plant-derived antibacterials” and “Developing  Galleria
mellonella (Greater  wax moth)  larvae into a laboratory model:  acute  toxicity  trials,
antibiotic  susceptibility  testing and replacement of  native  gut  bacteria  with human
faecal  microbiota”.  In  these  chapters  I  will  describe  the  experimental  work  of  the
project. 
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The  main  aim  of  the  first  results  chapter  was  to  test  whether  antibiotics  in  the
lepidopteran  host's  diet  cause  the  gut  bacteria  to  acquire  antibiotic  resistance.
Specifically I tested whether the insect gut bacteria acquire single-antibiotic and multi-
antibiotic resistance after  exposure to either ciprofloxacin or oxytetracycline.  In the
second results chapter I wanted to test if the antibiotic resistance present in the insect
gut can be induced by the plant-derived toxins present in the insect food and if we can
utilize the resistance to these toxins in assay-guided purification of the plant extracts.
Finally the aim of the last chapter was to assess the usefulness of  G. mellonella in
toxicity testing and antibiotic efficacy assays.
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2 Materials and methods
2.1 Media and solutions
2.1.1 Solutions
Alkaline PEG reagent: Mix 60 g poly(ethylene glycol) 200 (Sigma-Aldrich), 0.93 mL 2 M
KOH, and 39 mL distilled water. Adjust pH to 13.3 – 13.5 with KOH. Store at -4°C.
PBS buffer: Add 8.0 g/L NaCl, 0.2 g/L KCl, 1.44 g/L Na2HPO4 and 0.24 g/L KH2PO4 to
MiliQ water (Merck). The ready solution should have a pH of 7.4 when the correct
ratios  of  phosphates  are  used.  If  necessary,  carefully  adjust  pH  to  7.4  with  KOH.
Sterilize by autoclaving for 20 minutes at 121°C. 
PBS/tergitol: Prepare PBS as described above. Sterilize by autoclaving for 20 minutes at
121°C. Add 0.5% (w/v) tergitol and sterilize the solution by filtration through Minisart
syringe filters (16532-K, Sartorius Stedim).
TAE agarose: Use 50× TAE base (Formedium; final concentrations: 40 mM TRIS base, 20
mM acetic acid, 1 mM Na2EDTA) with 1.0 or 1.8% agarose (w/v). 1.0% agarose gels
were used for 16S PCR products and 1.8% agarose gels were used for tet-resistance
PCR products. 
2.1.2 Media
Lysogeny  Broth  (LB)  medium:  Use  LB  base  (LMM0202,  Formedium;  final
concentrations: 1% (w/v) tryptone, 0.05% (w/v) yeast extract, 1% (w/v) NaCl). Adjust
pH to 7.0 with HCl.  For solid media add 1% agar (AGA03,  Formedium).  Sterilize by
autoclaving for 20 minutes at 121°C.
LBG: Supplement LB medium with glucose at 20 g/L (G8270, Sigma Chemicals). Sterilize
by autoclaving for 20 minutes at 121°C.
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MacConkey Agar: Use MacConkey Agar base (212123, Difco; final concentrations: 17.0
g/L  pancreatic  digest  of  gelatin,  3.0  g/L  peptone  from  meat  and  casein,  10.0  g/L
lactose, 1.5 g/L bile salts no. 3, 5.0 g NaCl, 13.5 g/L agar, 0.03 g/L neutral red, 1.0 mg/L
crystal violet) according to the manufacturer’s instructions. Adjust pH to 7.1 with HCl.
Sterilize by autoclaving for 20 minutes at 121°C.
Mueller-Hinton  Agar:  Use  Mueller-Hinton  Agar  base  (105437,  Merck;  final
concentrations: 2.0 g/L meat infusion, 17.5 g/L casein hydrolysate, 1.5 g/L starch, 13.0
agar)  according to the manufacturer’s instructions. Adjust pH to 7.2 -  7.6 with HCl.
Sterilize by autoclaving for 20 minutes at 121°C.
Reinforced Clostridia Agar (RCA): Use Reinforced Clostridia Broth base (27546, Sigma
Chemicals; final concentrations: 3.0 g/L yeast extract, 10.0 g/L Lab-Lemco powder, 10.0
g/L  peptone,  5.0  g/L  glucose,  1.0  g/L  soluble  starch,  5.0  g/L  NaCl,  3.0  g/L  sodium
acetate, 0.5 g/L cysteine hydrochloride) according to the manufacturer’s instructions.
Add  1%  (w/v)  agar  (AGA03,  Formedium).  Adjust  pH  to  6.8  with  HCl.  Sterilize  by
autoclaving for 20 minutes at 121°C.
Tryptic  Soy  Agar  (TSA):  Mix  17.0  g/L  peptone  from  casein,  3.0  g/L  peptone  from
soymeal, 2.5 g/L glucose, 5.0 g/L NaCl, 2.5 g/L K2HPO4, and 10 g/L agar in MiliQ water
(Merck). Adjust pH to 7.3 with HCl. Sterilize by autoclaving for 20 minutes at 121°C.
TY agar: Add 6 g/L tryptone, 3 g/L yeast extract, 0.38 g/L CaCl2, and 10 g/L agar to
MiliQ water (Merck). Adjust pH to 7.0 with HCl. Sterilize by autoclaving for 20 minutes
at 121°C.
2.1.3 Test compounds
Toxicity testing:  Adenosine triphosphate, carbenicillin, chloramphenicol, chloroquine,
ciprofloxacin,  etoposide,  glucose,  glutamic  acid,  novobiocin,  sodium  chloride,
streptomycin S6501, and tetracycline were supplied by Inspiralis Ltd. at 25 mg/ml in
50% DMSO in  water  (Table 2-1). Due to insolubility issues, amsacrine was supplied at
8 mg/ml in 50% DMSO in water, kanamycin was supplied at 25 mg/ml in 25% DMSO in
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water, and norfloxacin was supplied at 25 mg/ml in 50% DMSO in water with 50 mM
KOH in the final  concentration.  Doxurubicin was only  available as  a  liquid and was
supplied at 5.5 mg/ml in 50% DMSO in water. A tube of pure 50% DMSO in water was
also supplied. All  compounds were supplied in numbered tubes without compound
names to avoid bias in the experiment. The identity of the compounds was assigned
only when the testing procedure was finished and the data from  Galleria mellonella
was  compared  to  material  safety  data  sheet  (MSDS)  pages  available  with  the
compounds.
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Table 2.1: The identity of compounds in the trial. The compounds were made at 25 mg/mL in
50% DMSO in water unless indicated otherwise.
Compound name Stock solution
concentration
[mg/mL]
Notes
Adenosine triphosphate 25
Amsacrine 8 Made at 8 mg/ml as precipitated at 25 
mg/ml
Blank: 50% DMSO in water 0
Carbenicillin 25
Chloramphenicol 25
Chloroquine 25
Doxurubicin 5.5 Only liquid available, made at 5.5 
mg/ml
Etoposide 25
Glucose 25
Glutamic acid 25
Kanamycin 25 Dissolved in 25% DMSO in water as 
precipitated in 50%
Norfloxacin 25 Made in 50% DMSO in water with 50 
mM KOH
Novobiocin 25
Sodium chloride 25
Streptomycin  S6501 25 Dissolved in 25% DMSO in water as 
precipitated in 50%
Tetracycline 25
Antibiotic  efficacy  testing:  Ampicillin,  ciprofloxacin,  rifampicin  and  tetracycline  for
efficacy testing were obtained from Sigma Chemicals. 
Determination of minimal inhibitory concentration: Vindoline, loganin, ajmalicine and
catharanthine were obtained from Sigma Chemicals and resuspended in ethanol at 5
mg/mL. 
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2.2 Insect methods
2.2.1 Insect husbandry
Plutella xylostella and Galleria mellonella were the only insects reared in the lab by us.
All other insects were collected and dissected on the same day or reared in the JIC
Insectary by the Insectary staff.
Plutella xylostella: Second to fourth instar P. xylostella larvae were obtained from the
JIC Insectary. The larvae were kept at room temperature in standard Petri dishes (90
mm, Sterilin) with four 5×5×5 mm cubes of artificial food. The food was replaced daily.
Galleria mellonella: A colony of G. mellonella was obtained from the JIC Insectary. The
colony was kept in the dark at 30°C for antibiotic feeding procedure (see Chapter 3)
and toxicity  testing,  and at  37°C for  antibiotic  efficacy testing (see Chapter 5).  The
larvae were kept in large Petri dishes (140 mm, Sterilin) filled with artificial food to
burrow through. The food was replaced at least once per week, unless not enough was
left for the larvae to feed on, in which case more food was added to the containers.
2.2.2 Artificial food
Plutella xylostella  food: General Purpose Diet for Lepidoptera (soy and wheat germ
based;  F9772,  Frontier  Agricultural  Services)  was  prepared  according  to  the
manufacturer’s instructions. Antibiotics were added to the agar base of the diet before
mixing  with  the  rest  of  ingredients.  Ciprofloxacin  was  added  at  a  range  of
concentrations: 1 µg/mL final food volume, 3 µg/mL, 10 µg/mL and 30 µg/mL, and
oxytetracycline  was added at  a  single  concentration 3  µg/mL.  The food was set  in
square petri dishes (100 mm, Sterilin), cut to 5×5×5 mm cubes, and stored in sealed
containers at 4°C when not used. 
Galleria  mellonella  food:  The  artificial  food  was  composed  of  300  mL  honey
(Sainsbury's  Honey,  Clear),  400  mL  glycerol  (G5516,  Sigma  Chemicals),  200  g  milk
powder  (Dried  Skimmed  Milk  Powder,  Marvel),  200  g  wholemeal  flour  (Strong
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Stoneground  100%  Wholemeal  Flour,  Sainsbury’s),  100  g  yeast  powder  (103753,
Merck), 100 g wheat germ (Neal’s Yard Wholefoods Natural Wheatgerm) and 400 g
bran (Neal’s Yard Wholefoods Natural Wheat Bran). First, the dry and wet ingredients
were mixed separately, and then the mixtures were mixed together. The diet was mixed
with beeswax pellets at a 2:1 ratio. Unused food was stored at 4°C. Oxytetracycline
(OTC) was added to the glycerol batches at 1 mg/100 g diet dry weight, 10 mg/100 g
diet dry weight, 100 mg/100g diet dry weight, 400 mg/100 g diet dry weight and 1000
mg/100 g diet dry weight. The food was prepared fresh at least once per week.
2.2.3 Collection of insects
These insects were collected as plant-insect pairs (see Chapter 4). Two adult giant lime
green stick insects (Diapherodes gigantea) were collected from the JIC Insectary after
they had died of old age. The insects were immediately frozen and stored at -20°C until
dissection.  Five  Plutella  xylostella larvae,  ten  death’s  head  hawkmoth  larvae
(Acherontia  atropos)  and  ten  beet  army  worm  (Spodoptera  exigua)  larvae  were
obtained from the JIC Insectary. Eleven cinnabar moth larvae (Tyria jacobaeae) were
collected from the playing fields of  University of  East  Anglia.  Ten rosemary beetles
(Chrysolina americana)  were collected from lavender  plants on the JIC  site.  Where
possible the insects were starved for two hours before dissection to enrich the gut
contents  in  bacteria.  The  insects  were  flash  frozen  in  liquid  nitrogen  and  surface
sterilized in 70% ethanol with a subsequent rinse in distilled water.
2.2.4 Insect dissection
Galleria mellonella dissections: All steps of the procedure were carried out on ice and
in a biological safety cabinet. A sterile Petri dish was used as a dissecting surface. One
larva was dissected at a time, to prevent defrosting of the samples. The head of a larva
was  cut  off,  while  the  insect  was  stabilized  with  forceps.  While  still  stabilizing  the
insect, an incision was made down the abdomen on the ventral side of the body using
a  sterile  razor  (Figure  2-1).  The  gut  contents,  which  are  brittle  when frozen,  were
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carefully picked out using fresh sterile forceps and placed in a sterile, pre-weighed 2 mL
tube. Three guts per tube were collected. 
Rosemary  beetle  (Chrysolina  americana)  gut  sample  preparation:  The  rigid
exoskeleton of the beetles prevented accurate dissection of the gut contents. Instead
whole insects were homogenized with sterile micropestles in 1.5 mL Eppendorf tubes
with 200 µL PBS buffer. 
Other insect dissections: All steps of the dissection procedure were carried out in the
biological  safety  cabinet.  A  sterile  Petri  dish was used as  a  dissecting  surface.  The
general procedure followed is shown in Figure 2-1. Using a sterile razor and stabilizing
the insect using sterile forceps the head of the insect was cut off. Still stabilizing the
insect body, an incision was made on the ventral side starting at the previous cut and
running  down  the  length  of  the  body.  The  gut  was  identified  as  a  large  tubular
structure running along the body. Where possible the gut tissue was cut open and the
frozen gut contents were collected. In other cases the entire gut was removed. Care
was taken not to confuse the insect gut with other internal body structures, such as the
Malphigian tubes, which can resemble the mammalian gut.
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2.2.5 Experimental procedures
Plutella  xylostella feeding  procedure:  Third  and  fourth  instar  P.  xylostella larvae
feeding on cabbage were collected from the JIC insectary. The larvae were divided in
groups of five and each group was supplied with different food: artificial food with no
antibiotic or artificial food with a dose of an antibiotic. The antibiotic doses were: 1
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Figure 2.1: A schematic of general dissection procedure. Prior to dissection, the insects were
euthanized by immersion in liquid nitrogen. All procedures were performed on ice and under
sterile conditions. a) Decapitate the insect. b) Make an incision down the abdomen of the
insect. c) Open the body cavity separating the insect tissues (yellow) from the gut contents
(brown). d) pick the gut contents with sterile forceps and place in an Eppendorf tube.
a) b)
c) d)
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µg/mL  ciprofloxacin,  3  µg/mL  ciprofloxacin,  10  µg/mL  ciprofloxacin,  30  µg/mL
ciprofloxacin, and 3 µg/mL oxytetracycline. Fresh artificial food was supplied daily for
three days. After three days the larvae had their guts dissected.
Galleria mellonella feeding procedure. The colony was divided into six groups, each
group  feeding  on  a  different  diet.  Ten  fifth  instar  larvae  were  collected  for  gut
dissection as described above. The remaining ones were moved to larger containers to
pupate. The pupae were moved to clean containers to pupate and the moths were
supplied with honey solution. The moths laid eggs along the edges of the lining of the
container. Eggs were collected and placed on fresh food with or without antibiotics.
This  procedure was  followed for  five  generations.  Larval  mortality  was high  in  the
groups feeding on 10 mg OTC/100 g diet or more, leading to cases when no individuals
feeding on those oxytetracycline concentrations were left. In such cases, a new colony
was established from antibiotic-free larvae on the appropriate antibiotic diet. 
Galleria mellonella injection procedure:  Five to ten larvae (250-320 mg each) were
selected at random for each step in the procedure. Any larva with darkening of the
cuticle was discarded. The test compounds were injected into the hemocoel in DMSO
or PBS buffer through the last left proleg (Hamilton syringe 701N, volume 10 μL, needle
size 26s, cone tip) unless stated otherwise. The larvae were placed on medical tissues
(Kimtech) to stop hemolymph leaking. The larvae were incubated in the dark for 5 days
and mortality was recorded daily. 
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Figure 2.2: A flowchart  representing consecutive steps in the acute toxicity test. A starting dose
of 5 mg/kg body weight was administered and the insects were scored for mortality. If the
mortality was over 40%, the compound is assigned the highest toxicity class. If the mortality is
below 40%, the dose was re-tested and the testing continued until a toxic dose was established.
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100%  DMSO  toxicity  testing  procedure:  A  flowchart,  adapted  from  the  OECD
guidelines for acute toxicity [122], was used to select the toxic dose of test compounds
(Figure2-  2).  The acute toxicity testing was started by injecting five larvae with the
initial dose of a compound (5 mg/kg body weight). Larvae mortality was recorded daily.
If  three or more larvae died, the compound was assigned the highest toxicity class
(GHS  1).  If  three  or  more  larvae  survived  for  five  days,  the  toxicity  testing  was
continued by re-testing the initial  dose (5 mg/kg body weight)  on a new cohort of
larvae. If three or more larvae of the second cohort survived, a higher dose (25 mg/kg
body weight) was tested in five fresh larvae. The experiment was continued until  a
toxic dose was established. If a compound was not toxic at the highest tested dose
(2000 mg/kg body weight), the compound was classified as non-toxic. The obtained
toxic dose was compared to a dose reported in Material Safety Data Sheet (MSDS) page
for the compound. Where possible the reported value used for the comparison was
from mouse or rat via an intraperitoneal injection, when such data were absent the
data  from  oral  toxicity  tests  in  a  mammalian  system  were  used.  Each  step  in  the
procedure  included  three  control  groups:  untreated  control,  traumatized  control
(cuticle was pierced with a needle) and buffer-injected control.
Low-DMSO toxicity testing procedure: A second round of testing was conducted to
control  for  DMSO toxicity.  Ciprofloxacin,  sodium chloride,  tetracycline,  glucose  and
streptomycin solutions were prepared with PBS buffer and tested by an intraperitoneal
injection on G. mellonella at 300 and 2000 mg/kg body weight. Five larvae were used
per test group. The test doses of the compounds in PBS buffer were injected into the
hemocoel of the larvae as described before. The mortality was recorded daily for five
days until a toxic dose was established.
Determination of the infective dose of bacteria to  Galleria mellonella: An infective
dose  of  bacteria  was  determined  by  injecting  groups  of  five  larvae  with  bacterial
suspension at 5×104 colony forming units (cfu) per injection, 5×105 cfu, 5×106 cfu and
5×107 cfu. The larvae were incubated for five days.  An infective dose was one that
caused  an  immune  response,  recognizable  by  the  darkening  of  the  cuticle.  In  G.
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mellonella larvae immune response leads to the formation of melanin plaques around
bacteria  immobilized  by  the  cells  of  immune  system.  These  plaques  appear  dark
through the cuticle. An infective dose of bacteria was one that caused 60-80% lethality
within 48 h, but not 100% lethality within 24 h. The larvae were incubated at 37°C as
bacterial  virulence changes  with temperature  and the experiment was designed to
mimic infection in humans.
Antibiotic efficacy testing in  Galleria mellonella:  A flowchart was used to assign an
antibiotic therapeutic dose against a panel of bacteria (Figure 2-3). For the antibiotic
efficacy  experiment  five  larvae  were  injected  into  the  last  left  proleg  with  a  pre-
determined infective dose of bacteria and incubated for two hours at 37°C. After the
incubation the larvae were injected in the last right proleg with the lowest dose of
antibiotic (5 mg/kg body weight) and returned to incubation at 37°C. The mortality was
recorded daily for five days. If three or more larvae survived, the lowest dose was re-
tested and the lowest antibiotic dose was assigned as therapeutic. If three or more
larvae died, the antibiotic was tested against the same infective dose of bacteria at a
higher dose (25 mg/kg body weight). The experiment was continued until a therapeutic
dose was assigned or an antibiotic was ineffective against the infection. The values
obtained were compared to values recommended for human use [123]: ampicillin – 50-
200 mg/kg body weight/day, ciprofloxacin – 10-15 mg/kg body weight/day, tetracycline
– 25-50 mg/kg body weight/day and rifampicin – 10-20 mg/kg body weight/day. Each
step in the procedure included three control groups: untreated control, traumatized
control (cuticle was pierced with a needle) and buffer-injected control.
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Figure  2.3:  A  flowchart   representing  consecutive  steps  in  the  antibiotic  efficacy  test.  A
flowchart  representing consecutive steps in the antibiotic efficacy test. A starting dose of 5
mg/kg body weight was administered and the insects were scored for survival. If the mortality
was under 40%, the compound was assigned the lowest therapeutic dose. If the mortality was
over 40%, a higher dose was tested until a therapeutic dose was established.
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Artificial food for replacing native microbiota with baby gut bacteria:  Faecal slurry
(gift from Lindsay Hall, Institute of Food Research) was prepared by homogenizing of
6.3 g baby V3 faeces and 18 mL of sterile PBS with sterile glass beads. The suspension
was filtered through 40 µm filters and 3 mL solution was mixed with 15 g insect food.
The food was replaced at least every 2-3 days. When not used the faecal slurry was
stored at -80°C.
Procedure for replacing native microbiota with baby gut bacteria: Two groups of 36
third instar larvae were obtained from the JIC Insectary: a group feeding on artificial
food with slurry  and a control  group.  Nine larvae were collected from each group
before the beginning of the feeding procedure. The larvae were supplied with artificial
food and artificial food with faecal slurry. After three days nine larvae were collected
from each group and fresh artificial food with and without faecal slurry was supplied to
the remaining insects. After one more day a further nine larvae were collected from
each group and fresh artificial  food was supplied again.  After  seven days from the
beginning of the experiment the remaining larvae were dissected. 
2.3 Microbiology
2.3.1 General procedure for identifying insect gut bacteria
Culturing of insect gut bacteria: The gut contents were suspended in 200 µL PBS buffer
and diluted 10, 100 and 1000 times. 50 µL of each dilution were plated on LB, LBG and
TSA  media.  The  plates  were  incubated  for  one  to  three  days  at  30°C  in  aerobic
conditions.  The  isolates  were  streaked  out  on  fresh  agar  plates  and  incubated  as
before. This ensured the purity of the bacterial isolates before identification.
Identification of bacteria: Each isolate was identified using 16S PCR with alkaline PEG
reagent  using  63f  and  1389r  primers  (5'  CAGGCCTAACACATGCAAGTG  3'  and  5'
ACGGGCGGTGTGTACAAG  3')  and  Taq DNA  polymerase  (28104,  Quiagen).  Single
colonies were picked from an agar plates and resuspended in 500 µl distilled water. The
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samples were spun down at 6000 rpm for 4 minutes. Without disturbing the pellets,
490 µl sample was removed and 100 µl alkaline PEG reagent was added. The samples
were mixed well by pipetting and incubated for 15 minutes at room temperature. 1 µl
was added to the Taq PCR mix, prepared according to the manufacturer’s instructions.
Reactions  were  carried  out  in  a  PTC-200  Thermo  Cycler  (MJ  Research).  The  initial
denaturation  was  carried  out  for  10  minutes  at  95°C,  followed  by  30  cycles  of
denaturation (95°C for 1 minute), annealing (57°C for 1 minute), and extension (72°C
for 2 minutes). The final extension was carried out at 72°C for 10 minutes. The PCR
products were soaked at 10°C until further use. The PCR products were separated on
1% agarose TAE gels and purified using QIAquick PCR Purification Kit (28104, Qiagen).
DNA was sequenced using a BigDye v3.1 kit (Applied Bioscience) in a 10 μL reaction
volume.  Reactions  contained  BigDye  3.1  mix,  1x  reaction  buffer,  50-100  ng  DNA
template  and  20  μM  sequencing  primer.  Reactions  were  carried  out  in  a  PTC-200
Thermo Cycler (MJ Research). The initial denaturation was carried out for 1 minute at
95°C, followed by 30 cycles of denaturation (95°C for 30 seconds), annealing (45°C for
15 seconds), and extension (60°C for 4 minutes). The final extension was carried out at
72°C for 10 minutes. The PCR products were soaked at 10°C until  further use.  The
samples were sent to The Genome Analysis Centre for processing.  Sequencing data
were returned in the form of .txt and .abi chromatogram trace files. The sequences
were  trimmed  to  remove  poorly  recognized  bases  and  run  through  the  blastn
algorithm  (http://blast.ncbi.nlm.nih.gov/Blast.cgi)  against  “Nucleotide  collection
(nr/nt)” database. Bacteria were identified if the sequence was ≥97% similar to 16S
RNA gene in the database and had an e-value close or equal to 0.
Table 2.2: Origin and summary of the type strains used. Pathogenicity group 1 are not a hazard
to human health, but pathogenicity group 2 bacteria are opportunistic human pathogens.
Species name Collection
number
Collection source pathoge
nicity
group
Gram 
stain
Bacillus 
amyloliquefaciens 
ATCC
23350
CRBIP soil 1 positive
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Species name Collection
number
Collection source pathoge
nicity
group
Gram 
stain
Bacillus aquimaris DSM
16205
DSMZ sea water of a tidal 
flat
1 positive
Bacillus 
licheniformis 
ATCC
14580
DSMZ soil 1 positive
Bacillus subtilis ATCC 6051 HPA boiled hay infusion 1 positive
Bacillus 
vietnamensis 
DSM
18898
DSMZ vietnamese fish sauce 1 positive
Burkholderia 
fungorum 
CIP
107096T
CRBIP fungus 2 negative
Enterobacter 
amnigenus 
ATCC
33072
HPA soil 2 negative
Enterobacter 
asburiae 
ATCC
35953
DSMZ lochia 2 negative
Escherichia coli ATCC
25922
HPA human 2 negative
Kocuria rhizophila ATCC BAA-
50
CRBIP rhizosphere of Typha 
angustiflora
1 positive
Microbacterium  
foliorum
DSM
12966
CRBIP phyllosphere of 
grasses
1 positive
Microbacterium 
gubbeenense 
DSM
15944
DSMZ surface of a smear-
ripened cheese
1 positive
Microbacterium 
oxydans 
DSM
20578
CRBIP air 1 positive
Microbacterium 
paraoxydans 
DSM
15019
DSMZ human blood 2 positive
Pantoea 
agglomerans 
ATCC
27155
DSMZ knee laceration 2 negative
Pseudomonas 
putida 
ATCC
12633
DSMZ soil 2 negative
Raoultella 
terrigena 
ATCC
33257
CRBIP drinking water 1 negative
Rhizobium pusense DSM
22668
DSMZ rhizosphere soil of 
chickpea
1 negative
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Species name Collection
number
Collection source pathoge
nicity
group
Gram 
stain
Rhodococcus 
erythropolis 
ATCC 4277 CRBIP soil 1 positive
Sanguibacter 
keddieii 
ATCC
51767
CRBIP bovine blood 1 positive
Sphingobacterium 
multivorum 
ATCC
33613
CRBIP human spleen 2 negative
Staphylococcus 
epidermidis 
ATCC
14990
CRBIP human nose 2 positive
Staphylococcus 
warneri 
ATCC
27836
CRBIP human skin 1 positive
Type strains.  For each identified gut-isolated strain a corresponding type strain was
obtained  from  one  of  the  following  culture  collections:  Centre  de  Resources
Biologiques  de  l'Institut  Pasteur  (Paris),  Health  Protection  Agency  (Salisbury)  or
Deutsche Sammlung von Mikroorganismen und Zellkulturen (Brunswick). The strains
obtained were: Bacillus amyloliquefaciens ATCC 23350, Bacillus aquimaris DSM 16205,
Bacillus  licheniformis ATCC 14580,  Bacillus  subtilis ATCC 6051,  Bacillus  vietnamensis
DSM 18898, Burkholderia fungorum CIP 107096T, Enterobacter amnigenus ATCC 33072,
Enterobacter  asburiae ATCC  35953,  Escherichia  coli ATCC  25922,  Kocuria  rhizophila
ATCC  BAA-50,  Microbacterium  foliorum DSM  12966,  Microbacterium  gubbeenense
DSM 15944,  Microbacterium oxydans DSM 20578,  Microbacterium paraoxydans DSM
15019,  Pantoea  agglomerans ATCC  27155,  Pseudomonas  putida ATCC  12633,
Raoultella  terrigena ATCC  33257,  Rhizobium  pusense DSM  22668,  Rhodococcus
erythropolis ATCC  4277,  Sanguibacter  keddieii ATCC  51767,  Sphingobacterium
multivorum ATCC 33613, Staphylococcus epidermidis ATCC 14990, and Staphylococcus
warneri ATCC 27836. The origin of each strain is given in Table 2-2. Strains classified as
type  2  pathogens  were  handled  according  to  JIC  Standard  Operating  Procedure
“Culturing Hazard Group 2 bacteria from insect guts”.
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2.3.2 Methods used for Galleria mellonella
Culturing of gut bacteria: 250 µl PBS/tergitol was added to each tube. Each tube was
disrupted in a FastPrep FP120 instrument (Qbiogene) for 45 s, five times. 50 µl of neat
suspension, 1:200 dilution and 1:4000 dilution were plated on LB, RCA and MacConkey
media. The plates were incubated for 24-48 h at 30°C in aerobic (LB and MacConkey
media) and anaerobic (RCA) conditions.
Culturing  of  bacteria  for  antibiotic  efficacy  testing:  Escherichia  coli (ATCC  25922),
Mycobacterium smegmatis (ATCC 700084), Pseudomonas aeruginosa (ATCC 15692) and
Staphylococcus aureus (ATCC 29213) were grown from glycerol stocks in LB broth at
37°C.
Identification of tetracycline resistance elements.  The gut samples with large gDNA
fragments  were  subjected  to  diagnostic  PCRs  to  establish  if  tetracycline  genes  are
present.  Ex  Taq  DNA  polymerase  (Clontech-Takara)  was  used  in  a  25  μL  reaction
volume,  containing  10  ng  template  DNA.  All  reactions  were  carried  out  in  a
Mastercycler nexus X2 (Eppendorf). The initial denaturation was carried out at 94°C for
10 minutes, followed by 35 cycles of denaturation (94°C for 30 seconds),  annealing
(variable  temperature  for  1  minute),  and extension (72°C for  2  minutes).  The  final
extension was carried out at 72°C for 10 minutes. The PCR products were soaked at
10°C until further use. The primers used are summarised in Table 2-3.
Table 2.3: A list of primers used to identify tet-resistance genes
Primer Target 
gene
Sequence (5'-3') size 
(bp)
Reference
1 63f 16S 
rRNA
CAGGCCTAACACATGCAAGTG ~500 Weisburg 1991[124]
1389r ACGGGCGGTGTGTACAAG
2 TetA-F tetA GCTACATCCTGCTTGCCTTC 210 Fan et al. 2007 
[125]TetA-R CATAGATCGCCGTGAAGAGG
3 TetB-F tetB TTGGTTAGGGGCAAGTTTTG 659 Fan et al. 2007 
[125]TetB-R GTAATGGGCCAATAACACCG
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Primer Target 
gene
Sequence (5'-3') size 
(bp)
Reference
4 TetC-F tetC CTTGAGAGCCTTCAACCCAG 418 Fan et al. 2007 
[125]TetC-R ATGGTCGTCATCTACCTGCC
5 TetD-F tetD GAATGCCTGCACCTTTCTGATG 346 Fan et al. 2007 
[125]TetD-R GGCAATAAATCCGGCGAAAA
6 TetE-F tetE TCGGGATTGTTAGTTGTCTTTTTC 549 Fan et al. 2007 
[125]TetE-R GTGGATTACCCTACCTGGATGGA
7 TetG-F tetG GCTCGGTGGTATCTCTGCTC 468 Fan et al. 2007 
[125]TetG-R AGCAACAGAATCGGGAACAC
8 TetH-F tetH GTGATGTGACTCCCGCTAAAAAT 407 Fan et al. 2007 
[125]TetH-R CCAGAACCGCCAAAGACATACC
9 TetJ-F tetJ ACAGACTCGCCAATCATTACGGTA 300 Aminov et al. 2002, 
2004 [126, 127]TetJ-R GCACCACCCAAAAAACCGAAAT
10 tetL_121F tetL CCGGCGAGTACAAACTGGGTGA 215 Tian et al., 2012 
[37]tetL_335R GCAGCTGCACCAGCTCCTTGAAT
11 tetL_363F tetL GCGCCTCTGCGAAAGGTACGC 631 Tian et al., 2012 
[37]tetL_994R GCGCGCAACTACAACCATCACGAG
12 TetY-F tetY ATTTGTACCGGCAGAGCAAAC 181 Aminov et al. 2002, 
2004 [126, 127]TetY-R GGCGCTGCCGCCATTATGC
13 TetZ-F tetZ CCTTCTCGACCAGGTCGG 204 Aminov et al. 2002, 
2004 [126, 127]TetZ-R ACCCACAGCGTGTCCGTC
14 Tet30-F tet30 CATCTTGGTCGAGGTGACTGG 210 Aminov et al. 2002, 
2004 [126, 127]Tet30-R ACGAGCACCCAGCCGAGC
15 TetBP-F tetBP AAAACTTATTATATTATAGTG 169 Aminov et al. 2001, 
2004 [126, 127]TetBP-R TGGAGTATCAATAATATTCAC
16 TetM-F tetM ACAGAAAGCTTATTATATAAC 171 Aminov et al. 2001, 
2004 [126, 127]TetM-R TGGCGTGTCTATGATGTTCAC 
17 TetO-F tetO ACGGARAGTTTATTGTATACC 171 Aminov et al. 2001, 
2004 [126, 127]TetO-R TGGCGTATCTATAATGTTGAC 
18 TetQ-F tetQ AGAATCTGCTGTTTGCCAGTG 169 Aminov et al. 2001, 
2004 [126, 127]TetQ-R CGGAGTGTCAATGATATTGCA 
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Primer Target 
gene
Sequence (5'-3') size 
(bp)
Reference
19 TetS-F tetS GAAAGCTTACTATACAGTAGC 169 Aminov et al. 2001, 
2004 [126, 127]TetS-R AGGAGTATCTACAATATTTAC 
20 TetT-F tetT AAGGTTTATTATATAAAAGTG 169 Aminov et al. 2001, 
2004 [126, 127]TetT-R AGGTGTATCTATGATATTTAC 
21 TetW-F tetW GAGAGCCTGCTATATGCCAGC 168 Aminov et al. 2001, 
2004 [126, 127]TetW-R GGGCGTATCCACAATGTTAAC 
22 Tet32-F tet32 TCGACCTACAGCGTGTTTACC 277 Aminov et al. 2001, 
2004 [126, 127]Tet32-R CTAATAGTTCATCGCTTCCGG 
23 Tet34-F tet34 TGCTGAAAAACAGATGCCAG 212 Szczepanowski et 
al., 2009 [128]Tet34-R TAACCTTCGCCATCACCTTC
24 tetX-1 tetX, 
tetX2
TTAGCCTTACCAATGGGTGT 242 Bartha et al., 2011 
[129]tetX-2 CAAATCTGCTGTTTCACTCG
25 tetX1-1 tetX TCAGGACAAGAAGCAATGAA 149 Bartha et al., 2011 
[129]tetX1-2 TATTTCGGGGTTGTCAAACT
2.3.3 Metagenomic analyses
gDNA  isolation.  The  genomic  DNA  (gDNA)  was  isolated  from  the  lysed  larval  gut
samples using FastDNA SPIN Kit for Soil (MP Biomedicals). 50 µL larval gut sample was
added to the lysing matrix tube with 978 μL PBS buffer and 122 μL MT buffer. The
samples were homogenized in FastPrep instrument for  3 minutes at  setting 6.  The
tubes were then centrifuged at 13,000 rpm for 15 minutes to pellet the cell wall debris.
The supernatant was transferred to clean 2.0 mL microcentrifuge tubes and 250 μL
Protein Precipitation Solution was added. The solutions were mixed by shaking the
tube by hand 10 times. The samples were centrifuged at 13,000 rpm for 10 minutes to
pellet the precipitated proteins. The supernatant was transferred to 15 mL tubes and
mixed with 1 mL resuspended Binding Matrix. The tubes were inverted by hand for 2
minutes to allow binding of DNA and then placed in a rack for  3 minutes to allow
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settling of the silica matrix. 500 μL of supernatant was discarded without disturbing the
settled Binding Matrix. The settled Binding Matrix was resuspended in the remaining
supernatant and transferred to the SPIN™ Filter tubes. The SPIN™ Filter tubes were
centrifuged at 13,000 rpm for 1 minute. 500 μL SEWS-M buffer was added to the filter
tubes and the Binding Matrix was resuspended gently, before centrifugation at 13,000
rpm for 1 minute. The centrifugation was repeated to dry the filters of residual wash
solution. The spin filters were dried for 10 minutes at room temperature and for 5
minutes at 37°C. The Binding Martix was resuspended in 100 μL DNase/Pyrogen-Free
Water and centrifuged at 13,000 rpm for 1 minute to elute the DNA. The samples were
separated by electrophoresis on 1% agarose TAE gel to confirm the presence of large
gDNA fragments. 
Metagenomics.  The gDNA isolated from the larval  guts was sequenced at ChunLab
(Seoul,  South Korea)  using MiSeq Nano platform. The sequencing workflow started
with incorporating barcodes into each sample. Many samples can be sequenced during
one run and barcodes are used to tell them apart after the sequencing reactions are
performed. After barcoding the samples were pyrosequenced, which is a method of
sequencing dependent on the synthesis of a DNA strand complimentary to the strand
being sequenced. The activity of the DNA polymerase incorporating one of four DNA
bases  is  then  detected  indirectly  with  other  chemiluminescent  enzymes.  The
sequenced region was the V3-V4 region of the 16S gene, which codes for one of the
variable regions of the 16S RNA and is frequently used in metagenomic analyses. After
the sequencing reactions, the resulting reads had their barcode labels and sequencing
primer sequences trimmed. These processed reads were then filtered and low-quality
sequences  were  discarded.  The  filtered  sequences  were  assembled  into  contigs,
continuous overlapping assemblies representing consensus DNA regions. These contigs
were then classified into operational  taxonomic units  based on sequence similarity
between them. Taxonomic classification was assigned to each operational taxonomic
unit at the species level using the ChunLab’s EzTaxon-e database and blastn algorithm
[130]. Chimeric sequences, which are contaminants originating from two separate DNA
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sequences, were filtered out using UCHIME program [131]. The sequencing reads were
supplied  in  .clc  format.  The  sequencing  results  analysed  and  visualised  with
CLcommunity software supplied by ChunLab.
2.3.4 Antibiotic susceptibility testing
Assay:  The minimal  inhibitory  concentrations  (MIC)  for  ampicillin,  chloramphenicol,
ciprofloxacin,  kanamycin,  rifampicin  and  tetracycline  were  determined  by  broth
microdilution [132] for  each gut-isolated strain and type strain pair.  Briefly,  96-well
plates with serial dilutions of antibiotics were inoculated with bacterial suspension and
incubated for 24 h at 30°C. The MIC was assigned when instead of a suspension of
bacterial growth, a well with a clear broth was present. To confirm lack of bacterial
growth, the OD was measured at 600 nm in a CLARIOstar plate reader (BMG Labtech).
The control organism was E. coli ATCC 25922.
Modification: The  MICs  for  catharanthine,  vindoline,  loganin,  loganic  acid,  and
ajmalicine were determined by broth microdilution method [134] for the gut-isolated
strains from the beet armyworm, matching type strains, Escherichia coli (ATCC 25922),
Mycobacterium smegmatis (ATCC 700084), Pseudomonas aeruginosa (ATCC 15692) and
Staphylococcus  aureus (ATCC 29213).   96-well  plates  with two-fold  dilutions  of  the
compounds  were  inoculated  with  bacterial  suspension  at  OD600 =  0.08-0.11  and
incubated for 24 h at 30°C. The MIC was assigned when instead of a suspension of
bacterial growth, a well with a clear broth was present. To confirm lack of bacterial
growth, the OD was measured at 600 nm in a CLARIOstar plate reader (BMG Labtech).
2.4 Plant extracts
2.4.1 Plant extract preparation
The  plant  extracts  were  prepared  by  homogenizing  dried  leaves   of  eucalyptus
(Eucalyptus dalrympleana), cabbage leaves (Brassica rapa), lavender leaves and flowers
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(Lavendula angustifolia), ragwort leaves (Jacobaea vulgaris), potato leaves (Solanum
tuberosum),  and Madagascar periwinkle leaves and roots (Catharantus roseus)  with
methanol. 100 g dried plant material was ground to fine powder either with a pestle
and mortar or using an electric coffee grinder (Andrew James Stainless Steel Wet and
Dry Coffee, Nut and Spice Grinder). The plant powders were soaked overnight in 300
ml methanol, filtered and soaked again twice in 300 ml methanol. The plant extract
had deep green, nearly opaque colour. The plant material was soaked until it was no
longer green. The  three methanolic extracts were filtered, pooled and concentrated in
an  EZ-2  Elite  evaporator  (GeneVac).  The  extracts  were  de-fatted  by  liquid-liquid
fractionation with petroleum ether in a 1:1 ratio. Only the methanol fraction was used
in subsequent purifications. 
2.4.2 Antibacterial activity testing
To standardize the different plant extracts, the crude extracts were dried to powder in
an evaporator (DNA SpeedVac, Savant) and resuspended in methanol at 100 µg/mL.
Lawns of bacteria were prepared by overlaying TY agar plates with a mixture of 3 mL
overnight bacterial culture at OD 0.08 – 0.11 and 3 mL molten and cooled TY agar.
Paper discs (Whatman, 5 mm) were infiltrated ten times with 10 µL aliquots of the
extract,  dried  to  remove  methanol,  and  placed on  the  bacterial  lawns.  After  24  h
incubation at 30°C the clear zones were measured with a ruler. 
2.4.3 Activity-guided fractionation
Solid-phase  extraction:  Plant  extracts  with  activity  against  bacteria  tested  were
purified on solid-phase extraction (SPE) weak anion exchange columns (Oasis WAX 6 cc
cartridge, Waters) according to the manufacturer’s instructions. Briefly, each column
was primed with 6 mL methanol and calibrated with 6 mL 2% formic acid in MiliQ
water (Merck) before loading no more than 5 mg sample resuspended in methanol.
The columns were then washed with 6 mL 2% formic acid, 6 mL methanol and 6 mL 5%
ammonium hydroxide in methanol. The flow through was collected, concentrated and
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assayed for antibiotic activity as described before. 
High-pressure liquid chromatography:  The active SPE fractions of plant extract were
subjected  to  reverse-phase  high-pressure  liquid  chromatography  (HPLC).  Non-
concentrated samples were used for the fractionation to avoid loss of accuracy when
too much sample is loaded. Before the fractionation the samples were centrifuged for
10 min. When the samples were too concentrated for the analysis, they were serially
diluted  at  1:10,  1:100  and  1:1000  ratios.  The  samples  were  run  on  a  Liquid
Chromatograph Mass  Spectrometer  LCMS-2020  (Single-quad,  Shimadzu).  Separation
was on an analytical 2×100 mm 3 µm Luna C18(2) column (Phenomenex) and semi-
preparative 10×250 mm 5 µm Luna C18(2) column (Phenomenex), run at 0.3 mL/min.
for  the  analytical  columns  and  3  mL/min.  for  the  semi-preparative  columns.  All
separations were run at 40°C. We used a gradient of methanol and 0.1% formic acid in
MiliQ  water  (Merck).  A  general  HPLC  method consisted  of  a  10  –  100% methanol
gradient over six column volumes followed by a 100% methanol was over two column
volumes and 10% methanol wash over two column volumes. UV/visible spectra (190-
600 nm) and UV chromatograms (260 nm) were collected at  6.25 Hz with a  time-
constant of 0.16 sec. using the on-line detector between the HPLC column and the
fraction collector. When fractions were collected, the fraction collector was set up to
collect  fractions  of  2  mL  throughout  the  duration  of  the  method.  After  the
fractionation all  fractions were dried in an evaporator and assayed for antibacterial
activity as described before.
2.4.4 Mass spectrometry
The Liquid Chromatograph Mass Spectrometer LCMS-2020 (Single-quad, Shimadzu) is a
mass spectrometer, but the instrument is most functional when used in high-pressure
liquid  chromatography.  The  instrument  can  reach  high  pressures  (above  6000  psi),
which means it  is  capable  of  separating peaks that  elute close together.  The mass
spectrometer  part  of  the  instrument  is  an  excellent  feature  for  mass-guided
fractionation, but is not accurate enough for precise identification of compounds. To
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precisely  identify  masses  of  compounds we used  LCMS-IT-ToF  Mass  Spectrometer
(Shimadzu).
To investigate the composition of some fractions, they were analysed on LCMS-IT-ToF
Mass Spectrometer.  The samples used in the analysis  were not concentrated.  They
were collected before the solvent was evaporated for antibiotic activity testing. The
samples were mixed with 20% methanol in 1:4 ratio and centrifuged for 10 min. The
supernatant was transferred to small glass inserts for analysis. Serial dilutions (1:10,
1:100  and  1:1000)  of  a  sample  were  prepared  when  the  original  sample  was  too
concentrated and reached above the limit of detection of the instrument. The samples
were run on a Prominence/Nexera UHPLC system attached to an ion-trap ToF mass
spectrometer (IT-ToF, Shimadzu). Separation was on a 100×2.1 mm 2.6 μm Kinetex EVO
C18 column (Phenomenex) using a gradient of acetonitrile versus 0.1% formic acid in
water, run at 0.6mL/min. at 40°C. In contrast with previous LC method, this method
was developed and optimised specifically for compounds in periwinkle leaf extract and
adapted  for  other  plant  extracts  (Tatsis,  personal  correspondence).  The  gradient
consisted of a 10 – 100% acetonitrile gradient over six column volumes followed by a
100% acetonitrile wash over two column volumes and 10% acetonitrile wash over two
column volumes.  Detection was by UV/visible absorbance and positive electrospray
MS. UV/visible data were collected from 200-600 nm at 6.25 Hz with a time-constant of
0.16  sec.  Full  MS  data  were  collected  from  m/z  150-2000  with  a  maximum  ion
accumulation time of 20 msec., and automatic sensitivity control set to a target of 70%
of optimum base peak intensity. The instrument also collected automatic MS2 data of
the  most  abundant  precursor  ions  at  an  isolation  width  of  m/z  3.0,  50%  collision
energy, and 50% collision gas, and 15 msec. ion accumulation time. The instrument was
set up to collect two successive spectra of each precursor ion that was selected, and
then ignore that precursor for 2 sec in favour of the next most abundant precursor.
Spray chamber conditions were 1.5 L/min.  nebulizer gas, 250°C curved desorbation
line, 300°C heat block, and drying gas “on”. The instrument was calibrated immediately
before use, using sodium trifluoroacetate cluster ions according to the manufacturer’s
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instructions.   The results were analysed with LabSolutions software (Shimadzu) and
Profiling Solution software (Shimadzu).
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3 The  impact  of  antibiotics  on  the  gut  microbiota  of  two
lepidopteran  hosts:  Plutella  xylostella and  Galleria
mellonella
Undergraduate project student Aristide Lebreton helped with some of the experiments
described in this chapter as part of his project. He helped set up and dissect P. xylostella
larvae feeding on artificial food containing oxytetracycline and isolated and identified
the gut bacteria from the larvae.
All data in this chapter was generated by me and I produced all figures and tables on
my own.
3.1 Abstract
Clinically-relevant multidrug resistance is sometimes present in bacteria not exposed to
human-made  antibiotics,  in  environments  without  a  high  concentration  of  these
compounds, such as the insect gut [121]. In this chapter we investigate the impact of
antibiotics on the insect gut microbiome by identifying antibiotic resistance in the gut
bacteria  of  the  larvae  of  two  lepidopteran  hosts:  Plutella  xylostella  and  Galleria
mellonella,  feeding  on  artificial  food  containing  the  antibiotics  ciprofloxacin  and
oxytetracycline.  For  P.  xylostella  larvae the resistance to  a  panel  of  antibiotics  was
assessed and it was discovered that antibiotic-resistant bacteria are present not only in
the guts of insects feeding on antibiotics, but also in guts of larvae feeding on artificial
food without antibiotics. In a follow-up experiment, five generations of G. mellonella
larvae were fed on artificial food containing a range of oxytetracycline doses. While
oxytetracycline-resistant  strains  were  isolated  from the  gut  of  G.  mellonella  larvae
feeding on antibiotics, more genetically diverse resistance elements were present in
samples  from  antibiotic-free  larval  guts.  Our  results  indicate  that  antibiotics  have
diverse  impact  on  the  insect  gut  microbiome,  beyond  only  inducing  antibiotic
resistance. Our findings highlight the significance of antibiotics in natural environments
and clinical settings.
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3.2 Introduction
3.2.1 Antibiotic resistance is ancient
Widespread antibiotic resistance in pathogenic bacteria is a global problem, posing a
significant  threat  to  public  health.  However,  antibiotic  resistance  is  not  a  modern
phenomenon.  Antibiotic  resistance  is  ancient  and originates  from the  environment
[133]. For example antibiotic resistance genes have been found in permafrost samples
dating from the Late Pleistocene period [80]. The sediment samples contained genes
conferring  resistance  to  β-lactams,  tetracyclines  and  glycopeptide  antibiotics,
illustrating that antibiotic resistance genes pre-date human antibiotic use. Phylogenetic
analyses of genetic sequences and protein structures of resistance elements also reveal
their ancient origin. β-lactamases are a diverse group of proteins with ancient origins
[134] and within that group OXA class β-lactamases have been predicted to have been
mobilized to a plasmid twice in the evolutionary history, at 116 and 42 million years
ago [135]. These findings suggest that antibiotic resistance genes have a role in the
fitness  of  some bacteria,  either  by  providing  protection  against  naturally-occurring
antibiotics or serving a different ancient metabolic role.
Antibiotic resistance has been shown to be a trait often accompanied by a high fitness
cost (see review by MacLean et al., 2010 [136]). Resistance elements are normally lost
in  the  absence  of  selective  pressure  unless  accompanied  by  rare  mutations
compensating  the  fitness  cost.   However,  antibiotic  resistance  can  be  found  in
environments that do not contain high levels of antibiotic resistance, indicating that
the genes can  persist  without  direct  selective  pressure  [121,  137].  Some antibiotic
resistance genes isolated from natural environments share a high level of similarity to
genes from human pathogens. 
3.2.2 Antibiotic resistance is widespread
Antibiotic  resistance  genes  are  present  in  environments  seemingly  not  affected  by
human factors, such as glaciers in Central Asia, North and South America, Greenland
and  Africa  [138].  48  different  resistance  genes  were  identified  from  54  samples
collected from glaciers. The most frequently recovered genes were two aminoglycoside
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acetyl  transferases  of  a  clinical  origin  (24/54  sites  and  18/54  sites),  streptomycin-
resistance gene strA with homology to genes of agricultural origin (21/54 sites), and a
metallo-β-lactamase blaIMP gene conferring resistance to carbapanem antibiotics (20/54
sites).  Similarly,  antibiotic  resistance  genes  with  homology  to  genes  from  human
pathogens  are  present  in  marine  environments.  Plasmids  from fish  farm sediment
bacteria  carried  multiple  antibiotic  resistance  elements,  enriched  in  tetracycline
resistance genes [139]. A total of 652 plasmids have been isolated, two thirds of them
carrying genes with less than 40% homology to known resistance elements. Six genes
had over 90% identity to known resistance elements from human pathogens, two of
them conferred resistance to macrolides, and the remaining four to aminoglycosides,
fluoroquinolones,  chloramphenicol  and  tetracycline.  However,  as  with  OXA  β-
lactamases discussed earlier, it is not possible to easily distinguish whether the genes
have the same role in the natural environment as in clinical setting or confer a novel
beneficial phenotype. 
3.2.3 Antibiotic resistance is present in the insect gut
Another reservoir of antibiotic resistance is the insect gut. Insects not exposed directly
to antibiotics can have antibiotic-resistant microbiota. Laboratory-reared Mexican fruit
flies,  Anastrepha  ludens,  harbour  predominantly  bacteria  of  the  genus  Listeria,
Enterobacter,  Providencia,  Serratia,  and  Staphylococcus [140].   The  bacteria  test
positive for ampicillin and penicillin resistance, even though their wheat germ- and
yeast  extract-based  diet  is  antibiotic-free.  A  more  striking  example  is  the  oil  fly
(Helaeomyia petrolei) larvae, which swim in asphalt seeps and feed on dead insects
trapped in the petroleum pools. Their gut microbiome is dominated by  Providencia
rettgeri [141],  which is resistant  to a  range of  antibiotics  (tetracycline,  vancomycin,
bacitracin,  erythromycin,  novobiocin,  polymyxin,  colistin,  and  nitrofurantoin)  and
organic  solvents  (overlays  with  cyclohexane,  xylene,  benzene,  toluene,  and  xylene-
cyclohexane). However, in the case of oil fly larvae, whose guts are exposed to crude
petroleum, the microbiota is  under high selective pressure to develop tolerance or
resistance to a variety of compounds. 
Insects associated with human habitats are often under high selective pressure for
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antibiotic-resistant  microbiomes.  For  example  bedbugs  (Cimex  lectularius)  from
hospital patients have been found to carry vancomycin-resistant Enterococcus faecium
and methicillin-resistant Staphylococcus aureus [100]. The bacteria were also resistant
to other antibiotics: E. faecium to ampicillin, teicoplanin, and aminoglycosides, and S.
aureus to erythromycin. Similarly, two Indian cockroach species Periplaneta americana
and Blattella germanica, collected from households and food-handling establishments,
carried a variety of pathogenic bacterial species, including  Pseudomonas aeruginosa,
Klebsiella pneumoniae and  Escherichia coli [142]. Each of the strains was resistant to
ampicillin, tetracycline and sulfamethoxazole/trimethoprim, with additional resistance
of  P.aerugionsa to cephalothin, chloramphenicol  and gentamycin,  K. pneumoniae to
gentamycin, and E. coli to piperacillin, cephalothin, chloramphenicol and ceftazidime.  
3.2.4 Insects as vectors mediating the spread of antibiotic resistance
Apart from being a reservoir of antibiotic resistance genes, insects can be vectors of
bacterial  diseases,  spreading antibiotic-resistant strains.  Antibiotic-resistant bacteria,
present in the faeces of farm animals fed antibiotics for growth promotion, are picked
up by flies (Diptera)  and cockroaches (Dictyoptera)  and spread between farms and
surrounding urban environments (see review by Zurek and Ghosh, 2014 [74]). A body
of evidence from different studies demonstrates a link between antibiotic use in animal
husbandry,  bacterial  resistance  in  livestock,  and  resistance  in  human  pathogens,
transmitted directly by insect vectors. 
Antibiotic use in agriculture has a profound effect on bacterial populations associated
with insects. Oxytetracycline is the most commonly used antibiotic in apiculture and
the long term exposure of bees to this antibiotic has led to abundance of tetracycline
resistance genes in the bee gut microbiota [37]. Oxytetracycline is used in the control
of European foulbrood, a disease of honeybees caused by Melissococcus plutonius. The
antibiotic  is  applied  mixed  with  sugar  or  water  and  reaches  minimal  inhibitory
concentrations in the larval guts within 24 h post treatment, but declines rapidly to a
level under MIC within two to five days [37, 143]. In the US bees have been exposed to
prophylactic  oxytetracycline  use  for  over  50  years  and  high  levels  of  tetracycline
resistance can be detected in the bee guts [37]. In contrast, such genes are rare and
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only  present  at  low frequencies in  bees not  exposed to antibiotics  (from countries
where  antibiotics  are  not  permitted  in  apiculture)  and  wild  bumblebees.  Together
these studies suggest that the exposure of insect microbiota to antibiotics leads to an
accumulation of antibiotic resistance. 
3.2.5 Implications of the presence of antibiotics in insect diets
Antibiotic-induced insect mortality is a significant issue, as insects are already facing
high extinction rates.  Over 40% invertebrate pollinator  species are estimated to be
facing extinction, threatening global agricultural production [144]. Declining pollinator
numbers  affect  food  and  biofuel  supply,  as  well  as  medicines,  fibres,  forage  for
livestock and construction materials. Importantly crops depend not only on managed
pollinators such as bees, but also on a wide variety of wild pollinators. The presence of
a variety of pollinators contributes to higher crop yields.
In natural  environments antibiotics can be contaminants contributing to ecotoxicity.
Ecotoxicity can be defined as the effects of pollutants, such as human-made antibiotics,
on ecosystems as a whole. Microbiomes are integral parts of all higher organisms and
changes  to  the  community  composition  or  bacterial  metabolism  affect  the  host
organisms.  Even  low  concentrations  of  antibiotics  in  the  environment  can  trigger
transcriptional changes in the microbiomes (see review by Martinez, 2009 [145]). The
impact of such changes on the ecosystems and human health is currently difficult to
assess.
3.2.6 Objectives
The  hypothesis  tested  was  that  insects  feeding  on  compounds  with  antibacterial
activity acquire antibiotic-resistant microbiota. This hypothesis was part of a proof of
concept  for  the experiments  in  the following  chapter  (see Chapter  4.  Investigating
antibiotic  resistance  in  the  insect  gut  bacteria:  the  search  for  novel  plant-derived
antibacterials), in which we look for evidence of multi-antibiotic resistance in the insect
gut as an indication of antibacterials in the plant diet.
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3.3 Results
The aim of this project was to demonstrate the correlation between the antimicrobial
compounds in the insect food and the presence of antibiotic resistance elements in the
insect gut. The data collected demonstrate that antibiotics have a pleiotropic effect on
insects, beyond inducing antibiotic resistance in the gut microbiome.
3.3.1 Plutella xylostella feeding on artificial food with ciprofloxacin
3.3.1.1 Diamondback moth (Plutella xylostella)
The objective of this project was to demonstrate that compounds with antimicrobial
activity in the insect food lead to the accumulation of antibiotic resistance genes in the
gut microbiome. The initial experiments were conducted on diamondback moth larvae
(Plutella xylostella),  which were feeding for  three days  on artificial  food containing
either ciprofloxacin or oxytetracycline. P. xylostella is a lepidopteran pest of cruciferous
plants, with a wingspan of 15 mm and a body length of 6 mm. The pale green larvae
have four instars, the first instar larvae burrow in the plant leaves, emerging after the
first moult to feed on the bottom leaf surface.
P. xylostella larvae are a notoriously destructive pest of cruciferous plants [146]. The
insects are often insecticide-resistant, but the mechanism is most likely not microbe-
mediated.  An  investigation  of  radish-fed  groups  of  P.  xylostella larvae,  revealed
presence of a wide range of bacterial species present at low abundance [147]. 342
different  operational  taxonomic  units,  all  below  2%  abundance,  were  identified
between all samples collected. The guts were dominated by Proteobacteria, especially
of  the order  Enterobacteriales.  The authors determined that  the differences in gut
microbiota composition were independent of the insecticide exposure of the sampled
larvae.
3.3.1.2 Gut bacteria isolated from P. xylostella exposed to ciprofloxacin
Cabbage-reared P.xylostella larvae were shifted to an agar-based artificial food spiked
with  a  range  of  ciprofloxacin  concentrations  (Figure  3-1).  Ciprofloxacin  was  the
antibiotic  of  choice,  because the resistance it  normally  induces  is  well-studied  and
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involves a point mutation in the DNA gyrase gene [148]. 
The doses of antibiotics were selected to be similar to physiologically-relevant human
doses.  An  estimate  was  calculated  of  how  the  antibiotic  doses  in  artificial  food
correlate to the doses recommended for human use. The recommended human dose
for ciprofloxacin is 25 mg/kg body weight/day [123]. Five larvae (approximate weight
20 mg each) fed on four 5×5×5 mm cubes of  artificial  food per day.  Assuming the
ciprofloxacin  dose  was  3  µg/ml,  the  larvae  consumed  1.5  µg  drug/100  mg  body
weight/day,  which  equals  to  15  mg/kg  body  weight/day  ciprofloxacin.  The  other
ciprofloxacin doses are summarised in Table 3-1.
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Figure  3.1:  Plutella  xylostella  larvae  feeding on artificial  food containing ciprofloxacin.  Light
green larvae at third and fourth instar eating cubes of agar-based artificial food containing no
drug,  1  µg/mL  ciprofloxacin,  3  µg/mL  ciprofloxacin,  10  µg/mL  ciprofloxacin  and  30  µg/mL
ciprofloxacin.
control – no drug 3 µg/mL ciprofloxacin1 µg/mL ciprofloxacin
10 µg/mL ciprofloxacin 30 µg/mL ciprofloxacin
artificial food
artificial food
caterpillars
caterpillars
Table 3.1: Antibiotic doses used in P. xylostella feeding study were selected to reflect a range of
physiologically  relevant  human  doses.  Ciprofloxacin  is  recommended  for  human use  at  25
mg/kg body weight/day. The lowest dose is representative of a sub-inhibitory antibiotic dose,
the two middle doses represent a low and high limit of the recommended human dose. The
highest dose is above the dose recommended for human dose, but is not high enough to have
toxic effects on the larvae.
ciprofloxacin dose in the artificial food ciprofloxacin dose per body weight
1 µg/mL 5 
3 µg/mL 15 
10 µg/mL 50 
30 µg/mL 150 
After  three days  the  P.  xylostella guts  were dissected  and their  gut  contents  were
plated.  Seven  different  bacterial  species  were  isolated  from  larvae  exposed  to
ciprofloxacin:  Bacillus  subtilis,  two  species  of  Sanguibacter,  three  species  of
Enterobacteria,  including  Enterobacter  amnigenus,  and  a  species  that  was  not
identified with the methods used (Table 3-2). 
Only Bacillus subtilis and Enterobacter amnigenus were used in following experiments.
Further work, requiring the use of type strains from a culture collection, was carried
out only with the strains identified to species level (B. subtilis and E. amnigenus). The
strains were used to assay for antibiotic susceptibility differences between the gut-
isolated strains and the type strains, therefore only the isolates identified to species
level were used.
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3.3.1.3 Antibiotic resistance in the gut bacteria of P. xylostella larvae 
At the next stage of this experiment, the strains identified were assayed for antibiotic
resistance in a broth microdilution assay [132]. The resistance profiles for the strains
exposed to antibiotics in the insect gut were compared to type strains obtained from
bacterial  culture collections  (Table 3-3).  There are three possible outcomes of  such
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Table 3.2: An overview of bacteria isolated from the guts of diamondback moth larvae feeding
on artificial  food  containing  a  range of  ciprofloxacin  doses.  The  experiment  was repeated
twice, each time the dissections included at least five larvae. 
comparison: 1) no difference between the strains tested, 2) gut-isolated strain is more
resistant than the type strain, 3) gut-isolated strain is more susceptible than the type
strain. 
In most cases there was no difference in antibiotic  susceptibility between the type
strain and the gut-isolated strain. In four cases differences in antibiotic susceptibility
were observed.  B. subtilis isolated from the  P. xylostella gut  was more resistant  to
ampicillin and chloramphenicol than the type strain and similarly  E. amnigenus  from
the diamondback moth larvae gut was more resistant to tetracycline than the type
strain.  B. subtilis from the insect gut was less resistant to ciprofloxacin, which it was
exposed to, than the type strain. We expected to see some differences in susceptibility
where the type strain is more antibiotic resistant than the gut strain. However it was
surprising that the B. subtilis type strain was more ciprofloxacin-resistant than the gut-
isolated strain, which was exposed to ciprofloxacin.
Table  3.3:  Antibiotic  susceptibility  profiles  of  the  gut  bacteria  from P.  xylostella  feeding on
artificial food with ciprofloxacin. The antibiotic susceptibility of the gut-isolated strains and the
type strains was assessed in a broth microdilution assay. Differences in antibiotic-resistance
levels between the strains have been highlighted in green when the gut-isolated strain was
more resistant than the type strain and in red when the type strain was more resistant than the
gut-isolated strain. p < 0.001.
Minimal inhibitory concentrations of antibiotics in broth dilution
assay [μg/mL]
Bacillus subtilis Enterobacter amnigenus
gut strain type strain gut strain type strain
ampicillin >64 2 >64 >64
chloramphenicol 16 2 2 2
ciprofloxacin <0.01 0.02 <0.01 <0.01
kanamycin 1 1 2 2
rifampicin 2 2 2 2
tetracycline 1 1 0.03 0.02
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3.3.2 Plutella xylostella feeding on artificial food with oxytetracycline
3.3.2.1 Re-design of the experimental procedure
To further test the hypothesis the experiment was re-designed based on a study by
Tian  et  al.  [37].  In  this  study  the  impact  of  oxytetracycline  use  in  beehives  was
investigated.  Over 50 years oxytetracycline was heavily used in apiculture, leading to a
significant increase in tetracycline resistance elements in the guts of bees treated with
the  antibiotic  compared  with  the  wild  bee  populations.  Based  on  these  data,  the
Plutella experiment was re-designed: the artificial food was spiked with oxytetracycline
and  the  feeding  procedure  was  extended  to  span  a  number  of  generations.
Oxytetracycline was added to the artificial food at 3 µg/ml, which is equivalent to the
recommended human dose for oxytetracycline (15 mg/kg body weight/day) (Table 3-
4). The feeding procedure was extended to prolong the exposure of the larvae to the
antibiotic and to sample antibiotic-fed insects over generations.
Table  3.4:   The antibiotic  dose used in P.  xylostella  feeding study was selected to reflect  a
physiologically-relevant human dose.  Oxytetracycline is  recommended for  human use at  15
mg/kg body weight/day.
oxytetracycline dose in the artificial food oxytetracycline dose per body weight
3 µg/ml 15 
The  initially  cabbage-reared  larvae,  at  third  and  fourth  instar,  were  moved  to  an
artificial food spiked with oxytetracycline. The food was replaced daily, after three days
the larvae were dissected and their gut bacteria identified. A group of larvae was kept
to establish a long-term colony feeding on artificial food, but high pupae mortality and
no egg-laying  halted the progress  of  the experiment.  It  is  possible  that  the pupae
mortality was caused by the antibiotic present in the artificial food that either had a
direct  toxic  effect  on  the  larvae  pre-pupation,  or  indirectly  affected  the  pupae  by
changing the composition of the larval gut microbiota. Only few adults emerged from
the surviving pupae. The moths did not produce any eggs as oviposition is dependent
on the host cruciferous plant [25]. In Plutella xylostella females oviposition is induced
by non-volatile indole glucosinolates produced by cruciferous plants. 
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3.3.2.2 Identification of  bacteria from the guts of  P.  xylostella  larvae feeding on
oxytetracycline
Even though the experiment could not  continue as  planned to include subsequent
generations of larvae hatched on artificial food, the strains from the P. xylostella larvae
feeding on oxytetracycline were identified. Only two different bacterial species were
identified:  Enterobacter  amnigenus and  Sanguibacter  keddieii.  E.  amnigenus and
bacteria from the genus Sanguibacter were also identified in the previous experiment,
when  diamondback  moth  larvae  were  feeding  on  artificial  food  containing
ciprofloxacin,  which  suggests  that  the  culturable  fraction  of  the gut  microbiome is
relatively  stable.  Surprisingly  only  two  bacterial  species  were  isolated  from  the  P.
xylostella guts,  which  can  contain  over  300  different  bacterial  strains  [147].
Diamondback moth microbiome is dominated by Enterobacteriales, which are readily
cultured by the methods employed in our study and we expected to culture a higher
diversity of species.
3.3.2.3 Antibiotic resistance in the gut bacteria of P. xylostella larvae
The bacterial  strains  isolated from  P.  xylostella feeding on artificial  food containing
oxytetracycline were assayed for antibiotic resistance by broth microdilution [132]. As
before for most antibiotics tested, there was no difference between the gut-isolated
strain, exposed to oxytetracycline, and the test strain (Table 3-5). Only in two cases
there were differences in antibiotic susceptibility between the gut-isolated strains and
type strains:  S. keddieei gut-isolated strain was less resistant to chloramphenicol and
ciprofloxacin than the type strain. As discussed before such differences are surprising,
but  not  unexpected.  However,  we  expected  the  gut-isolated  strains  to  be  more
oxytetracycline resistant than the type strains, as the gut-isolated strains were exposed
to oxytetracycline, but we have seen no differences between the isolates. 
It is possible that no differences in antibiotic susceptibility between the gut-isolated
strains and the type strains were detected because the bacteria were not exposed to
the antibiotics in the insect gut for long enough. It  is also possible that rearing the
larvae initially  on cabbage introduces bacterial  strains  or  chemical  compounds that
protect the microbiome from the antibiotic in the artificial food. Ideally, the insects
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should  feed  on  the  same  type  of  food  throughout  their  life.  Additionally  the  two
experiments  described  above  also  demonstrate  that  the  type  strains  are  not  a
sufficient control for antibiotic resistance and a more accurate method should be used
instead. 
Table  3.5:  Antibiotic  susceptibility  profiles  of  the  gut  bacteria  from P.  xylostella  feeding on
artificial food with oxytetracycline. The antibiotic susceptibility of gut-isolated strains and the
type strains was assessed in a broth microdilution assay. Differences in antibiotic-resistance
levels between the strains have been highlighted in green when the gut-isolated strain was
more resistant than the type strain and in red when the type strain was more resistant than the
gut-isolated strain. p < 0.05.
Minimal inhibitory concentrations of antibiotics in broth dilution
assay [μg/mL]
Sanguibacter keddieii Enterobacter amnigenus
gut strain type strain gut strain type strain
ampicillin 2 2 >64 >64
chloramphenicol 1 2 16 16
ciprofloxacin 1 >64 <0.01 <0.01
kanamycin 2 2 1 2
rifampicin 0.02 0.02 2 2
oxytetracycline 0.02 0.02 0.02 0.02
To investigate further the response of the insect gut microbiomes to antibiotics, we
addressed the issue of  insufficient antibiotic  exposure in the gut by switching to a
different insect species. Plutella is not the only lepidopteran that can be reared on
artificial diets and other species can be permanently fed artificial food. 
3.3.3 Galleria mellonella feeding on artificial food with oxytetracycline
3.3.3.1 Greater wax moth (Galleria mellonella)
Another  lepidopteran  host  used  in  this  study  is  the  greater  wax  moth  (Galleria
mellonella).  G. mellonella  is a larger, easier to dissect insect (with fifth instar larvae
reaching up to 30 mm long),  and can be reared on artificial  diet over a number of
generations. Greater wax moths are pests of beehives, and are also commonly used in
immunity research, bacterial virulence and antibiotic efficacy studies. 
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In  contrast  to  Plutella  xylostella,  the  gut  microbiota  of  G.  mellonella is  simple,
containing  mainly  one  bacterial  species.  Enterococcus  faecalis (syn.  Streptococcus
faecalis)  has  been  identified  in  the  guts  of  G.  mellonella  using  culture-dependent
methods  [149].  Culture-independent  methods  confirmed  Enterococcus  species  are
present in the larval guts, but identified the dominant strain as Enterococcus munditii
[150].  The  strain  has  no  role  in  insect  digestion  [151]  but  together  with  the  host
provides colonisation resistance against invading pathogens [152].
3.3.3.2 Continuation of the experiment designed for P. xylostella
We decided to continue the investigation into the impact of antibiotics on the insect
gut microbiota, taking into consideration the points discussed above. To continue the
experiment over more than one generation of  insects,  a  lepidopteran host able  to
sustain growth on artificial food was chosen. Greater wax moths (Galleria mellonella)
are sometimes reared on honeycomb or beehive debris, but more commonly feed on
bran-  and wheat  germ-based artificial  food (Figure  3-2).  The insects  can reproduce
while on artificial food diet. Additionally instead of assessing antibiotic resistance by
comparing the antibiotic susceptibility profiles of the gut isolated strains and the type
strains, we used targeted PCR amplification of all known tetracycline resistance genes.
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Figure 3.2: G. mellonella larvae feeding on artificial food in a Petri dish.
3.3.3.3 Feeding procedure
For the purpose of this experiment,  a  G. mellonella colony was set up with groups
feeding  on  artificial  food  without  antibiotics  and  with  different  concentrations  of
oxytetracycline. The doses chosen were 1 mg/100 g food, 10 mg/100 g food, 100 mg/
100  g  food,  400  mg/100  g  food  and  1000  mg/100  g  food.  The  concentrations  of
antibiotics were chosen to span a range of doses. Estimating that 20 larvae fed on 25 g
artificial  food  for  a  week,  the  lowest  dose  (1  mg/100  g  food)  equals  to  8
oxytetracycline, which is half of the recommended human dose. The relation between
the other oxytetracycline concentrations in the artificial food and the estimated dose
per kg body weight is summarized in Table 3-6. The 10 mg/100 g food dose is similar to
a  high  human  dose  and  the  remaining  doses  are  high  enough  to  have  a  feeding
deterrent or toxic effect on the larvae.
Table 3.6: Antibiotic doses used in G. mellonella feeding study were selected to reflect a range
of physiologically relevant human doses. Oxytetracycline is recommended for human use at 15
mg/kg body weight/day. The lowest dose is representative of a sub-inhibitory antibiotic dose.
The  10  mg/100g  diet  oxytetracycline  dose  represents  a  high  therapeutic  dose.  The  three
highest doses are above the dose recommended for human dose and are high enough to have
toxic effects on the larvae.
dose in artificial food dose per body weight
1 mg/100 g diet 8 
10 mg/100 g diet 80 
100 mg/100 g diet 800 
400 mg/100 g diet 3200 
1000 mg/100 g diet 8000 
The feeding procedure was carried out over five generations. A colony was established
for  the  control  group,  not  feeding  on  antibiotics.  Moths  reared  on  food  without
antibiotics laid eggs that hatched on food without antibiotics and that process was
continued over five generations. Larvae were sampled from each generation. The same
process was followed for the group feeding on artificial food with oxytetracycline at 1
mg/100 g food. Groups feeding on higher oxytetracycline concentrations sometimes
experienced high mortality at early larval stage and as pupae, and it was not always
possible  to  collect  larvae  from each generation  (Table  3-7).  For  example,  the third
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generation of  larvae feeding on 10 mg oxytetracycline/100 g food died at  an early
stage,  so  no  larvae  were  sampled  and  no  adults  were  collected  for  mating  and
oviposition. We moved eggs from the control group not exposed to antibiotics to the
artificial food with 10 mg oxytetracycline/100 g food, but they also died at an early
stage. We repeated the process for the fifth generation of insects and they managed to
grow to fifth instar when the larvae were sampled.
Table 3.7: G. mellonella larvae collected from the feeding procedure. The + indicates at least 10
larvae were collected and the - indicates it was not possible to collect suitably large larvae and
no larvae were collected at all. In some cases  the larvae in an natibiotic-treated group died
and not only no larvae could be collected, but also no larve reached maturity and laid eggs. In
the interest of continuing the experiment, in such cases eggs laid by the adults from the control
(no drug) group were moved to the food spiked with oxytetracycline. 
Oxytetracycline 
dose
Subsequent generations of G. mellonella larvae feeding on artificial
food with oxytetracycline
1st
generation
2nd
generation
3rd
generation
4th
generation
5th
generation
no drug + + + + +
1 mg OTC/100 g
diet + + + + +
10 mg OTC/100 
g diet + + - - +
100 mg 
OTC/100 g diet + - + - +
400 mg 
OTC/100 g diet + - + - +
1000 mg 
OTC/100 g diet - + - - +
The  samples  were  stored  in  a  freezer  before  dissections,  to  avoid  inconsistencies
between  dissections  performed  at  different  times.  The  entire  guts  were  dissected
under sterile conditions and pooled into groups of three. From other experiments it
was  predicted  a  single  gut  does  not  contain  enough  bacteria  for  the  downstream
processing, such as PCR amplification of the tetracycline resistance genes. The samples
were plated on LB agar and MacConkey agar under aerobic conditions, and RCA media
under anaerobic conditions. 
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3.3.3.4 Isolation of gut bacteria
Only three different isolates were cultured from the G. mellonella guts: two strains of
Enterobacteria from the initial  stock insects obtained from the Insectary before the
start of the experiment, and Bacillus subtilis strain isolated from the fourth generation
of insects feeding on diet with 1 mg OTC/100 g food. No bacteria were cultured from
any other sample. When plated on oxytetracycline selective media, the Enterobacteria
were  oxytetracycline-sensitive  and  the  B.  subtilis was  oxytetracycline-resistant.  The
presence  of  oxytetracycline-sensitive  Enterobacteria  were  predicted  from  previous
studies. Galleria mellonella is a monoxenic insect associated with Enterococcus species
[149, 150]. When assayed for antibiotic susceptibility, the strain is normally resistant to
β-lactam antibiotics and susceptible to tetracyclines [152]. When the gut microbiome is
disturbed with antibiotics, colonisation resistance of G. mellonella gut is compromised
and it can be invaded by non-native bacterial strains. An example of such strain is  B.
subtilis isolated from the guts of larvae feeding on 1 mg OTC/100 g food. The isolate is
not a member of typical G. mellonella microbiome. It is also oxytetracycline-resistant,
demonstrating how after  exposure to a  low dose of  an antibiotic  native antibiotic-
susceptible microbiota can be replaced by an invading antibiotic-resistant strain.
3.3.3.5 Identification of tet resistance elements from the G. mellonella guts
After plating, genomic DNA was isolated from the larval gut contents and subjected to
diagnostic PCRs for tetracycline-resistance elements. The same genes confer resistance
to both tetracycline and oxytetracycline [153], and our assays probed a wide variety of
them (Table 3-8). The microbiome was probed for the presence of all genes, coding for
a range of ribosome protection proteins and efflux pumps, surveyed by Tian et al. [37]
and  additional  novel  tetracycline  resistance  genes  discovered  after  the  study  was
published.  These  genes,  tetX  and  tetX2,  code  for  tetracycline  destructases,
flavoenzymes that inactivate tetracyclines by an oxidative mechanism [154]. 
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Table 3.8: An overview of tet-resistance genes surveyed in the guts of G. mellonella larvae.
gene name gene product type Reference
tetA efflux pump Fan et al., 2007 [125]
tetB efflux pump Fan et al., 2007 [125]
tetC efflux pump Fan et al., 2007 [125]
tetD efflux pump Fan et al., 2007 [125]
tetE efflux pump Fan et al., 2007 [125]
tetG efflux pump Fan et al., 2007 [125]
tetH efflux pump Fan et al., 2007 [125]
tetJ efflux pump Aminov et al., 2002, 2004 [126, 127]
tetK efflux pump Chopra and Roberts, 2001 [153]
tetL efflux pump Tian et al., 2012 [37]
tetY efflux pump Aminov et al., 2002, 2004 [126, 127]
tetZ efflux pump Aminov et al., 2002, 2004 [126, 127]
tet30 efflux pump Aminov et al., 2002, 2004 [126, 127]
tetBP ribosomal protection protein Aminov et al., 2001, 2004 [126, 127]
tetM ribosomal protection protein Aminov et al., 2001, 2004 [126, 127]
tetO ribosomal protection protein Aminov et al., 2001, 2004 [126, 127]
tetQ ribosomal protection protein Aminov et al., 2001, 2004 [126, 127]
tetS ribosomal protection protein Aminov et al., 2001, 2004 [126, 127]
tetT ribosomal protection protein Aminov et al., 2001, 2004 [126, 127]
tetW ribosomal protection protein Aminov et al., 2001, 2004 [126, 127]
tet32 ribosomal protection protein Aminov et al., 2001, 2004 [126, 127]
tet34 efflux pump Szczepanowski et al., 2009 [128]
tetX tetracycline destructase Bartha et al., 2011 [129]
tetX2 tetracycline destructase Bartha et al., 2011 [129]
A number of different genes were identified (Table 3-9). The stock larvae had a tetM
gene,  which codes  for  a  ribosome protection  gene.  The  tetM ribosome protection
protein complexes with 70S ribosome, directly blocking the tetracycline binding site
[155]. It is hypothesised the tetM ribosome protection protein dislodges tetracycline
from tetracycline  binding  site  to  confer  resistance.  A  variety  of  genes  was  present
among the larvae not feeding on antibiotics: tetB, tetC, tet30, tetD and tetL. All these
genes code for efflux pumps. The genes tetB, tetC, tetD and tet30 belong to group 1 of
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tetracycline efflux proteins, which are found predominantly in Gram-negative bacteria
and belong to major facilitator superfamily (MFS) tetracycline transporter family. The
efflux  proteins  exchange  a  proton  for  a  tetracycline-cation  complex  against  a
concentration gradient [156]. The gene tetL belongs to group 2 of tetracycline efflux
proteins, found primarily in Gram-positive species. The proteins confer resistance to
tetracycline and chlortetracycline. This dimeric efflux protein exchanges a proton for
tetracycline-divalent cation complex [157].
Table 3.9: An overview of tetracycline resistance elements from the guts of Galleria mellonella
larvae feeding on artificial food containing oxytetracycline. The groups of larvae for which no
samples were collected due to mortality at an early stage have been shaded out. A sample
where no results were obtained due to DNA degradation was marked with (*).
Oxytetracycline 
dose
Subsequent generations of G. mellonella larvae feeding on artificial
food with oxytetracycline
1st
generation
2nd
generation
3rd
generation
4th
generation
5th
generation
no drug tetB
tetC
tetB
tetC
tetB
tetC
tet30
tetB
tetD
tetB
tetD
tetL
1 mg OTC/100 g
diet tetB
tetB
tetD
tetB
tetD
tetB
tetD
tetB
tetD
10 mg OTC/100 
g diet
tetB
tetD
tetB
tetD
tetB
tet30
100 mg 
OTC/100 g diet tetB * -
400 mg 
OTC/100 g diet tetD - -
1000 mg 
OTC/100 g diet - -
These results indicate that the gene pool is diverse and dynamic, even in the absence
of  selective  pressure.  When the  selective  pressure  is  present,  fewer  genes  can  be
observed  in  the  population.  Larvae  fed  a  1  mg  OTC/100  g  food,  only  have  two
tetracycline resistance genes: tetB and tetD. Larvae fed 10 mg OTC/100 g diet also have
tetB and tetD gene, with an additional tet30 gene detected in the fifth generation. Only
the tetB gene was detected in samples from larvae feeding on 100 OTC mg/100 g diet.
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Similarly only the tetD gene was detected in samples from 400 mg OTC/100 g diet
group. No tetracycline resistance genes were detected in the group feeding on the
highest concentration of oxytetracycline, 1 g/100 g diet.
3.3.3.6 Metagenomic analysis of the G. mellonella gut contents
The genomic DNA samples from G. mellonella guts were prepared for a metagenomic
analysis.  Out of 61 gut samples prepared,  47 had detectable bacterial  DNA. Out of
those only 25 have met the criteria for the minimum DNA concentration required for
the amplification with sequencing primers (over 30 ng/µl and the presence of DNA
fragments over 1 kb). The primers used were standard primers used in 16S sequencing
[124].
A  low  DNA  concentration  recovered  from  G.  mellonella larvae  guts  supports  the
possibility that the larval guts did not contain a dense bacterial community. Out of 25
samples that  have met the sequencing criteria  only  two successfully  went through
amplification with the sequencing  primers.  These two samples  were antibiotic-free
stock larvae collected before the beginning of the experiment and the first generation
of  larvae  feeding  on  400  mg  OTC/100  g  food.  The  other  samples  failed  the
amplification most likely due to a poor quality of DNA, such as sheared or otherwise
damaged DNA. 
Nearly 20,000 valid reads were recovered from each sample, with the antibiotic-free
stock larvae reads assigned to 2,673 operational taxonomic units (OTUs) and the reads
from larvae fed 400 mg OTC/100 g food assigned to 4,310 OTUs. Valid seqencing reads
are all sequences that passed the bioinformatic control steps used to identify artifacts
of the sequencing protocol. They are the reads of the sequences in the initial sample
and  exclude  any  read  that  is  likely  to  be  a  by-product  of  the  sample  preparation
methods or the sequencing protocol (for example two constructs merged together or a
sequence  containing  an  untrimmed  label).  Using  EzTaxon  database  each  OTU  was
identified down to species level by finding the closest related type strain. Some of the
strains  are  environmental  isolates  lacking  a  valid  name  in  the  current  systematic
nomenclature. In such cases, for the purpose of clarity of the figures, the strain name
assigned from EzTaxon was displayed in figures, even though it is not a valid species
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name.
3.3.3.7 Species identified from the guts of G. mellonella
Both samples were analysed for alpha-diversity, also known as species richness, which
indicates the biodiversity of a single community (in our case, each sample containing
DNA from three larval guts). The species richness can be described with the use of a
rarefaction curve (Figure 3-3).  A rarefaction curve is  plotted as the number of new
operational taxonomic units discovered as more sequences are being read. It allows
comparison  of  species  richness  from differently  sized  communities.  Even though  a
similar number of reads was recovered from both communities, the oxytetracycline-fed
larvae had guts yielded nearly two times more different operational taxonomic units,
suggesting the gut communities from antibiotic-fed larvae were more diverse than in
the  antibiotic-free  larvae.  This  result  supports  the  hypothesis  that  oxytetracycline
disrupts the simple native gut microbiota, which provides colonisation resistance, and
allows establishment of a more diverse microbial community.
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Figure 3.3: Rarefaction curves of metagenomic samples from G. mellonella guts. Species richness
in the guts of G. mellonella larvae feeding on artificial food with and without antibiotics. The
rarefaction curve shows the rate of increase in the number of species that are discovered as
more reads are being sequenced. More different bacterial strains were identified in the guts of G.
mellonella feeding on artificial food with oxytetracycline than in the guts of larvae not exposed
to the antibiotic.
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99%  reads  from  the  antibiotic-free  sample  belonged  to  just  one  phylum,  the
Firmicutes, and it was the only identifiable phylum of bacteria present in the sample
(see Figure 3-4a). By “identifiable” I mean that some reads were assigned to reads from
unidentified  or  unclassified bacteria,  often  from large  metagenomic  studies,  where
only short fragments of their genomes  were sequenced. The remaining reads were
eukaryotic, plant DNA from the G. mellonella food, and unmatched sequences, which
had less than 97% similarity to any sequence in the EzTaxon-e database. On the other
hand,  reads  from the oxytetracycline-fed larvae  guts  were more diverse,  with 95%
bacterial  reads  and  3%  archaeal  reads  (see  Figure  3-4b).  The  remaining  2%  reads
belonged to Eukaryota and unmatched sequences. Within the bacterial reads, not only
Firmicutes (81% total reads) were present, but also Proteobacteria (4%), Thermotogae
(3%) and Bacteroides (1%). For both G. mellonella gut samples the phylum Firmicutes
was dominated by the Enterococcaceae family. This finding supports previous culture-
dependent  studies  that  have  found only  Enterococcus  species  in  G.  mellonella gut
[152].  In  previous  studies  predominantly  Enterococcus  faecalis (syn,  Streptococcus
faecalis)  was  isolated,  but  it  was  later  identified  to  be  more  likely  a  strain  of
Enterococcus faecium (syn. Streptococcus faecium) [158]. Previous culture-independent
studies described a gut community composed of Enterococcus species, dominated by
Enterococcus  mundtii [150].  In  our  study  we  found  a  diverse  set  of  Enterococcus
species. The gut microbiome from the oxytetracycline-free sample was dominated by
Enterococcus  mundtii,  and  the  remaining  strains  were:  strain  EU465963_s,
Enterococcus dispar,  strain Enterococcus_uc, strain Enterococcus_uc_s. All  remaining
strains were present below 1.00% abundance. The gut community of oxytetracycline-
fed  larvae  was  dominated  by  strain  EU465963_s,  with  strain  Enterococcus_uc  and
strain  Enterococcus_uc_s  also  present.  The  remaining  strains  were  present  below
1.00% abundance. E. mundtii was detected at 0.03%. Some of the strains isolated lack
valid phylogenetic names. For example strain EU465963_s is a candidate Enterococcus
species isolated from African elephant faeces [159]. The strain has not been cultured
and only partial sequence of the 16S gene is available.
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Figure  3.4: The composition of microbial communities identified in the guts of G. mellonella
larvae
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The bacterial diversity discovered in the guts of Galleria mellonella feeding on artificial
food with and without oxytetracycline is higher than the diversity described before. It is
possible that the insects sampled in the previous studies were not monoxenic. The guts
might have contained a variety of closely related Enterococcus strains that are difficult
to  identify  apart,  without  modern  molecular  biology  techniques  and  sufficient
sampling depth. Even with sensitive PCR methods, if not enough reads are sequenced,
the microbial community might appear as monoxenic.
3.4 Discussion
The purpose of this experiment was to test whether insects feeding on compounds
with antibacterial activity acquire antibiotic-resistant gut microbiota. We identified two
bacterial strains from the guts of  Plutella xylostella feeding on ciprofloxacin, but they
were not more ciprofloxacin-resistant than the type strains. Similarly, two strains were
isolated from the guts of  P. xylostella feeding on oxytetracycline and again the gut-
isolated strains were not more oxytetracycline resistant than the corresponding type
strains. We continued the experiment over five generations using another lepidopteran
host, Galleria mellonella, feeding on artificial food with oxytetracycline. We identified a
tetracycline-resistant strain of  Bacillus subtilis in the guts of larvae feeding on a low
dose of oxytetracycline.
3.4.1 P.  xylostella feeding  on  artificial  food  with  ciprofloxacin  or
oxytetracycline
3.4.1.1 Comparison of bacteria cultured
In two separate experiments with Plutella xylostella gut bacteria, three different strains
have been identified:  Enterobacter amnigenus, shared between the microbiota from
ciprofloxacin-fed  larvae  and  oxytetracycline-fed  larvae,  Bacillus  subtilis from
ciprofloxacin-fed larvae, and Sanguibacter keddideii from oxytetracycline-fed larvae. In
the light of previous investigations into  P. xylostella gut composition [147], we have
cultured  only  about  1%  gut  microbiome.  It  is  possible  that  our  culture  methods
favoured  the  growth  of  certain  bacteria  and  their  growth  inhibited  the  growth  of
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slower growing cells.
3.4.1.2 The  lack  of  ciprofloxacin  and  oxytetracycline  resistance  in  the  guts  of  P.
xylostella larvae feeding on these antibiotics
Bacteria  isolated  from  the  guts  of  P.  xylostella feeding  on  either  ciprofloxacin  or
oxytetracycline were assayed for antibiotic susceptibility and their resistance profiles
were compared to type strains obtained from a culture collection. In many cases no
differences in the resistance levels between type strains and gut isolated strains were
detected. We hypothesised that it  is  one of the most likely scenarios after  the gut
community was exposed to antibiotics. In a complex community like the insect gut,
there is a possibility of detoxification by either the host or a member of the microbial
community. It is also possible not all members of the microbial community are exposed
to toxic concentrations of the antibiotic, for example by forming a biofilm.
It  was  predicted  that  some  of  the  strains  would  acquire  ciprofloxacin  and
oxytetracycline resistance in response to these antibiotics in their hosts’ diets, but such
a response was not observed. No differences in oxytetracycline-resistance levels were
observed  in  oxytetracycline-fed  larvae.  The  B.  subtilis strain  from  the  guts  of  P.
xylostella feeding on ciprofloxacin was less ciprofloxacin-resistant than the type strain,
in spite of the fact that the gut isolated strain was exposed to ciprofloxacin and the
type strain was not. The  B. subtilis type strain ATCC 6051 was originally deposited in
1930 as  B. subtilis Marburg [160] and ciprofloxacin was not approved for clinical use
until 1987 [161]. 
3.4.1.3 Resistance  to  other  antibiotics  in  the  guts  of  P.  xylostella  feeding  on
ciprofloxacin and oxytetracycline
It was hypothesised that antibiotic containing diets would induce multi-drug resistance.
This was true for some strains, such as ampicillin- and chloramphenicol-resistant  B.
subtilis from ciprofloxacin-fed larvae. In most cases no resistance difference between
gut-isolated  strain  and  type  strain  was  identified,  even  though  the  antibiotic
concentrations in the food were physiologically relevant. The 10 mg/mL ciprofloxacin
dose  roughly  equals  to  50  mg/kg  body  weight/day,  which  is  the  top  limit  of
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ciprofloxacin dose recommended for human use (25 – 50 mg/kg body weight/ day)
[123]. The 3 mg/mL dose of oxytetracycline in artificial food is roughly equal to 15 mg
antibiotic/kg  body  weight/day,  which  is  the  recommended  human  dose  of
oxytetracycline.  One  possible  explanation  of  this  finding  is  that  the  antibiotics
underwent  chemical  transformations  in  the  insect  gut.  Both  ciprofloxacin  and
oxytetracycline are most stable at acidic pH and lepidopteran guts normally have basic
pH.  Oxytetracycline  is  stable  at  room  temperature  and  acidic  pH  [162],  but
concentrated solutions (over 5% w/v) at neutral or basic pH degrade within one to
seven days  [163].  All  solutions  used were less  concentrated  than 5% (w/v),  but  to
confirm the stability of the antibiotics in the insect gut, the gut contents and faeces
should be assayed for antibiotic concentration. 
Another possibility  is  that  the antibiotics  in the insect food induced transcriptomic
changes leading to antibiotic tolerance or resistance, but not cell  death. The use of
veterinary fluoroquinolone antibiotic enrofloxacin on dairy farms has been shown to be
associated with reduced antibiotic susceptibly in dairy calves [164]. The animals were
treated for diarrhoea or respiratory disease with a range of veterinary antibiotics, but
only the enrofloxacin use induced significant levels of resistance to other antibiotics,
such  as  fluoroquinolones  nalidixic  acid  and  ciprofloxacin,  and  a  cephalosphorin
ceftriaxone. Ciprofloxacin is known to induce recombination of DNA via either RecBCD-
or RecFOR-dependent mechanism [165]. The mechanism depends on double-strand
DNA breaks and stimulates the recombination between both identical and divergent
DNA sequences. The resulting increased genetic variation can include the acquisition,
evolution and spread of antibiotic resistance elements.
3.4.2 G. mellonella feeding on artificial food with oxytetracycline
3.4.2.1 Bacteria cultured from the guts of G. mellonella
Only three strains were cultured from two samples of  Galleria mellonella guts, even
though  nearly  200  guts  were  sampled.  The  control  sample  collected  before  the
experiment commenced contained two Enterococcus strains, which constitute typical
wax moth microbiota [166]. The strains were oxytetracycline-sensitive. A tetracycline-
86
resistant  B.  subtilis strain  was identified  from the guts  of  fourth  generation  larvae
feeding on oxytetracycline at 1 mg/100 g food. This dose of oxytetracycline is roughly
equal to half of the recommended human dose. The presence of tetracycline-resistant
B. subtilis indicates that sub-inhibitory antibiotic concentrations selected for antibiotic
resistant phenotypes. This supports the hypothesis that antimicrobial compounds in
the insect gut lead to the acquisition of resistance, but a single isolate is not sufficient
to prove this hypothesis.
No  bacteria  were  recovered  from  most  wax  moth  guts.  Only  three  isolates  were
recovered from the total  of  195 guts  dissected.  Such low recovery was not  due to
storage conditions, as two of the isolates were grown from the oldest samples (the
stock insects from the JIC Insectary collected when the experiment was set up). Sample
storage conditions can have an impact on the quality of the data collected. However for
insect  specimens different  storage conditions  such as  freezing,  ethanol,  DMSO and
CTAB, have little to no effect on the structure of bacterial community within the insect
gut [167]. Equally surface sterilization in ethanol was shown to have no impact on the
structure of the bacterial community recovered [167]. In the light of these findings it is
unlikely that the storage conditions or sample preparation were responsible for the low
number of bacteria cultivated from the wax moth guts.
Not only were few bacterial species cultured from the G. mellonella guts, but also little
bacterial DNA was recovered from these samples. It is unlikely that the protocol used
for the isolation of bacterial strains and the DNA extraction was not robust enough or
too  selective  to  suit  the  gut  samples.  Similarly  to  the  sample  storage  conditions,
different  validated  genomic  DNA  extraction  protocols  allow  extraction  of  different
amounts and quality of DNA, but ultimately the bacterial communities sequenced are
undistinguishable [168]. In practice that means different methods of DNA isolation for
sequencing do not have enough bias to produce different results. In our study both the
few bacterial species cultured from the insect guts and the low concentrations of DNA
recovered from the gut samples, point to low abundance of bacteria in the guts, not to
inefficient protocols that failed to detect the presence of bacteria.
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3.4.2.2 Metagenomic analysis
The metagenomic analysis of  G. mellonella gut contents adds an extra dimension to
what  was  already  known  about  the  composition  of  its  gut  microbiota.  Previously
described  as  having  extremely  simple  gut  community  composed  of  one  member
species [150, 166], antibiotic-free G. mellonella harbours a community dominated by a
subset  of  closely-related  Enterococcus species.  The  community  is  dominated  by
Enterococcus mundtii. G. mellonella-derived Enterococcus species have been previously
described as antibiotic-producers preventing colonisation by other species [151, 169]
and  our  results  confirm  low  abundance  of  other  bacteria  consistent  with  this
hypothesis. However, it is not possible to hypothesise further about other potential
roles of Enterococcaceae in G. mellonella.
3.4.2.3 Survey of tet resistance genes in G. mellonella gut
A  variety  of  tetracycline  resistance  genes  was  identified  from  antibiotic-free  G.
mellonella larvae. Interestingly, the bacteria cultivated from the guts of insects before
the  antibiotic  treatment  were  tetracycline-sensitive,  even  though  tetracycline
resistance gene tetM was detected in the sample. The stock insects brought to the
Insectary to set up a colony had tetM resistance gene coding for a ribosomal protection
protein, but after feeding on artificial food, the only detectable tet resistance genes
were efflux pumps. 
These results suggest a shift in microbiota after the colony was moved, even though
the artificial food was prepared according to the same recipe. The initially-collected
insects, collected before the start of the experiment, harboured only tetM ribosomal
protection protein. After rearing the insects on artificial food for five generations, we
only  detected  tet  genes  which  are  efflux  proteins.  After  feeding  the  insects
oxytetracycline, only a sub-set of these tet efflux proteins was detected. The shift in
microbiota from harbouring only the tetM gene to hosting a range of efflux pumps
seems to be caused by both the artificial food, which selected for a variety of efflux
pump genes and the oxytetracycline in the artificial food selected for a narrower range
of efflux pumps: tetB and tetD.
No  resistance  genes  were  identified  in  the  guts  of  larvae  feeding  on  the  highest
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concentrations of oxytetracycline. The high concentration of antibiotic has probably led
to total loss of microbiota from the gut. However, high concentrations of DNA were
recovered from the samples and the metagenomic analysis confirmed the presence of
bacteria in the guts of larvae exposed to high levels of oxytetracycline in their food. 
3.4.3 Limitations of the study
3.4.3.1 The use of type strains as experimental controls
A limitation of the study was the use of the bacterial type strains used as controls. Type
strains are not a sufficient control for antibiotic susceptibility, because they are not a
true  negative  control  which  would  have  a  baseline  antibiotic  susceptibility.  A  type
strain is normally the first isolate of a certain species deposited in a culture collection.
Any other isolate of the species is closely related, but there is no conserved set of
characteristics for the species. Bacterial isolates of the same species can have different
sets of characteristics, such as antibiotic resistance genes. 
The  microbiota  composition,  not  only  their  resistance  levels,  changes  during  the
feeding experiment and the control strains used should reflect this change. Using the
type strains has the advantage that if a new strain is acquired in the antibiotic-treated
sample, a control type strain can be obtained easily from a culture collection. When
the use of type strains is omitted it is more difficult to make comparisons between
strains when a new strain is acquired.
3.4.3.2 Low numbers of bacterial strains recovered from the insect guts
The  Plutella experiments  only  surveyed the culturable  strains,  missing the diversity
represented by the unculturable strains. We tried to account for that missing diversity
when  the  study  was  re-designed  using  G.  mellonella.  The  Galleria experiments
surveyed the unculturable strains by a metagenomic analysis and by the amplification
of tetracycline resistance genes, but their functionality could not have been tested due
to the poor recovery of culturable strains from the larval guts. Ideally we would like to
compare the results from culture-dependent and –independent methods.
To increase the number of strains cultured from the insect guts and to obtain enough
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DNA  for  downstream  analyses  the  gut  samples  were  pooled  in  the  G.  mellonella
experiment.  The  protocol  was  developed  for  another  experiment  (see  Chapter  5,
Replacement of native gut microbiota) where we managed to culture multiple isolates
from  each  sample.  In  the  current  study  the  sample  pooling  helped  reach  DNA
concentrations required for PCR and metagenomic analyses, but did not aid recovering
more bacterial strains from the guts on solid agar media. 
3.4.3.3 Comments about artificial food
Notably  some  groups  of  G.  mellonella larvae  experienced  higher  mortality  when
feeding on the artificial food. There are two possible issues leading to this: mortality
associated with the food itself and mortality associated with the addition of antibiotics.
The first problem is normally caused by sub-optimal composition of the diet and the
mortality occurs in all groups. That was not the case for Plutella xylostella or Galleria
mellonella.  The artificial  food was composed to optimise insect growth and health,
even though such diets do not facilitate easy handling of  the insects.  For example,
larvae on low-protein diets cease silk production making it is easier to clean the food
containers and finding the pupae ready for eclosure (emergence of the adult form).
However such a low-protein diet also leads to fragile pupae, which break easily when
handled. 
There was mortality in the groups of G. mellonella larvae feeding on artificial food with
high concentrations of oxytetracycline, but not in P. xylostella feeding on ciprofloxacin
or oxytetracycline. Mortality associated with antibiotics in the artificial food is often
due to the loss of obligate bacterial symbionts. However,  G. mellonella can be grown
axenically, and the larvae are healthy and able to digest their diets as efficiently as non-
axenic cultures [170]. It is more likely that the mortality in the groups of wax moth
larvae exposed to high concentrations of oxytetracycline was due to a toxic dose of the
antibiotic  in  the diet.  The highest  doses  were selected as  part  of  a  wide range of
concentrations, spreading from sub-inhibitory concentration to above a toxic dose, in
an  attempt  to  capture  the  impact  of  antibiotics  on  the  insect  gut  microbiota  at
different physiological concentrations.
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3.4.4 Summary and conclusions
The aim of this chapter was to test whether the microbiomes of insects feeding on
artificial  food containing  antibiotics  acquire  antibiotic  resistance.  In  the  first  set  of
experiments  Plutella  xylostella feeding  on  ciprofloxacin  contained gut  bacteria  that
were  more  susceptible  to  ciprofloxacin  than  the  corresponding  type  strain.  We
observed increased resistance to other antibiotics, such as ampicillin, chloramphenicol
and tetracycline.  To further test  our hypothesis  the experiment was re-designed to
include  oxytetracycline.  P.  xylostella larvae  feeding  on  artificial  food  with
oxytetracycline, had no increased oxytetracycline resistance levels and the gut bacteria
were  more  susceptible  to  chloramphenicol  and  ciprofloxacin  than  the  type  strains
obtained  from  a  culture  collection.  It  was  not  possible  to  expose  the  insects  to
antibiotics over a number of generations due to pupae mortality and no oviposition in
adults. Instead we adopted a different lepidopteran host: greater wax moth  Galleria
mellonella. We identified oxytetracycline-sensitive bacterial strains in the guts of larvae
collected before the experiment started and an oxytetracycline-resistant strain from
larvae  feeding  on  sub-inhibitory  doses  of  the  antibiotic.  A  survey  of  tetracycline
resistance  genes  present  in  the  larval  guts  identified  a  number  of  different  efflux
pumps in the guts of insects feeding on artificial food without antibiotics and a smaller
sub-set of these efflux pumps in the guts of insects feeding on artificial food containing
oxytetracycline. 
The  results  of  P.  xylostella experiments  do  not  demonstrate  increased  antibiotic
resistance in response to the exposure to ciprofloxacin and oxytetracycline in the insect
diet. The G. mellonella experiment demonstrated a bottom line diversity of tetracycline
resistance genes in the larval  gut and persistence of some of these elements upon
exposure to oxytetracycline. The experiments described show that exposure of bacteria
to an antibiotic in the insect gut does not lead to rapid acquisition of resistance to this
particular antibiotic, unlike the exposure of bacteria to antibiotics on solid or liquid
media.  The  effects  of  antibiotics  on insect  gut  microbiomes are  more  nuanced,  as
demonstrated  here  and  elsewhere.  The  dynamic  resistome  of  the  agriculture-
associated  insects’  gut  in  the  absence  of  a  selective  pressure,  in  the form of  high
concentration of clinically relevant antibiotics, can contribute to the dissemination of
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resistance genes throughout environments. 
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4 Investigating antibiotic resistance in the insect gut bacteria:
the search for novel plant-derived antibacterials
Parts of the work described in this chapter were performed by undergraduate students
under my supervision. Ryan Hull dissected death’s head hawkmoth larvae, identified
the gut bacteria, and performed preliminary antibiotic susceptibility and plant extract
susceptibility assays.  George Newell  dissected beet armyworm larvae,  identified the
gut bacteria, performed antibiotic susceptibility testing and preliminary plant extract
purification.
I would like to thank Prof. Sarah O’Connor and members of her group: Dr Richard Payne
and Dr Evangelos Tatsis for their advice on Catharanthus roseus.
All data in this chapter was generated by me and I produced all figures and tables on
my own.
4.1 Abstract
In this chapter we investigated six different insects feeding on medicinal or toxic plants,
and the antibiotic resistance of their gut bacteria. We wanted to further explore the
phenomenon of antimicrobial resistance that can be found in the gypsy moth larvae in
the absence of clinically relevant levels of antibiotics [121]. There were two aims to
these  experiments:  firstly  to  determine  if  antibiotic  resistance  is  a  common
phenomenon in the insect gut,  and secondly to test whether the elevated levels of
antibiotic  resistance  in  insect  gut  microbiota  can  aid  identification  of  antibacterial
compounds from the insect food-plants. We selected plant/insect pairs based on the
medicinal or toxic properties of the plant, and identified a number of different bacterial
strains  from  the  insects’  guts,  some  of  them  typically  associated  with  the  human
microbiota. After culturing the gut bacteria we tested the antibiotic susceptibility of
these strains and compared it to the susceptibility of type strains obtained from culture
collections. We also tested the susceptibility of both the gut-isolated strains and type
strains to the plant extracts, and used the differences as a guide for fractionation of the
plant extracts. Five out of six extracts tested had antibacterial properties. In some cases
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type strains were more resistant to the plant extract than the gut-isolated strains that
have been exposed to the plant extract. We used mass spectroscopy to identify some
of the metabolites present in the plant extract fractions with antibiotic activity. We
successfully  identified  the  most  abundant  compounds  from Madagascar  periwinkle
extracts and confirmed their antibacterial properties. To summarize, in this chapter we
have  shown  that  antibiotic-resistant  bacteria  can  be  found  in  the  guts  of  insects
feeding  on  medicinal  and  toxic  plants  and  that  metabolites  with  antibacterial
properties  can  be  identified  through  assay-guided  fractionation  of  plant  extracts.
Overall, our approach was successful for identifying antibiotic resistance in the guts of
a variety of insects and for fractionating the plant extracts, but the identification of
plant metabolites remained the main bottleneck in discovery of novel compounds with
antibacterial properties.
4.2 Introduction
4.2.1 Antibiotic discovery void
The antibiotic discovery gap encouraged the search for novel compounds in unusual
places. A wide variety of microbiomes have been screened: soil [171], marine [172] and
even human gut microbiome [173]. Attention has turned towards microbes considered
unculturable. The methods of bacterial culture have been optimised for strains that
cannot be cultured using standard protocols [174] and bioinformatic techniques allow
analysis of strains that cannot be cultured by available protocols [175]. 
Even though such approaches are a recent development, they have already led to the
discovery of novel compounds with antibiotic properties. Teixobactin is an example of
an antibiotic discovered in a screen of bacteria that cannot be grown under standard
laboratory  conditions  [87].  The  screen was conducted by  diluting  soil  samples  and
flowing the suspensions through a microchannel device. The protocol was set up so
that single bacterial cells were separated before the device was placed back in the soil
to allow diffusion of nutrients and growth of bacteria in their native environment. Over
10,000  isolates  have  been  screened  through  this  method  and  strain  candidate
Eleftheria terrae has been shown to produce a potent antibiotic [87]. The antibiotic
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was named teixobactin. Its mechanism of action requires binding precursors of cell wall
components:  peptidoglycan  and  teichoic  acid,  and  therefore  inhibiting  cell  wall
synthesis.  Interestingly  teixobactin-resistant  mutants  cannot  be  readily  obtained  in
vitro with Staphylococcus aureus or Mycobacterium tuberculosis. The lack of resistance
does not indicate that resistance is not going to appear in clinical settings, but it is likely
going to appear later and less frequently.
4.2.2 Phytochemicals as novel antimicrobials
Surprisingly,  a  chemical  space  that  remains  underexploited  is  plant-produced
compounds. Even though plants evolve slower than bacteria, they have larger genomes
and produce an extensive variety of chemical scaffolds. Plants are thought to have over
100,000  secondary  metabolites,  many  of  which  have  antibacterial  activity  [176].
Phytochemicals  have  been  developed  as  extremely  successful  medicines,  including
antimalarial drugs quinine [10] and artemisinin [12], yet there are no commercially-
available plant-derived antibiotics.
An  interesting  approach  in  the  search  for  novel  plant-derived  medicines  is
bioprospecting. Bioprospecting can be defined as a systematic search and development
of biological resources, especially genetic and biochemical ones, particularly utilizing
indigenous knowledge. The key element of bioprospecting is that the approach needs
to be systematic. For example, it was discovered that medicinal plants from related
genra are used in the same therapeutic areas in different parts of the world [177].
Plants from Nepal, New Zealand, and the Cape of South Africa have been arranged in a
genus-level molecular phylogenetic tree.  3.6 – 14.0% plants assessed had a record of
medicinal  use  in  traditional  practices  and plants  indicated  for  treatment  of  certain
diseases  grouped  together  between  different  regions.  The  medicinal  plants  also
grouped  together  with  plants  used  to  produce  pharmaceutical  drugs  used  in
conventional medicine. Such clustering is probably caused by independent discoveries
of  medicinal  properties  by  the  indigenous  cultures  rather  than knowledge  transfer
between cultures. Such clustering also allows identification of good candidate genera
for natural products for drug discovery.
An example of how bioprospecting can lead to bioactive compounds is the isolation of
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evocarpine and four related quinolone alkaloids from the fruits of  Evodia rutaecarpa
[178]. The fruits of E. rutaecarpa are known in traditional Chinese medicine as Fructus
Euodiae  or  Wu  Zhu  Yu,  and  are  used  to  treat  infections  and  inflammation.  The
compounds  were  isolated  from  the  ripe  dry  fruits  that  are  used  to  prepare  the
traditional decoction. Evocarpine was the most active among the compounds tested
against methicillin-susceptible and methicillin-resistant Staphylococcus aureus, but not
Escherichia  coli reference  strain.  Such  studies  confirm  the  activity  of  traditional
medicines and provide candidate molecules for drug development.
Not all plants used in traditional medicine have a specific mode of action. The activity
of some plants is a result of the placebo effect or general cytotoxicity. In many cases
traditional herbal remedies lack quality control and clinical data on their efficacy and
safety, or the data are of sub-standard quality [179]. The chemical composition of plant
formulations  is  often  extremely  variable  and  even  standardized  formulations  are
frequently understudied. In some clinical studies, traditional remedies fail to show a
significant benefit. For example, in a large clinical study of traditional Chinese medicine
remedies  for  childhood  bronchial  asthma  there  was  no  statistically  significant
difference in many clinical indicators between the different remedies and the placebo
group [180]. 
Additionally,  toxicity  of  plant  preparations  can  be  easily  underestimated.  Even  the
oldest records of traditional Chinese medicine specify a category of toxic plants [181].
The category encompasses a third of herbs described and these plants are only to be
used  for  a  short  period  of  time.  Interestingly,  even  though  the  toxicity  of  plant
preparations for humans is a significant issue, hardly any plant is completely free from
herbivory.
A  number  of  insects  feed  on  plants  and  their  products,  including  the  plants  with
medicinal  properties.  It  is  not uncommon for  insect  gut  bacteria to be resistant  to
antimicrobial or toxic components of their foods or to contribute to the detoxification
of such compounds. Royal jelly is a honey bee secretion used for nutrition of queens
and larvae  and has  a  potent  antimicrobial  effect  [182].  While  core  honey bee  gut
bacteria  are  resistant  to  the  antibacterial  activity  of  royal  jelly,  the  corresponding
environmental  strains, non-core species and control  strains not associated with bee
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colonies are susceptible [183]. In a disc diffusion assay, six out of eight core isolates
were  fully  resistant  to  royal  jelly,  the  other  two  isolates  (Neisseriaceae sp.  and
Lactobacillus sp.  A)  were  mildly  susceptible  and  the  corresponding  environmental
isolates were fully susceptible.  For example  Lactobacillus kunkeei gut-isolated strain
was  fully  resistant  while  the  flower-isolated  strain  was  susceptible.  This  finding
suggests that honey bee gut bacteria are specialized to thrive in the gut environment.
In some cases the gut bacteria are responsible for detoxification of the plant food in
the insect gut before digestion. For example apple maggot flies (Rhagoletis pomonella)
harbour in their guts  Pantoea agglomerans, a bacterial strain capable of detoxifying
phloridzin, a potent insecticidal compound present in apple leaves [184]. The flies feed
on phloridzin-rich  leachate  present  on the apple  leaves  and die  if  the  toxin  is  not
utilized by P. agglomerans. Additionally, the bacteria-processed leachate contains more
amino acids, making it more nutritious for the flies. Both the honey bee and the apple
maggot fly examples illustrate how the relationship between insects and their food is
mediated by the insect gut microbiota.
4.2.3 Food with antibacterial activity can lead to antibiotic resistance in
the insect gut
The  insect  diet  exerts  a  strong  selective  pressure  on  the  gut  bacteria  and  can
potentially lead to antibiotic resistance. It was demonstrated in the previous chapter
that  diet  can  exert  a  selective  pressure  on  the  gut  bacteria.  Bacteria  resistant  to
ampicillin, chloramphenicol and tetracycline were found in the guts of diamondback
moth  larvae  feeding  on  artificial  food  containing  ciprofloxacin  and  oxytetracycline
resistant  bacteria  were  found  in  the  guts  of  greater  wax  moth  larvae  feeding  on
oxytetracycline-containing  food.  Surprisingly  a  variety  of  efflux  pumps  conferring
resistance to tetracyclines  were also present  in  the guts  of  insects  not  exposed to
antibiotics for over at least six generations.
Similarly, a range of antibiotic resistance genes was identified in gypsy moth (Lymantria
dispar) gut [121]. The gypsy moth larvae, feeding on a variety of trees (larch, white oak,
willow and aspen) in the wild,  were collected and their  cultured gut bacteria were
resistant  to  many  common  antibiotics:  carbenicillin,  ceftazidime,  chloramphenicol,
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gentamycin,  erythromycin,  kanamycin,  nalidixic  acid,  rifampicin,  streptomycin,
tetracycline and vancomycin. Functional metagenomic analysis of the cultured isolates
was conducted to identify novel antibiotic resistance elements. Libraries of the isolates
were prepared as for metagenomic sequencing analyses, but prior to sequencing they
were screened by plating on antibiotic-containing media to identify genes conferring
resistance to these antibiotics. The analysis revealed three types of genes responsible
for  the  resistant  phenotypes:  1)  a  multidrug  resistance  protein  of  the  resistance-
nodulation-cell  division superfamily,  2) an AraC/XylS family transcriptional  regulator,
and 3) a novel extended-spectrum β-lactamase. 
These novel resistance elements from  Lymantia dispar and tet-resistance genes from
antibiotic-free Galleria melonella are of clinical relevance. The presence of these genes
in insect gut bacteria confers antibiotic resistance phenotypes and can readily spread
to  the  environments  inhabited  by  the  insects.  More  importantly  the  antibiotic
resistance elements  present  in  the  insect  guts  in  the  absence  of  clinically  relevant
levels of antibiotics suggests that the genes can be maintained in response to other
environmental stimuli. We hypothesise that the stimuli responsible for the antibiotic
resistance are components of the insect food with antibacterial activity. 
4.2.4 Aims of this chapter
Previous work has shown that unexpected antibiotic resistance can be found in the
guts of insects feeding on plants. The aims of this chapter were two-fold. Firstly to see
whether the phenomenon of unexpected resistance to antibiotics found in gypsy moth
gut bacteria feeding on the leaves of various trees could be found in other plant-insect
pairs, i.e. is this a general phenomenon? Secondly to test the hypothesis that insect gut
bacteria can be utilized in assay-guided fractionation of plant extracts leading to the
identification of plant fractions with antibacterial activities. We proposed to compare
antibiotic susceptibility profiles and plant extract susceptibility of gut-isolated bacterial
strains and corresponding type strains and use the differences in the susceptibility to
plant extracts between the two different isolates to identify plant extracts with the
most promising antibiotic activity.
98
4.3 Results
To test the hypothesis that antibacterial activity of medicinal plants can be identified
with the use of insect gut bacteria, we assayed gut bacteria from a variety of insects
and their susceptibility to the food plant extracts. This involved the selection of six
plant-insect  pairs  and  an  examination  of  the  antibiotic  susceptibility  of  their  gut
bacteria.
4.3.1 Giant  stick  insect  (Diapherodes gigantea)  feeding on eucalyptus
(Eucalyptus dalrympleana)
4.3.1.1 Diapherodes gigantea
One of  the first  plant/insects pairs we chose to investigate was a giant stick insect
feeding on eucalyptus. Eucalyptus is a plant with known medicinal properties [185] and
a number of eucalyptus trees grow near the JIC, supplying food for the insects and
material for plant extract preparation. The stick insects were already kept in the JIC
Insectary, and they are large and easy to dissect. A single specimen provides sufficient
amount of gut contents for protocol development. Together the medicinal properties
of the plant and the convenience of the insect make this plant/insect pair an ideal
starting point for this part of the project. 
D. gigantea are insects of the order Phasmatodea, native to the Caribbean. The insects
do not have larval  stages,  and instead they hatch as  nymphs and moult  five times
before reaching adulthood. They are characterised by sexual dimorphism, with larger
lime-green females reaching up 15 to 20 cm length and smaller brown males reaching
10-15  cm length  (Figure  4-1).  Both  sexes  have underdeveloped wings,  that  cannot
sustain flight, but the males can make long jumps.
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4.3.1.2 Gut dissections
We obtained two female adult stick insects from the JIC Insectary. The insects died of
old age and did not have to be euthanized.  Before the dissection the insects were
stored in a freezer to avoid decomposition. The digestive tracts of the insects were
dissected aseptically by making a laceration along the body of the insect and picking
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Figure  4.1:  Giant  stick  insect  (Diapherodes  gigantea)  feeding  on  eucalyptus  (Eucalyptus
dalrympleana). Female stick insect is shown in the top panel and male stick insect is shown in
the bottom panel. Photo by Andrew Davies, JIC, Norwich.
out the gut, which resembles a large tube filling most of the body cavity. The gut can be
easily identified as it contains partially digested green and brown plant material with
large undigested seeds. 
The gut contents were serially diluted, plated on solid media and incubated in aerobic
conditions.  We  initially  incubated  the  gut  bacteria  in  both  aerobic  and  anaerobic
conditions, but we have not obtained any obligatorily anaerobic bacteria. For every
new species of insects we initially cultivated the gut bacteria with and without oxygen,
but  in  every  case  there  were  no  bacterial  strains  that  would  grow  exclusively  in
anaerobic conditions. Insects’ guts are normally anoxic [187] and the low oxygen levels,
especially  in  the  midgut,  are  maintained  by  endogenous  chemical  processes,
suggesting that the bacteria isolated from the insect guts are facultatively anaerobic. A
possible explanation for this is that the insect gut bacteria are often environmental
strains that are adapted both to the outside environment and the insect gut, or strains
specific to the insect gut that need to withstand the aerobic conditions during vertical
transfer from the mother to the egg.
4.3.1.3 Identification of the gut bacteria
Three bacterial species were cultivated from the stick insect guts and identified by 16S
PCR  using  alkaline  PEG  reagent.  Briefly,  the  PCR  conditions  facilitate  the  lysis  of
bacterial  cells  and  the  release  of  genomic  DNA.  The  16S  gene  is  amplified  with
universal primers that are specific for bacteria but not unique for any particular group
of  bacteria.  The  16S  gene  codes  for  the  16S  ribosomal  RNA which  is  a  structural
component of the prokaryotic ribosome. It  is  composed of a series of single-strand
loops and double-strand stems. The double-strand stems contain complementary RNA
strands. The loop regions of the RNA are free to mutate and correspond to the variable
regions of the gene. They allow distinguishing between closely related bacteria. The
stem regions of the RNA are much more conserved and that regions of the gene evolve
much slower than the variable regions.
We  identified  the  three  bacterial  isolates  from  the  D.  gigantea guts:  Bacillus
amyloliquefaciens,  Microbacterium  oxydans and  Sphingobacterium  multivorum.  B.
amyloliquefaciens and  M. oxydans are environmental  strains, first isolated from soil
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and air  respectively.  S.  mulitvorum,  on the other  hand,  was first  isolated from the
human spleen. From our observations, insect gut microbiota often contain a mixture of
environmental isolates and strains considered to be human pathogens. 
To investigate the antibiotic  resistance in the guts  of  the stick  insects we obtained
bacterial type strains, matching the strains isolated from the stick insect guts, from the
Centre de Resources Biologiques de l'Institut Pasteur in Paris (CRBIP) culture collection.
Both the gut-isolated strains and type strains were assayed for antibiotic susceptibility
by  the  broth  microdilution  method.  It  was  hypothesised  that  in  response  to
antimicrobial  compounds  in  eucalyptus,  the  gut  isolated  strains  would  be  more
antibiotic resistant than the type strains. 
4.3.1.4 Antibiotic susceptibility testing
The gut-isolated strains and the type strains were tested in a broth microdilution assay
for  their  susceptibility  to  ampicillin,  chloramphenicol,  ciprofloxacin,  kanamycin,
rifampicin and tetracycline. This panel of antibiotics was chosen based on their varied
mechanisms of action. Ampicillin inhibits the final stage of cell wall synthesis leading to
cell  lysis.  Chloramphenicol  prevents  protein  synthesis  by  inhibiting  the  peptidyl
transferase activity of the ribosome. Ciprofloxacin is a gyrase inhibitor and kills cells by
creating breaks in DNA. Kanamycin inhibits protein synthesis by interfering with the
30S  ribosomal  subunit.  Rifampicin  disrupts  RNA  synthesis  by  inhibiting  RNA
polymerase. Finally, tetracycline prevents protein synthesis by blocking the attachment
of the aminoacyl-tRNAs to the ribosome. 
In most cases there was no difference in antibiotic  susceptibility between the type
strains and gut-isolated strains (Table 4-1). B. amyloliquefaciens gut-isolated strain was
more resistant to ciprofloxacin and tetracycline than the type strain. M. oxydans from
the stick insect gut was more resistant to ciprofloxacin, but less resistant to tetracycline
when compared to the type strain. Gut-isolated S. multivorum was more susceptible to
tetracycline than the type strain, unsurprisingly as the type strain is a clinical isolate.
102
Table  4.1:  Antibiotic  susceptibility  profiles  of  the  gut  bacteria  from  D.  gigantea  and
corresponding type strains.  MICs for six different antibiotics were assessed by a broth dilution
assay. Differences in antibiotic-resistance levels between the strains have been highlighted in
green when the gut-isolated strain was more resistant than the type strain and in red when the
type strain was more resistant than the gut-isolated strain. p < 0.005.
Minimal inhibitory concentrations of antibiotics in broth dilution
assay [μg/mL]
Bacillus
amyliliquefaciens
Microbacterium
oxydans
Sphingobacterium
multivorum
gut strain type
strain
gut strain type
strain
gut strain type
strain
ampicillin >64 >64 >64 >64 >64 >64
chloramphenicol 2 2 1 1 1 1
ciprofloxacin 0.25 <0.01 0.03 <0.01 0.25 0.25
kanamycin 1 1 >64 >64 >64 >64
rifampicin 1 1 1 1 1 1
oxytetracycline 1 0.03 2 >64 0.25 32
4.3.1.5 16S metagenomic analysis
Sample preparation
Only a small proportion of bacteria can be cultured under laboratory conditions. It is
often  repeated  that  99%  bacteria  are  unculturable. To  assess  what  proportion  of
bacterial strains is recovered from the insect gut by culture-dependent methods, we
compared the bacteria  isolated from the insects’  digestive tracts by plating and by
sequencing of the whole gut communities. Our metagenomic analysis was a study of all
16S genes recovered directly from the stick insects’ gut contents.
To conduct this study another two stick insects were dissected as described before.
Bacteria from their guts were cultivated and identified. Additionally bacterial genomic
DNA (gDNA) was isolated from the samples using a kit optimised for the use with soil
bacteria.  Initially  we used a protocol  in which bacterial  cell  wall  was enzymatically
digested,  but  the yields and quality  of  gDNA were low, probably  due to enzymatic
degradation of the genetic material during the lengthy digestion of thick bacterial cell
walls. Instead we opted for MP Bio Kit for Soil which utilizes bead-beating in a tissue
lyser to break open cells. The bead-beating can be performed at a low temperature or
the samples can be cooled down in between the beating steps.  The yield of  gDNA
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greatly improved with the use of the kit.
Sequencing
After the gDNA extraction the gut samples were submitted for 16S sequencing with
Chun  Lab  (Seoul,  Korea).  The  sequencing  lab  performed  quality  controls,  such  as
measuring  the  amount  of  DNA  in  samples  and  assessing  their  quality,  and  the
metagenomic library construction before sequencing on the MiSeq Nano platform. The
initial bioinformatics analysis, such as trimming of the initial reads, contig assembly,
filtering  low  quality  reads  and  chimeric  sequences,  was  also  performed  by  the
sequencing lab. The data were read and processed in CLcommunity software.
Before the metagenomic analysis results are discussed it is important to mention the
difference  between  the  terms  operational  taxonomic  units  and  bacterial  species.
Species can be defined as a group of organisms consisting of similar individuals capable
of exchanging genes and producing fertile offspring.  Within this definition the term
does not apply to bacteria. A more rigorous definition is the operational taxonomic
unit, which refers to a group of sequences with 97% similarity. Here we understand
bacterial species as a group of strains with 97% identity between 16S genes and we use
the terms species and operational taxonomic units interchangeably.
Species richness
The samples were analysed for species richness, the measure of diversity of bacterial
strains present in the insect guts. Even though the samples contain different number of
valid reads, they can be compared with the use of the rarefaction curves. A rarefaction
curve plots  the number of  new operational  taxonomic  units  discovered (which can
treated as new bacterial species identified in each sample) against the number of reads
sequenced. This type of plot shows not only which sample contained more different
bacterial strains as the same number of sequences was being analysed, but also if the
communities  were  sampled  at  a  sufficient  depth.  When  the  sequencing  was  deep
enough (the sufficient number of sequences was read), no new operational taxonomic
units are being discovered, i.e. every strain in the sample has been identified.
104
The two samples, originating from two separate stick insects, contained 9450 and 8450
valid reads, yielding 97 and 53 operational taxonomic units (OTUs) respectively. The
rarefaction curve reached a plateau indicating that the bacterial diversity in the guts
has been sufficiently sampled (Figure 4-2). Out of the sample with 97 different OTUs,
only 12 were present at above 1% abundance (Figure 4-3). The most abundant strain
was Serratia marcescens, which constituted 33% bacterial reads retrieved from the G.
gigantea guts.  The other gut sample contained 53 OTUs and five of them were present
above  1%  abundance.  Again,  S.  marcescens was  the  dominating  strain  in  the  gut
community with 91% abundance. S. marcescens is a common pathogen of insects but it
can be also found in healthy insects [188].
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Figure  4.2:  Rarefaction  curves  of  metagenomic  samples  from  two  D.  gigantea  guts.  A
rarefaction curve shows the rate of increase in the number of species that are discovered as
more reads are being sequenced.  These data indicate that one of the samples had larger
species diversity as more OTUs were discovered from it and that both guts were sampled
sufficiently to discover most strains present in them.
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Figure  4.3: The composition of D. gigantea gut community by genus (inner ring) and species
(outer ring) level. The composition of two gut communities was shown separately. The first
sample (a) had contaminant plant DNA and higher species diversity. The second community (b)
was dominated by S. marcescens. Bacteria with less than 1% abundance were pooled together
into the “other bacteria” category.
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S. marcescens was the dominant species, constituting 33% and 91% each gut dissected
(Figure 4-3). The only bacterial order found in the guts was Enterobacteriales. Only one
of the D. gigantea guts contained plant material (15%), which indicates that either the
samples were insufficiently homogenized before DNA isolation or one of the insects
ceased feeding earlier and its gut was enriched in bacteria. Other strains shared by the
two gut communities are:  Pantoea beijingensis,  Lellottia amnigena, and Enterobacter
asburiae. 
Culture-dependent methods
Because the metagenomic analysis was performed on a new set of insect guts,  we
cultured and identified strains from these samples as described before. A set of strains
was identified:  Serratia marcescens,  Microbacterium paraoxydans,  Kocuria rhizophila
and Pectobacterium cypripedi. The older samples, used for the assessment of antibiotic
resistance  in  the  insect  gut,  contained  a  different  set  of  strains:  Bacillus
amyloliquefaciens,  Microbacterium oxydans and  Sphingobacterium multivorum.  It  is
unusual  no strains  are shared between the two sets  of  D. gigantea guts.  The only
closely  related strains  are  the two  Microbacterium species.  There are  two possible
explanations for this observation: 1) the two sets of stick insects had very different gut
microbiomes, or 2) we have not plated enough cells to sample the true diversity in the
insect guts. Most likely the differences observed are due to the combination of both
these factors.
Comparison of culture-dependent and –independent methods
Surprisingly initially only Serratia marcescens and Pantoea cypripedii were found both
in the cultured strains and the metagenomic dataset. To investigate if 16S sequences
belonging  to  the  strains  we  cultured  from  the  insect  guts  are  present  in  the
metagenomic dataset, we searched the datasets for sequences with 97% similarity to
the  sequences  from  the  cultured  strains.  We  used  the  CLcommunity  software  to
browse  the  metagenomic  datasets  from  the  stick  insect  guts.  A  BLAST  search  for
sequences matching the cultured strains can be performed on the metagenomic data
from the stick insects’ guts. When the datasets were queried for sequences matching
the 16S gene from  M. paraoxydans and  K. rhizophila, sequences with ≥97% identity
were returned. This indicates that either these strains were present in the stick insect
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gut but were misidentified, or a close relative was present in the gut community and
the  algorithm used to  align  the  16S  sequences  cannot  distinguish  between closely
related sequences. 
Such discrepancy is  a result  of differences between the databases used for  species
identification  in  each  method.  For  identification  of  cultured  strains  the  GeneBank
database was used and the metagenomic database was based on TaxonEZ. TaxonEZ is
carefully  curated  database  and  its  main  purpose  is  to  allow  for  identification  of
bacterial strains down to species level. GeneBank is a larger, less curated database that
allows identification of the most related strains without the focus on nomenclature and
phylogeny.
Additionally the algorithm used is blastn which is optimised for similar, not identical
sequences.  The  algorithm  permits  gaps  in  sequence  alignments  and  scores  these
alignments to assign a sequence with the best overall similarity. We chose to use blastn
because of its robustness, sacrificing the accuracy of the match.
Metagenomics - summary
In our comparison of culture-dependent and –independent methods we have shown
that we can culture less than 3% strains from the  D. gigantea guts. We were able to
culture the most abundant strain, Serratia marcescens and some less abundant strains.
We  have  also  found  discrepancies  in  the  bioinformatic  analyses  of  the  sequences
generated by the culture-dependent and –independent methods.
4.3.1.6 Eucalyptus extract preparation
To test the antibacterial properties of the eucalyptus leaves, an extract was prepared
by infusing dried eucalyptus leaves in methanol for three days, replacing the solvent
daily. The antibacterial activity of the extract was assayed by the disc diffusion method.
Paper discs were infiltrated with the eucalyptus extracts and dried to evaporate the
methanol. The discs were placed on bacterial lawns of the gut-isolated strains and type
strains of  Bacillus amyloliquefaciens,  Microbacterium oxydans and  Sphingobacterium
multivorum. It was hypothesised that the type strains would be more susceptible to the
plant extracts as they have not been exposed to them before. 
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It was observed that sometimes the type strain was more resistant to the eucalyptus
extract  than  the  gut–isolated  strain  (Table  4-2).  No  differences  in  plant  extract
susceptibility were observed for B. amyloliquefaciens, both the gut-isolated strain and
type strain were fully resistant to the eucalyptus extract. As predicted gut-isolated S.
multivorum strain was more resistant to the eucalyptus extract than the type strain
that had not been exposed it. Surprisingly, the opposite was observed for M. oxydans.
The gut-isolated strain was more eucalyptus extract susceptible than the type strain
that  has  not  been  previously  exposed  to  it.  M.  oxydans has  shown  unexpected
ciprofloxacin resistance in the antibiotic susceptibility testing and it is possible that the
strain is generally more resistant to a number of compounds or conditions.
Table  4.2:  The  susceptibility  of  the  gut  bacteria  from D.  gigantea  and  corresponding  type
strains to eucalyptus leaf extract. The values were obtained in a disc diffusion assay. The discs
carried 10 μg dried eucalyptus extract. The differences in plant extract susceptibility between
the strains were highlighted with green when the gut-isolated strain was more resistant than
the type strain and in red when the type strain was more resistant than the gut-isolated strain.
The assay was repeated three times.
Diameter of hinhibition zones [mm]
Bacillus
amyliliquefaciens
Microbacterium
oxydans
Sphingobacterium
multivorum
gut strain type
strain
gut strain type
strain
gut strain type
strain
crude 0 0 7 4 10 17
HPLC fraction 0 0 12 10 7 14
It should be noted that to compare the antibacterial activity of extracts from different
plants, the extracts were standardized. Each extract was dried in an evaporator until a
dry pellet was obtained. Sometimes large amounts of waxy material were present in
the  samples  and  the  pellets  would  not  appear  dry.  In  such  cases  the  pellet  was
evaporated  until  no  more  reduction  in  volume  occurred.  The  pellets  were  then
weighted and re-suspended in methanol at 100 µg/mL. These re-suspended extracts
were used to infuse paper discs before assaying on the bacteria from the insect guts
and the corresponding type strains. This procedure was carried out to standardize the
concentrations of plant extracts and compare their antibacterial properties.
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4.3.1.7 Eucalyptus extract fractionation
Preliminary fractionation
After we established the eucalyptus extract has an antibacterial activity, we attempted
to purify an active fraction of the extract. Initially the crude extract was centrifuged to
remove insoluble matter from the solution and that crude extract was directly injected
onto the HPLC with an analytical C18 column. Only small volumes of non-concentrated
sample can be analysed with such approach. Multiple repetitions of the injection were
required  to  obtain  enough  HPLC  fractions  for  antibiotic  activity  testing.  We  have
discovered that the active fraction was very tightly bound to the column matrix and the
column needed to be washed with large volumes of methanol to remove it. 
Normal-phase HPLC fractionation
Extremely  high  affinity  of  the  active  fraction  to  the  C18  matrix  indicates  that  the
components are highly hydrophobic.  A more suitable method of separation in such
case is normal phase HPLC. The difference between normal phase and reverse phase
HPLC is the polarity of the column matrix (stationary phase) and the solvents (mobile
phase). In the older type of chromatography, the normal phase, the stationary phase is
polar and the mobile phase is non-polar. For example a separation on a silica column
might  be  performed using  a  gradient  of  hexane  and  acetonitrile.  In  reverse  phase
chromatography the stationary phase is non-polar and the mobile phase is polar. For
example a fractionation can be performed on a C18 column (a matrix made of long
hydrocarbon chains) using a gradient of water and methanol.
Similar to previous fractionation with reverse phase chromatography, the compounds
responsible for the activity were very tightly bound to the column matrix. The column
required washing with large amounts of solvent to release the activity. In this case
however, the compound was too hydrophilic for the separation on normal phase HPLC.
Introduction of sample preparation methods before fractionation
It  was surprising that the active fraction contained a compound that would be too
hydrophobic and too hydrophilic at the same time. However these two fractionations
demonstrated that the crude extracts have many components and further processing
of the extract before HPLC fractionation is advisable.
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We developed  two  methods  for  processing  the  extracts  before  HPLC  fractionation
(Figure  4-4).  Firstly,  to  remove  any  waxy  substances  that  could  interfere  with  the
fractionations, we de-fatted the concentrated methanol extract using an equal volume
of  petroleum  ether.  To  separate  the  most  hydrophobic  compounds  the  resulting
methanol  extract  was  partitioned  with  equal  parts  of  chloroform  and  water.  The
methanol/water  partition  was  dried  and  resuspended  in  methanol  before
fractionation.
Secondly, we added a solid-phase extraction (SPE) process. SPE is a type of sample
preparation technique where the sample is applied to a matrix (solid phase) and is
washed with different solvents to separate compounds from the sample based on their
affinities  to  these  solvents.  SPE  is  a  popular  way  of  filtering  samples  before  HPLC
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Figure 4.4: A schematic of plant extract fractionation.
fractionation to remove compounds that could permanently bind the HPLC matrix. In
our case SPE was used to allow a two-dimensional fractionation: one of the dimensions
being separation based on polarity, using C18 matrix, and the second dimension being
ion-exchange SPE which separates compounds based on their charge.
We also tried size exclusion chromatography, which separates molecules based on their
size  but  this  type  of  separation  was  not  accurate  enough.  The  samples  obtained
contained a large mixture of different compounds and the separation was unreliable.
Final fractionations
We eventually settled on a mixture of  methods described above. After establishing
antimicrobial activity of the extract, it was concentrated and de-fatted with petroleum
ether.  The aqueous partition was further purified using weak anion exchange solid
phase extraction cartridges.  The active methanol fraction was fractionated on HPLC
using C18 matrix. However separation of the peaks was not possible with this matrix as
the sample was too hydrophilic (Figure 4-5). The compounds present in the sample did
not bind to the C18 matrix and all eluted at the same time, at the beginning of the
gradient. 
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Figure 4.5: HPLC chromatogram of the eucalyptus extract.  The sample was fractionated using
Shimadzu LCMS-2020 (single-quad), semi-preparative C18 column and 10 – 100% methanol
gradient. The UV/vis detector scanned 190-800 nm wavelengths. The extracted wavelengths
are  254  nm,  detecting  UV-active  compounds.  All  fractions  were  assayed  for  antibacterial
activity in a disc diffusion assay and the active fraction  was highlighted in blue.
The presence of a mixture of compounds of different sizes was confirmed in mass-
spectrometry analysis.  Between 20 and 25 different masses were identified for the
most abundant ions in the sample, ranging between 264.8250 m/z and 630.9556 m/z
(Table 4-3). Two of the masses were identified as formic acid and trifluoroacetic acid,
which are markers added to chromatographic solvents. Not only were we not able to
separate the compounds, but it is also not possible to determine the structure of these
compounds with their masses only.
Table  4.3: A list of most abundant ions  in the eucalyptus extract fraction with antibacterial
activity  detected by LCMS-IT-ToF Mass  Spectometer  (IT-ToF,  Shimadzu)  using analytical  C18
column and 10 -100% acetonitrile gradient against 0.1% formic acid in water. The ions were
analysed against common contaminant ions such as formic acid. The samples were compared
with others that did not have an antibiotic activity and the ions shared between them were not
considered to have antibiotic properties.
ion m/z
ratio
retention
time [min.]
compound name comments
458.9500 4.467
520.7500 4.594
344.0000 7.233
248.8000 4.706 present in samples without antibacterial activity
226.8250 6.200 TFA
330.9000 6.73
112.9417 5.917 formic acid dimer
250.8583 7.600
384.7500 4.461
444.9000 6.113
518.9250 6.711
731.3000 4.967
296.8583 6.994
755.4083 5.100 present in samples without antibacterial activity
The further purification and identification of the compounds from the active fraction of
the eucalyptus extract could not be continued. We cannot determine the structures of
these compounds with nuclear  magnetic  resonance (NMR),  as sufficient amount of
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pure  material  cannot  be  obtained  using  the  current  methods.  We  cannot  further
separate the compounds with our current methods without the knowledge of their
structures that would allow us to select method that would separate them. 
4.3.2 Diamondback  moth  (Plutella  xylostella)  feeding  on  cabbage
(Brassica rapa)
4.3.2.1 Plutella xylostella
The next plant/insect pair was diamondback moth feeding on cabbage. A colony of P.
xylostella was already set up in the JIC Insectary and we used these larvae for some of
our  previous  work  (see  previous  chapter).  There  are  no  data  on  the  medicinal
properties  of  cabbage,  but  it  was  selected  from  other  brassicas  based  on  their
anecdotal  medicinal  properties  in  Polish  folklore.  Cabbage  and  cabbage  juice  are
believed to have health benefits and are sometimes used as a treatment for intestinal
parasites.
Diamondback  moths,  of  order  Lepidoptera,  are  globally  distributed,  economically-
important pests of cruciferous crops. As mentioned in the previous chapter, they are
small moths with a wingspan of 15 mm and a body length of 6 mm (Figure 4-6), and
the larvae feed on bottom leaf surfaces during four larval instars. 
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P.  xylostella larvae  are  a  notorious  pest,  due  to  a  lack  of  natural  enemies  and
developing resistance to all conventional insecticides, including the Bt toxin [146]. Few
effective  natural  enemies  of  diamondback  moths  are  known,  and mildly  successful
parasitoids are not capable of long migrations that the moths are noted for. A wide
range insecticide resistance has been described in  P. xylostella,  including carbamate
(most  kill  insects  by  reversibly  inactivating  acetylcholinesterase),  organophosphate
(which  kill  by  irreversible  inactivation  of  acetylcholinesterase),  pyrethroid  (which
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Figure  4.6: Diamondback moth (top panel) and larva (bottom panel). Photo by Russ Ottens,
University of Georgia,  Bugwood.org.
depolarize axonal membranes),  abamectin (which causes hyperpolarization of nerve
cells),  benzoylphenylurea  (which  inhibit  chitin  synthesis)  and
dichlorodiphenyltrichloroethane  –  DDT  (which  depolarizes  neurons).  Additionally,
extensive  insecticide  use often  kills  the parasitoids  of  diamondback  moths,  further
impeding  the  biological  control  efforts.  Another  biological  control  is  Cry  toxin-
producing Bacillus thuringiensis. In the alkaline insect gut the toxin inserts into the cell
membranes,  forming pores.  Even before the introduction of  transgenic  Bt crops,  P.
xylostella exhibited resistance to a wide repertoire of Bt toxins, including detoxification
enzymes and systems for toxin excretion (see review by Pardo-Lopez et al., 2013 [189]).
The  resilience of  diamondback  moths  allows them to feed on unpalatable  or  toxic
plants without the health costs. The gut bacteria live in a hostile niche in comparison
with other insects with less harsh diets. The bacteria are exposed to the compounds
making the plants  unpalatable to other insects and we hypothesised high levels  of
resistance can be seen in the P. xylostella gut bacteria. 
4.3.2.2 Gut dissections
Five final instar P. xylostella larvae feeding on cabbage were collected and starved for
two hours. Such procedure allows the insect guts to be enriched in bacteria as the food
already present in the gut is being digested. The guts were dissected under aseptic
conditions and immediately plated out on agar media.
The gut contents were plated as described for the stick insects. The gut bacteria were
cultured and identified by 16S sequencing. The strains identified were  Sanguibacter
keddieii and Raoultella terrigena. One of the strains, S. keddieii, had been isolated in a
separate  experiment  from  P.  xylostella feeding  on  artificial  food  containing
oxytetracycline  (Chapter  3),  which  indicates  that  a  proportion  of  the  microbiota  is
stable and persistent in the conditions observed. S. keddieii is a rare bacterial species,
previously isolated from the blood of otherwise heathy cows [190].  R. terrigena was
previously classified as Klebsiella terrigena and is normally isolated from soil and water
[191].
S.  keddieii and  R.  terrigena type  strains  were  obtained  from  Centre  de  Resources
Biologiques de l'Institut Pasteur (Paris) culture collection and both the type strains and
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gut-isolated strains were assayed for antimicrobial susceptibility (Table 4-4). In nearly
half of the tests performed there were differences in antibiotic susceptibility between
the  gut-isolated  strain  and  the  type  strain.  The  R.  terrigena type  strain  was  less
resistant  to ampicillin  than the gut-isolated strain.  S.  keddiei type  strain  was more
resistant  to  ampicillin,  chloramphenicol,  ciprofloxacin  and  kanamycin  than the  gut-
isolated strain. The differences in antibiotic resistance levels of S. keddiei were unusual
and higher than the other strains tested. 
Table  4.4:  Antibiotic  susceptibility  profiles  of  the  gut  bacteria  from  P.  xylostella  and
corresponding type strains.  MICs for six different antibiotics were assessed by a broth dilution
assay. Differences in antibiotic-resistance levels between the strains have been highlighted in
green when the gut-isolated strain was more resistant than the type strain and in red when the
type strain was more resistant than the gut-isolated strain. p < 0.001.
Minimal inhibitory concentrations of antibiotics in broth dilution
assay [μg/mL]
Sanguibacter keddieii Raoultella terrigena
gut strain type strain gut strain type strain
ampicillin 16 >64 >64 16
chloramphenicol 1 2 1 1
ciprofloxacin <0.01 0.03 <0.01 <0.01
kanamycin 2 >64 1 1
rifampicin 1 1 2 2
tetracycline 1 1 1 1
To follow up the antibiotic susceptibility testing, we assayed the susceptibility of the
bacterial strains to the cabbage extract. Cabbage extract was prepared by macerating
cabbage leaves in methanol and concentrating the extract by evaporation. The extract
and tested for  antibacterial  activity by the disc  diffusion assay.  The extract did not
inhibit the growth of any of the P. xylostella gut or type strains (Table 4-5). Since only
two  strains  were  isolated  from  the  guts  of  diamondback  moth  larvae,  we  tested
additional strains: an indicator strain Escherichia coli ATCC 25922, and strains isolated
from  the  stick  insect  gut:  Bacillus  amyloliquefaciens,  Microbacterium  oxydans and
Sphingobacterium multivorum, with their corresponding type strains. No antibacterial
activity was observed against any of these strains.
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Table  4.5:  The  susceptibility  of  the  gut  bacteria  from P.  xylostella  and corresponding  type
strains to cabbage leaf extract. The values were obtained in a disc diffusion assay. The paper
discs were infiltrated with up to 20 μg dried cabbage extract. The experiment was repeated
three times.
Diameter of inhibition zones [mm]
Sanguibacter keddieii Raoultella terrigena
gut strain type strain gut strain type strain
crude 0 0 0 0
After no antibacterial activity was detected in the cabbage extract, no further work was
carried out. We decided to focus on other plant/insect pairs, even though it would be
interesting to further investigate why some plants have antibacterial activity and others
do not.
4.3.3 Cinnabar  moth (Tyria  jacobaeae)  feeding  on  ragwort  (Jacobaea
vulgaris)
4.3.3.1 Cinnabar moth
The goal of this project was to investigate both medicinal and toxic plants. Our choice
of a toxic plant was ragwort (Jacobaea vulgaris), which is poisonous to some animals,
but  it  also is  a  food source for  some insects,  such as  cinnabar  moth larvae (Tyria
jacobeae). Conveniently ragwort plants are abundant on the playing fields around JIC
and we could collect large amounts of plants with cinnabar moths feeding on them.
Cinnabar moth belongs to the order Lepidoptera and feed specifically on plants of the
genus  Senecio (ragworts and groundsels). The black and orange-yellow striped larvae
reach up to 35 mm and the black and red adults have a wingspan of 32 – 42 mm and
body length up to 20 mm (Figure 4-7). 
Ragwort is a plant of ecological importance in the UK, being a food source for a variety
of insect species. However, ragwort is poisonous to horses and cattle and T. jacobaeae
larvae are sometimes used as biological control [192]. Ragwort is hepatotoxic due to a
variety of alkaloids present in the plants. The poisonous compounds from ragwort are
sometimes believed to have evolved as chemical defence against herbivores. However,
some herbivores sequester a  sub-group of  ragwort alkaloids,  pyrrolizidine alkaloids,
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and use them as a predation deterrent themselves [193]. Tyria jacobeae is capable of
sequestering  one  of  the  alkaloids,  senecionine.  Additionally  the  larvae  modify  the
compound into N-oxide. The modified senecionine N-oxide is nontoxic and stored by
the  insect,  but  can  be  oxidized  and  regain  its  toxicity  in  the  guts  of  the  potential
insectivore.
119
Figure  4.7: Cinnabar moth larvae (top panel) and adults (bottom panel) feeding on ragwort.
Photo by Eric Coombs, Oregon Department of Agriculture, Bugwood.org.
4.3.3.2 Gut bacteria
Five bacterial strains were isolated from the guts of cinnabar moth larvae feeding on
ragwort  leaves:  Burkholderia  fungorum,  Bacillus  licheniformis,  Kocuria  rhizophila,
Staphylococcus  epidermidis and  Staphylococcus  warneri.  Staphylococcus species  are
common members of human skin microbiota, but it is not uncommon for insect gut
microbiota to include such isolates. As described in the previous chapter,  E. faecalis,
bacterial  species  most  commonly  found  in  human  microbiota,  is  a  member  of  G.
mellonella gut microbial community. It is unlikely these species are a contamination
introduced during gut dissections as the procedure was carried out in sterile conditions
following appropriate dissection procedures.
S. epidermidis and S. warneri are the only isolates in the guts of cinnabar moth larvae
that  are  normally  associated  with  human  microbiota.  All  the  remaining  bacterial
isolates are environmental strains:  B. fungorum was first isolated from a fungus and
both B. licheniformis and K. rhizophila are soil bacteria.
4.3.3.3 Antibiotic resistance
Type strains matching the gut isolated species were obtained from CRBIP and DSMZ
culture collections and all isolates were assayed for antibiotic susceptibility. In many
cases  the type  strain  was more resistant  to antibiotics  than the gut-isolated strain
(Table 4-6). The B. fungorum type strain was more resistant than the gut-isolated strain
to ciprofloxacin and kanamycin. The B. licheniformis type strain was more resistant to
three antibiotics than the gut-isolated B. licheniformis: ampicillin, chloramphenicol and
oxytetracycline.  There  were  no  differences  in  antibiotic  susceptibility  between  K.
rhizophila gut isolated strain and the type strain. The S. epidermidis gut-isolated strain
was more resistant to ampicillin than the type strain and S. warneri gut-isolated strain
was more resistant to ciprofloxacin than the type strain. Additionally,  S. warneri type
strain was more resistant to rifampicin and oxytetracycline than the gut strain. The
large number of cases where the type strain was more antibiotic-resistant than the gut-
isolated strain was unexpected, but as observed with eucalyptus extract they are not
always an indication of the absence of antibacterial activity in the plant extract.
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Table 4.6:  Antibiotic susceptibility profiles of the gut bacteria from the cinnabar moth larvae
and corresponding type strains.  MICs for  six  different antibiotics  were assessed by a broth
dilution  assay.  Differences  in  antibiotic-resistance  levels  between  the  strains  have  been
highlighted in green when the gut-isolated strain was more resistant than the type strain and
in red when the type strain was more resistant than the gut-isolated strain. p < 0.001.
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4.3.3.4 Ragwort extract
Ragwort  extract  was  prepared  by  soaking  the  dried,  ground  leaves  in  methanol,
concentrating  the  initial  infusion  and  partitioning  it  to  remove  most  hydrophobic
compounds.  The  extract  was  tested  for  antibiotic  activity  in  a  disc  diffusion  assay
against gut-isolated strains from the guts of cinnabar moth larvae and the matching
type strains (Table  4-7).  There were no differences in  ragwort  extract susceptibility
between the gut-isolated strain and type strain of  B. licheniformis.  Four gut-isolated
strains were more resistant to the ragwort extract than the corresponding type strains:
B. fungorum,  S. epidermidis and S. warneri.  K. rhizophila gut-isolated strain was more
susceptible to the ragwort extract than the type strain. Surprisingly, the strains were
equally antibiotic-susceptible, making it difficult to hypothesise what caused increased
resistance to the plant extract.
Even though three out of five type strains tested were more resistant to the plant
extract than their corresponding gut strain, the ragwort extract exhibited a high level of
antibiotic  activity  and the extract  was investigated further.  The partitioned ragwort
extract was fractionated on weak anion exchange SPE and HPLC (Figure 4-8). There
were a number of different peaks present in the chromatogram, indicating the extract
was a mixture of different compounds. It  was not practical to purify different plant
extracts at the same time, as the process is very labour-intensive and the fractionation
of other extracts was prioritised. 
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Table 4.7: The susceptibility of the gut bacteria from the cinnabar moth guts and corresponding
type strains to ragwort leaf extract. The values were obtained in a disc diffusion assay. The
discs  were  infiltrated  with  10  μg  dried  ragwort  extract.  The  differences  in  plant  extract
susceptibility between the strains were highlighted with green when the gut-isolated strain was
more resistant than the type strain and in red when the type strain was more resistant than the
gut-isolated strain. The assay was repeated three times.
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Even though we have not fractionated the ragwort extract,  it  was subjected to MS
analysis. Mass spectroscopy is less labour-intensive than the fractionation procedure
and it was performed on the ragwort samples to detect the presence of known ragwort
metabolites. The most abundant ions in the ragwort extract are listed in Table 4-8. We
did  not  detect  any  of  the  usual  contaminant  ions  such  as  formic  acid,  which  is
consistent  with  the  lack  of  extract  fractionation  and  minimal  sample  preparation
before  the  mass  spectroscopy.  We  have  not  detected  the  presence  of  the  most
abundant  pyrrolizidine  alkaloids  and  their  N-oxides,  which  are  the  compounds
responsible for the toxicity of ragwort to cattle. These alkaloids are: jacobine (m/z 351),
jaconine (m/z  387),  jacozine  (m/z  349),  otosenine  (m/z  381),  retrorsine (m/z  351),
seneciphilline  (m/z  333),  senecionine  (m/z  335),  and  senkirkine  (m/z  366),
acetylerucifoline  (m/z 392),  erucifoline  (m/z  350),  integerrimine (m/z 335),  jacoline
(m/z 369), riddelline (m/z 350), senecivernine (m/z 335), spartioidine (m/z 333), and
usaramine  (m/z  351).  The  N-oxides  have  m/z  ratios  n+16.  The  low levels  of  these
metabolites suggest that the pyrrolizidine alkaloids were either not extracted from the
plant  material  or  not  selected  for  in  the  assay-guided  fractionation,  and  are  not
responsible for the antibacterial activity of the ragwort extract.
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Figure  4.8: HPLC chromatogram of the ragwort extract.The sample was fractionated using
Shimadzu LCMS-2020 (single-quad), semi-preparative C18 column and 10 – 100% methanol
gradient. The UV/vis detector scanned 190-800 nm wavelengths. The extracted wavelengths
are 254 nm, detecting UV-active compounds. 
Table  4.8: The most abundant ions present in the ragwort extract. The most abundant ions
present in the ragwort extractdetected by LCMS-IT-ToF Mass Spectometer (IT-ToF, Shimadzu)
using analytical C18 column and 10 -100% acetonitrile gradient against 0.1% formic acid in
water.
Ion m/z retention time [min.]
231.0846 0.966
255.0473 1.013
525.3544 0.192
436.4304 4.851
357.1159 0.779
214.9145 1.352
214.9158 0.547
185.0451 0.848
229.0695 0.963
371.0949 0.804
Cinnabar  moth  larvae  feeding  on  ragwort  was  an  interesting  plant/insect  pair  to
investigate.  Many  of  the  bacterial  strains  isolated  from  the  insect  guts  were  less
antibiotic-resistant and less resistant to the ragwort extract than their corresponding
type strains. Nonetheless the ragwort extract exhibited a high level of antibiotic activity
and contained a number of compounds which could be investigated for antibacterial
activity.
4.3.4 Rosemary  beetle  (Chrysolina  americana)  feeding  on  lavender
(Lavendula angustifolia)
4.3.4.1 Rosemary beetle
Another plant/insect pair investigated was rosemary beetle and lavender. Lavender was
chosen  as  an  example  of  typically  medicinal  plant.  L.  angustifolia’s  former  known
species name, Lavendula officinalis, refers to its medicinal uses. As with cinnabar moth
and ragwort, the lavender plants grow around the JIC and rosemary beetles can be
found feeding on them. Additionally large amounts of plant material for extractions can
be obtained from gardening centres.
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Rosemary beetles are small beetles in the order Coleoptera. The larvae, reaching up to
8 mm long, are grey with darker stripes along their bodies and the adult beetles are
metallic with purple and green stripes and reach 5 – 8 mm body length (Figure 4-9).
The C. americana beetles cannot fly. The insects are native to Eastern Europe and the
Mediterranean region, but have been found in the UK since 1990s.
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Figure 4.9: Rosemary beetles feeding on lavender. Photo by Katarzyna Ignasiak, JIC, Norwich.
The  beetles  are  adapted  to  feeding  on  plants  in  the  family  Lamiaceae,  including
rosemary,  lavender  and  thyme.  In  our  study  the  insects  were  feeding  on  lavender
(Lavendula angustifolia), an evergreen shrub, previously known as Lavendula officinalis
due to its medicinal properties.
4.3.4.2 Rosemary beetle gut bacteria
Adult  beetles  were  collected  from  the  lavender  plants  growing  outside  the  Chatt
building on the JIC site. The beetles are small  and have a rigid exoskeleton making
dissections  difficult.  Instead the insects  were surface-sterilized and ground up.  The
whole-insect suspensions were plated on agar media for culturing gut bacteria. Five
different  bacterial  strains  were  isolated  from  surface-sterilized  rosemary  beetles:
Microbacterium  foliorum,  Microbacterium  gubbeenense,  Pantoea  agglomerans,
Rhodococcus erythropolis and Staphylococcus epidermidis. 
The bacteria that we refer to as gut bacteria are for rosemary beetle all bacteria that
can be isolated from the entire insect.  The rosemary beetle microbiota is probably
dominated by the gut bacteria. As discovered for other insects, some of the rosemary
beetle bacteria are environmental isolates while other strains are members of human
microbiota.  In  case  of  the  rosemary  beetle  microbiota,  three  strains  were  of
environmental  origin:  M. foliorum was first  isolated from the surface of  leaves,  M.
gubbeenense from cheese and  R. erythrypolis from soil. The two remaining bacterial
strains were human-associated: both  P. agglomerans and  S. epidemidis can be found
on human skin.
4.3.4.3 Antibiotic susceptibility testing
Matching type strains were obtained from the CRBIP and DSMZ culture collections and
antibiotic susceptibility of all isolates was assessed in a broth microdilution assay (Table
4-9).  In  comparison with other  insect  gut  microbiomes there  were few differences
between the strains isolated from the insect guts and the matching type strains. There
were  no  differences  in  antibiotic  susceptibility  to  ampicillin,  chloramphenicol,
ciprofloxacin, kanamycin, rifampicin or oxytetracycline between the type strains and
gut-isolated  strains  of  M.   foliorum,  M.  gubbeenense,  P.  agglomerans and  R.
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erythropolis. The S. epidermidis type strain was more susceptible to ciprofloxacin and
kanamycin than the gut  strain.  Even though not  many differences  in  the antibiotic
susceptibility between the strains have been detected, in two cases when this was the
case the gut-isolated strain was more resistant than the type strain, indicating it was
under selective pressure. The increased antibiotic resistance of the rosemary beetle
gut bacteria was encouraging for further investigation of the antibacterial activity of
the lavender extract.
4.3.4.4 Lavender extract
The  rosemary  beetles  feed  on  lavender  leaves,  but  the  plants  harvested  for  the
preparation of the lavender extract also had flowers. Out of convenience both leaf and
flower  lavender  extracts  were  prepared  and  assayed  for  antibiotic  properties.  The
strains were tested in a disc diffusion assay for susceptibility to lavender extract (Table
4-10). The leaf extract was antibacterial against two of the bacterial strains used and
the flower extract was active against all five strains. Both extracts exhibited only a mild
level  of  activity.  In  most  cases  there  were  no  differences  in  the  susceptibility  to
lavender extracts. The S. epidermidis gut strain was more resistant to lavender flower
extract than the type strain and the  M. foliorum type strain was more resistant to
lavender leaf extract than the gut-isolated strain. It  was hypothesised that the gut-
isolated strains would be more resistant to the plant extracts that it was exposed to
before.  The  difference  between  M.  foliorum gut-isolated  strain  and  type  strain  is
opposite to what was predicted. 
Only a mild level of antibacterial activity was detected in the rosemary extracts and the
flower  extract  was  more  active  than  the  leaf  extract.  Only  the  flower  extract  was
investigated further. The lavender flower extract was subjected to purification with SPE
and HPLC. Low level antibacterial activity was detected in five HPLC fractions ranging
between 17 – 50% methanol (Figure 4-10). The low level of activity hindered the assay-
guided fractionation as separating the peaks in HPLC lowered the individual antibiotic
activity  of  each  peak  below  detection  level.  An  identification  of  the  most  active
components of the extract was not possible without a large-scale increase in the HPLC
efficiency or improving the sensitivity of the assay. 
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Table  4.9: Antibiotic susceptibility profiles of the gut bacteria from the rosemary beetles and
corresponding type strains. MICs for six different antibiotics were assessed by a broth dilution
assay. Differences in antibiotic-resistance levels between the strains have been highlighted in
green when the gut-isolated strain was more resistant than the type strain and in red when the
type strain was more resistant than the gut-isolated strain. p < 0.005.
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Table  4.10:  The  susceptibility  of  the  gut  bacteria  from  the  rosemary  beetle  guts  and
corresponding type strains to lavender extract. The values were obtained in a disc diffusion
assay. The discs were infiltrated with 10 μg dried ragwort extract.  The differences in  plant
extract susceptibility between the strains were highlighted with green when the gut-isolated
strain was more  resistant  than the  type  strain  and in red when the  type  strain  was more
resistant than the gut-isolated strain. The assay was repeated three times.
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Our experiments do not confirm the strong medicinal properties of lavender extracts.
Even though the antibiotic  resistance differences between the gut bacteria isolated
from the rosemary beetles and the type strains were promising, we have not detected
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Figure 4.10: HPLC chromatogram of the lavender extract. The sample was fractionated using
Shimadzu LCMS-2020 (single-quad), semi-preparative C18 column and  10 – 100% methanol
gradient. The UV/vis detector scanned 190-800 nm wavelengths. The extracted wavelengths
are  254  nm,  detecting  UV-active  compounds.  The  fraction  with  antibacterial  activity  was
highlighted in blue.
strong antibiotic activity in the lavender extracts. The low level of antibiotic activity in
the lavender extracts and their active fractions hindered the experiment progress and
prevented the identification of the active components.
4.3.5 Death’s  head hawkmoth (Acherontia atropos)  feeding on potato
(Solanum tuberosum)
4.3.5.1 Death’s head hawkmoth
Death’s  head  hawkmoth  larvae  feeding  on  potato  were  investigated  as  another
example of an insect feeding on a toxic plant. We were particularly interested in the
potential  antibiotic  activity  of  the  potato  leaves,  which  are  toxic  and  grown  in
abundance as a waste product of potato crops. 
Death’s head hawkmoth belongs to order Lepidoptera and is primarily found in Europe.
The larvae are yellow-green with diagonal yellow and purple stripes on the sides and a
tail horn (Figure 4-11). The fourth instar reaches 120 – 130 mm. The brown and yellow
moths have a wingspan of 90 – 130 mm and body length of 40 – 60 mm. The most
striking feature of the adults is a pattern on the thorax resembling human skull, linked
to folklore association of the moths with supernatural and evil forces. When disturbed
the moths produce a short squeaks by drawing air in and out of their pharynx [194].
The  insects  are  polyphagous,  feeding  on  plants  in  the  families  Solanaceae
(nightshades), Verbenaceae (verbena family), Oleaceae (olive, ash and jasmine), and
Bignoniaceae  (bigonias,  most  noted  for  ornamental  flowers).  A.  atropos can  also
parasitize beehives without being detected and attacked by the bees due to chemical
camouflage [195]. The hawkmoths produce four fatty acids, two unsaturated ones (9-
hexadecenoic  acid  and 9-octadecenoic  acid)  and two saturated ones (hexadecanoic
acid and octadecanoic acid),  which prevent detection by bees. The hawkmoth fatty
acids belong to a group of bees’ signals to distinguish nest mates from invaders, but
the exact mechanism of recognition is not known. In our study the hawkmoth larvae
were feeding on potato leaves (Solanum tuberosum), which A. atropos is a mild pest of.
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4.3.5.2 Gut bacteria
Death’s head hawkmoths were brought into the JIC Insectary. The larvae were reared
feeding exclusively on potato plants. Ten of the larvae were collected and dissected.
Their gut contents were plated. Three different bacterial strains were isolated from the
guts  of  death’s  head  hawkmoths:  Enterobacter  asburiae,  Pseudomonas  putida and
Roultella terrigena.  E. asburiae is a species normally isolated from clinical specimens,
while the two other isolates,  P. putida and  R. terrigena,  are environmental  bacteria
commonly isolated from soil and water. Raoultella terrigena was isolated in a previous
experiment from the guts of diamondback moth larvae.
133
Figure  4.11: Death’s head hawkmoth larva (top panel) and adult (bottom panel). Photo by
Andrew Davies, JIC, Norwich.
4.3.5.3 Antibiotic susceptibility testing
After obtaining type strains matching each death’s  head hawkmoth gut isolate, the
strains were assayed for antibiotic susceptibility. There were differences in antibiotic
susceptibility in the majority of tests performed and most of the type strains were
more antibiotic-resistant than their matching gut-isolated strain (Table 4-11). The  E.
asburiae type strain was more resistant than the gut isolated strain to all antibiotics
tested:  ampicillin,  chloramphenicol,  ciprofloxacin,  kanamycin,  rifampicin  and
tetracycline.  The  P.  putida type  strain  was  more  resistant  to  chloramphenicol,
kanamycin, rifampicin and tetracycline. R. terrigena type strain was more resistant than
the  gut  strain  to  chloramphenicol  and  more  susceptible  than  the  gut  strain  to
kanamycin and tetracycline. 
Table  4.11:  Antibiotic  susceptibility  profiles  of  the  gut  bacteria  from  the  death 痴  head
hawkmoth  larvae  and  corresponding  type  strains.  MICs  for  six  different  antibiotics  were
assessed  by  a  broth  dilution  assay.  Differences  in  antibiotic-resistance  levels  between  the
strains have been highlighted in green when the gut-isolated strain was more resistant than
the type strain and in red when the type strain was more resistant than the gut-isolated strain.
p < 0.005.
Minimal inhibitory concentrations of antibiotics in broth dilution
assay [μg/mL]
Enterobacter
asburiae
Pseudomonas putida Raoultella terrigena
gut strain type
strain
gut strain type
strain
gut strain type
strain
ampicillin 8 >64 >64 >64 >64 >64
chloramphenicol 1 4 2 >64 1 2
ciprofloxacin <0.125 0.5 <0.125 <0.125 <0.125 <0.125
kanamycin 8 16 4 8 16 8
rifampicin 4 16 4 8 8 8
oxytetracycline 1 2 0.25 2 1 0.5
4.3.5.4 Potato leaf extract 
Potato leaf extract was prepared from dried potato leaves and assayed for antibacterial
activity  on  the panel  of  bacteria  isolated  from the  hawkmoth larvae  guts  and the
matching type strains (Table 4-12). There were no differences in  potato leaf extract
susceptibility between the gut isolates and type strains of E. asburiae and P. putida. R.
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terrigena gut-isolated strain was more susceptible to the potato leaf extract than the
type strain, contrary to what was expected. The strains had some unexpected antibiotic
resistance differences. The type strain was more chloramphenicol-resistant than the
gut-isolated strain, opposite to the predicted resistance profile. It is possible that both
the chloramphenicol  resistance and the increased  potato leaf  extract resistance are
due  to  the  same  mechanism.  Because  of  the  matching  differences  in  antibiotic
susceptibility and the plant extract susceptibility, the antibacterial activity in the potato
leaf  extract  was  investigated  further,  even  though  the  activity  levels  were  low  in
comparison with other extracts.
Table 4.12: The susceptibility of the gut bacteria from the death's head hawkmoth larvae guts
and corresponding type strains to the potato leaf extract. The values were obtained in a disc
diffusion assay. The discs were infiltrated with 10 μg dried ragwort extract. The differences in
plant extract  susceptibility  between the strains were highlighted with green when the gut-
isolated strain was more resistant than the type strain and in red when the type strain was
more resistant than the gut-isolated strain. The assay was repeated three times.
Diameter of inhibition zones [mm]
Enterobacter
asburiae
Pseudomonas putida Raoultella terrigena
gut strain type
strain
gut strain type strain gut strain type
strain
crude 7 7 6 6 10 7
The active methanol partition of potato leaf extract was subjected to fractionation on
weak anion exchange SPE and HPLC. As observed before with eucalyptus extracts, the
antibacterial activity eluted at the beginning of the gradient (Figure 4-12). This suggests
that the antibacterial activity is either due to a common phytochemical present in both
plant species, or the activity is caused by an artefact of the fractionation procedure,
such as accumulation of formic acid. The fractionation of the different plant extracts
followed the same workflow and it is possible that it was biased towards a certain class
of chemicals. 
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Because the fractionation of the potato leaf extract resembled the fractionation of the
eucalyptus  extract,  it  was  decided  to  pursue  purification  of  just  one  of  them.
Antibacterial  activity  of  the  eucalyptus  extract  was  higher  than  the  activity  of  the
potato leaf extract, and eucalyptus extract was selected for further purifications (see
section 4.3.1.7). 
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Figure 4.12: HPLC chromatogram of the potato leaf extract. The sample was fractionated using
Shimadzu LCMS-2020 (single-quad), semi-preparative C18 column and 10 – 100% methanol
gradient. The UV/vis detector scanned 190-800 nm wavelengths. The extracted wavelength is
254  nm,  detecting  UV-active  compounds.  The  fraction  with  antibacterial  activity  was
highlighted in blue.
4.3.6 Beet  armyworm  (Spodoptera  exigua)  feeding  on  Madagascar
periwinkle (Catharanthus roseus)
4.3.6.1 Beet armyworm
We  decided  to  investigate  the  antibiotic  properties  of  Madagascar  periwinkle
(Catharanthus  roseus)  as  the  plant  is  known  to  contain  alkaloids  with  medicinal
properties. Sarah O’Connor’s group in JIC Biological Chemistry Department specializes
in C. roseus metabolites and we decided to use their expertise.
Beet armyworm is an important agricultural pest in the order Lepidoptera, native to
Asia but present worldwide. The larvae are 15 – 20 mm long, dull green with darker
stripes along the body (Figure 4-13). The adults are grey-brown moths with a wingspan
of 26 – 32 mm. The insects are normally killed by frost and overwinter in warmer areas
or greenhouses, but invade colder areas annually.
S.  exigua are  pests  of  vegetable,  field,  and  flower  crops,  including  alpha  alpha,
asparagus, aubergine, bean, beet, broccoli, cabbage, cauliflower, celery, chickpea, corn,
cotton,  cowpea,  lettuce,  onion,  pea,  peanut,  pepper,  potato,  radish,  safflower,
sorghum, soybean, spinach, sugar beet, sweet potato, tobacco, tomato, and turnip. In
our  study  armyworm  larvae  were  feeding  on  Madagascar  periwinkle  (Catharantus
roseus), a plant endemic to Madagascar. 
4.3.6.2 Catharanthus roseus
C.  roseus is  a  plant  commonly  used in  traditional  medicine  throughout  the  world.
Ethnopharmacological  uses  of  Madagascar  periwinkle  range  from  diabetes,
hypertension, malaria, dengue fever, dysentery, insect bites, skin infections, diarrhoea,
leukaemia, eye irritation, indigestion, toothache, sore throat, lung congestion and as a
sedative and tranquilizer [196].
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However  the  plant  is  probably  best  known  for  the  terpenoid  indole  alkaloids  it
produces which are used in cancer therapy. Vinblastine and vincristine are used in the
treatment  of  leukaemia  and  Hodgkin's  lymphoma.  Both  vinblastine  and  vincristine
decrease the white blood cell count. Their mechanism of action depends on inhibiting
microtubule  assembly  by  binding  tubulin,  therefore  preventing  the  separation  of
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Figure  4.13: Beet armyworm larva and moth.  Beet armyworm larva (top panel)  and moth
(bottom panel). Photo by John C. French Sr., Retired, Universities: Auburn, Georgia, Clemson
and Missouri, Bugwood.org.
chromosomes during metaphase and leading to cell death [197].
The  production  of  vinca  alkaloids  used  in  cancer  therapy  is  dependent  on  the
Madagascar periwinkle crops, even though their semi-synthetic production is possible.
The precursors to terpenoid indole alkaloids can be synthesised in yeast [198], but their
production is not economically viable. The use of terpenoid indole alkaloids in cancer
therapy  and the dependence of  the supply  chain on  the  Catharantus roseus crops
makes Madagascar periwinkle one of the most economically important plants. 
4.3.6.3 Antibiotic resistance in beet armyworm gut bacteria
Four  bacterial  strains  were  isolated  from beet  armyworm  guts:  Bacillus  aquimaris,
Bacillus  vietnamensis,  Microbacterium  paraoxydans and  Rhizobium  pusense.  B.
aquimaris,  B.  vietnamensis and  R.  pusense are  environmental  isolates,  and  M.
paraoxydans is a clinical isolate. As discussed before it is not unusual for an insect gut
to contain both environmental strains and isolates of clinical importance.
Type strains matching the strains isolated from the beet armyworm guts were obtained
from the DSMZ culture  collection and all  of  the strains were assayed for  antibiotic
efficacy (Table 4-13). Differences in antibiotic susceptibility were detected in over a half
of  the  tests  performed.  B.  aquimaris type  strain  was  more  susceptible  to
chloramphenicol and kanamycin, but more resistant to rifampicin than the gut-isolated
strain.  B.  vietnamensis type strain  was  more  resistant  to  five  out  of  six  antibiotics
tested:  ampicillin,  chloramphenicol,  ciprofloxacin,  kanamycin  and  rifampicin.  M.
paraoxydans type  strain  was  more  susceptible  to  ampicillin  and  more  resistant  to
ciprofloxacin  than  the  gut-isolated  strain.  R.  pusense gut-isolated  strain  was  more
resistant than the type strain to ciprofloxacin, kanamycin and tetracycline. Differences
between antibiotic resistance levels were identified between the type strains and the
gut-isolated strains.  In six cases the gut-isolated strains were more resistant and in
seven cases the type strains were more resistant.
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Table 4.13: Antibiotic susceptibility profiles of the gut bacteria from the beet armyworm larvae
and corresponding type strains.  MICs for  six  different antibiotics  were assessed by a broth
dilution  assay.  Differences  in  antibiotic-resistance  levels  between  the  strains  have  been
highlighted in green when the gut-isolated strain was more resistant than the type strain and
in red when the type strain was more resistant than the gut-isolated strain. P < 0.01.
oxytetracycline
rifam
picin
kanam
ycin
ciprofloxacin
chloram
phenicol
am
picillin
8 4 >64
0.5 8
>64
gut strain
aquam
aris
Bacillus
M
inim
al inhibitory concentrations of antibiotics in broth dilution assay [μg/m
L]
8 16 32 0.5 2
>64
type strain
8 4 32 0.5 4 32
gut strain
vietnam
iensis
Bacillus
8 16
>64 1
32
>64
type strain
16 16
>64 1
32
>64
gut strain
paraoxydans
M
icrobacterium
16 16
>64 4
32 32
type strain
32 16
>64
32 32
>64
gut strain
pusense
Rhizobium
 8 16 32 0.5 32
>64
type strain
4.3.6.4 Madagascar periwinkle extract
After establishing the antibiotic resistance profiles of the gut bacteria from the beet
armyworm,  we  investigated  the  antibiotic  activity  of  the  periwinkle  extract.  Some
140
metabolites are more abundant in the aerial parts of the plant and others in the roots
and it was decided to investigate the extracts of both, even though the insects do not
feed on  the  roots.  The  extracts  were  prepared by  soaking  the  dried  ground  plant
material in methanol. They were tested for antibacterial activity against gut-isolated
strains and type strains (Table 4-14). 
There were no differences in Madagascar periwinkle leaf extract susceptibility between
the  gut  strains  and  type  strains  of  the  two  Bacillus isolates:  B.  aquimaris and  B.
vietnamensis.  The  R. pusense gut isolate was more resistant than the type strain to
both the leaf and root extract. Contrary to what was expected, in a number of cases
the type strain was more resistant to the C. roseus extract than the gut-isolated strain,
even though the gut isolate was exposed to the plant extract and the type strain was
not.  M. paraoxydans type strain was more resistant to both the leaf and root extract
than the gut strain and both B. aquimaris and B. vietnamensis type strains were fully
resistant to the periwinkle extract while the gut-isolated strains were susceptible. All
three type strains that were unusually resistant to the periwinkle extract, were also
antibiotic-resistant opposite to how they were predicted to be in comparison to the gut
isolates.
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Table  4.14: The susceptibility of the gut bacteria from the beet armyworm larvae guts and
corresponding type strains to the Madagascar periwinkle extract. The values were obtained in
a disc diffusion assay. The discs carried 10 μg dried eucalyptus extract. The differences in plant
extract susceptibility between the strains were highlighted with green when the gut-isolated
strain was more  resistant  than the  type  strain  and in red when the  type  strain  was more
resistant than the gut-isolated strain. The assay was repeated three times.
flow
er extract
leaf extract 
16 6
gut
strain
aquam
aris
Bacillus
Diam
eter of inhibition zones [m
m
]
0 6
type
strain
17 6
gut
strain
vietnam
iensis
Bacillus0 6
type strain
28 8
gut strain
paraoxydans
M
icrobacterium
20 6
type strain
17 6
gut strain
pusense
Rhizobium
 20 7
type
strain
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4.3.6.5 Extract fractionation
The root extract had higher antibiotic activity than the leaf extract and it was selected
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Figure  4.14:  HPLC chromatogram of  the  Madagascar  periwinkle  extract.  The  sample  was
fractionated using Shimadzu LCMS-2020 (single-quad), semi-preparative C18 column and 10 –
100%  methanol  gradient.  The  UV/vis  detector  scanned  190-800  nm  wavelengths.  The
extracted wavelengths are 254 nm (red), detecting UV-active compounds, and 354 nm (blue)
detecting conjugated double bonds.
for  further  purification.  As  mentioned  before  the  HPLC  fractionation  is  a  labour-
intensive process and only few extracts have been processed that way. Some of the
downstream analyses, such as mass spectroscopy, are less time-consuming and can be
performed for  numerous samples.  That  is  why some plant  extracts  have not  been
fractionated, but we obtained preliminary data on their most abundant metabolites. 
The  root  extract  was  partitioned  with  petroleum ether  to  remove  fats  that  would
interfere with further purification. The partitioned extract was further purified on SPE.
The fractions were similar to each other and the antibacterial activity was not specific
to a particular fraction. For periwinkle extract, the SPE fractionation was not accurate
enough and instead the crude de-fatted extract was fractionated on HPLC (Figure 4-14).
As with other plant extracts described above the active fraction eluted at the beginning
of the methanol gradient with fractions containing less than 15% methanol, suggesting
the active components of the extract did not interact with the C18 matrix of the HPLC
column.  The  HPLC  fraction  with  the  antibiotic  activity  was  analysed  by  mass
spectroscopy to determine which metabolites were present.
The  root  extract  sample  fractionated  on  HPLC was  subjected  to  LC-MS analysis  to
assess how many different compounds make up the fraction with antibiotic activity.
The most abundant ions are listed in Table 4-15. Some of the ions were identified by
running their  m/z ratios against  the annotated metabolites in the Medicinal  Plants
Consortium  database  (http://metnetdb.org/mpmr_public/).  The  most  abundant  ion
detected was serpentine. The other abundant ions were matched to metabolites with
unknown structures. The identifiers of these metabolites are shown in Table 4-15, but
the database does not provide any more information about these compounds. Present
in the root extract were also loganic acid, serpentine and catharanthine. The structures
of the metabolites with known structures are shown in Figure 4-15.
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Table  4.15: A list of most abundant ions present in the periwinkle root extract fraction with
antibacterial  activity,  detected  by  LCMS-IT-ToF  Mass  Spectometer  (IT-ToF,  Shimadzu)  using
analytical C18 column and 10 -100% acetonitrile gradient against 0.1% formic acid in water.
The ions were matched with some known metabolites from C. roseus metabolomics database
based on their m/z ratios. For ions without a good match in the database, the closest match
was listed. 
Ion m/z retention time [min.] compound name
349.1700 7.755 serpentine
397.2112 6.928 MDC-Cat-HPLC-E-POS-F1-397.2-6.93
315.0734 6.429 MDC-Cat-HPLC-E-POS-F1-315.119-6.43
396.2036 10.808 MDC-Cat-HPLC-E-POS-F1-396.184-10.81
350.1733 5.658 MDC-Cat-HPLC-E-POS-F1-350.172-5.66
377.0871 2.360 loganic acid
349.1539 2.893 serpentine
337.1836 7.153 catharanthine
398.2159 10.314 MDC-Cat-HPLC-E-POS-F1-398.145-10.31
397.2108 6.928 MDC-Cat-HPLC-E-POS-F1-397.2-6.93
The non-fractionated leaf extract was also subjected to mass spectroscopy. The most
abundant ion identified was vindoline, followed by loganic acid, and serpentine (Table
4-16). As before, a number of ions were matched to metabolites with an unknown
structure. The structures of the known metabolites are shown in Figure 4-15. Some of
the metabolites were shared between the leaf and root extracts. Both serpentine and
loganic acid were found in the root extract and leaf extract.
We  confirmed  the  presence  of  vindoline  in  the  leaf  extract  using  commercially-
available vindoline as LC-MS standard.  However, at  the time of the experiment the
other compounds were not available and we were not able to confirm their presence in
the samples.
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Neither of the extracts contained a single metabolite and it is difficult to hypothesise
which  one  of  the  metabolites  identified  was responsible  for  the antibiotic  activity.
Instead we established minimal inhibitory concentrations (MICs) for the commercially
available compounds detected in the fractions (Table 4-17). The differences between
the  metabolites  from the  periwinkle  extracts  and tested  compounds  are  shown in
Figure 4-16. Vindoline had the lowest MIC, with 150-600 µg/mL. Previous data also
discovered vindoline to be the most active terpenoid indole alkaloid, but the MIC was
found  to  be  1000  µg/mL  [199].  The  other  compounds  tested,  ajmalicine,
catharanthinine and loganin, had MICs between 300-1250 µg/mL. The MIC values are
not as low as hoped for, as successful antibiotics have MICs lower with at least an order
of magnitude. Interestingly, the lowest MIC values were obtained for permeable E. coli
strain, suggesting the compounds kill cells more effectively when they can efflux into
cells easily.
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Figure  4.15:  Chemical  structures of  the identified metabolites  from C.  roseus  extract  with
antibacterial  activity.  The  active  fraction  from  the  root  extract  contained  serpentine  (a),
loganic acid (b) and catharanthine (c). The leaf sample contained vindoline (d) as the most
abundant metabolite, followed by loganic acid (b) and serpentine (a). 
Table 4.16: Most abundant ions present in the periwinkle leaf extract. A list of most abundant
ions present in the periwinkle leaf extract, detected by LCMS-IT-ToF Mass Spectometer (IT-ToF,
Shimadzu) using analytical C18 column and 10 -100% acetonitrile gradient against 0.1% formic
acid in water. The extract only has a mild antibacterial activity. The ions were matched with
some known metabolites from C. roseus metabolomics database based on their m/z ratios. For
ions without a good match in the database, the closest match was listed. 
Ion m/z retention time [min.] compound name
457.2317 0.829 vindoline
397.2108 2.193 MDC-Cat-HPLC-E-POS-F1-397.2-6.93
377.0871 2.360 loganic acid
349.1539 2.893 serpentine
521.06 1.884 MDC-Cat-HPLC-E-POS-F1-521.204-2.05
458.2358 0.829 MDC-Cat-HPLC-E-POS-F1-458.207-9.83
439.219 0.84 MDC-Cat-HPLC-E-POS-F1-439.202-9.5
520.9128 0.400 MDC-Cat-HPLC-E-POS-F1-520.217-9.48
656.8851 0.200 MDC-Cat-HPLC-E-POS-F1-656.345-13.73
397.2112 5.554 MDC-Cat-HPLC-E-POS-F1-397.2-6.93
Table 4.17: Minimal inhibitory concentrations of the main metabolites from C. roseus extracts.
Where  the  metabolite  was not  commercially  available  we tested the  closest  metabolite  or
precursor that was available.
strain Minimal inhibitory concentration [mg/mL]
vindoline loganin ajmalicine catharanthine
Escherichia coli 0.3 0.6 0.6 0.6
Escherichia coli (permeable) 0.15 0.3 0.6 0.3
Mycobacterium smegmatis 0.6 0.6 0.6 0.6
Pseudomonas aeruginosa 0.3 0.6 0.6 0.6
Staphylococcus aureus 0.3 0.6 0.6 0.6
Bacillus vietnamensis 0.3 0.6 0.6 1.25
Microbacterium paraoxydans 0.3 0.6 0.6 0.6
Rhizobium pusense 0.3 0.6 0.6 0.6
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For  the  periwinkle  extract  we  managed  to  identify  some  of  the  components
contributing to the extracts’ antibiotic activity. Even though these compounds are not
148
Figure 4.16: Differences between the metabolites identified in the periwinkle extract and the
commercially-available  compounds  assayed  for  minimal  inhibitory  concentrations.  (a)
Serpentine and ajmalicine, b) loganic acid and loganin, c) catharanthine and d) vindoline.
as active as currently used antibiotics, they might have interesting modes of action and
should be investigated further. These experiments show that it is possible to identify
components of plant extracts with antibacterial activity using the approach of utilizing
the insect gut bacteria for activity-guided fractionation.
4.4 Discussion and Conclusions
4.4.1 Giant stick insect feeding on eucalyptus
4.4.1.1 Gut microbiota
The bacteria from the stick insect guts were cultured twice, from two pairs of insects.
Among the genera isolated there was only one that was shared between the two pairs,
genus Microbacterium represented by M. oxydans and M. paraoxydans. Such different
microbiota recovered from insects from the same colony suggests a high degree of
intra-species  variability  due  to  differences  between  individuals.  The  differences  in
microbiome composition are not a result of different diets, as the insects were feeding
on eucalyptus leaves from the same tree. 
It is important to note that the stick insects were the only insects collected after they
died, rather than euthanised after collection. The stick insects died of old age and their
gut microbiota was probably affected by it. A correlation between middle and old age
and  gut  microbiota  has  been  demonstrated  in  mice  [200].  Old  age  and  frailty
associated with it,  is  linked with the increased abundance of certain bacterial  taxa.
Functional profile of the gut microbiome also changed in older mice: the biosynthesis
of  vitamins  B12  and  B7  decreased,  bacterial  DNA  repair  was  impaired,  creatine
degradation was increased and the utilisation of  monosaccharides was higher than
oligosaccharides, leading to the deterioration of the gut homeostasis. It is possible that
similar changes can be observed in the stick insect gut when it is compared to younger
specimens.
Equally few bacterial species are shared between our study and previous findings. A
study  focusing  on  the  characterisation  of  order  Phasmatodea  (stick  insects)  gut
anatomy  and  microbiology  implemented  culture-dependent  methods  to  find   four
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microbial species in the gut of  D. gigantea feeding on  Eucalyptus citriodora [186]. In
the crop there  was one bacterial  and  one fungal  species:  Serratia  marcescens and
Cryptococcus  ramirezgomezianus,  the  midgut  was  colonised  exclusively  by
Enterobacter cloacea, and the hindgut was the most species-rich with three bacterial
strains:  E.  cloacea,  Erwinia  persicina,  S.  marcescens.  Another  study  identified  S.
marcescens and  Spiroplasma species  in  D.  gigantea guts  via  targeted  culture-
independent  methods  [201].  The  authors  did  not  speculate  about  the  role  of  S.
marcescens,  but  Spiroplasma species  are  a  common  commensal  endosymbiont,
maternally transmitted, and in some insects responsible for impaired reproduction by
inducing the selective elimination of male progeny. 
Our metagenomic analysis of the D. gigantea gut community confirms the abundance
of  S.  marcescens in the digestive tract.  However from genomic data alone it  is  not
possible  to  propose  a  role  for  S.  marcescens,  which  is  both  a  human  pathogen,
common  in  hospital-acquired  infections  [202],  and  an  insect  pathogen  sometimes
utilized as a model species in immunity studies [188].
4.4.1.2 Antibiotic resistance
As discussed in the previous chapter, we hypothesised that antibiotic resistance in the
insect gut is induced by antibacterial compounds in the insect food. As a way of testing
this hypothesis we compared antibiotic susceptibility profiles of strains isolated from
the insect gut and type strains from a culture collection. For D. gigantea gut bacteria
this hypothesis was correct apart from in one case, when M. oxydans type strain was
more  tetracycline  resistant  than  the  gut-isolated  strain.  Such  discrepancies  can  be
explained by the pleiotropic effects of bacterial responses to external stimuli, when an
increase  or  decrease  in  resistance  to  an  antibiotic  can  be  a  result  of  seemingly
unrelated gene action.
4.4.1.3 Eucalyptus extract
We only identified a mild antibacterial activity in the eucalyptus leaf extract. Antibiotic
activity in eucalyptus extracts is normally described in the context of the eucalyptus
essential oil. Eucalyptus oil (from E. globulus) is known to have an antibacterial activity,
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but  it  is  relatively  low  compared  to  other  essential  oils  [203].  Essential  oils  are
notorious for their high content of reactive and unstable compounds. However, our
plant  extract  processing  methodology  focused  on  and  selected  for  hydrophilic
compounds,  as  hydrophobic  oily  substances  interfered  with  preliminary  HPLC
fractionations. 
The  take-home  message  from  our  exploration  of  the  stick  insect  and  eucalyptus
plant/insect pair is that it is easy to identify antibiotic resistance in the insect gut and to
identify  extracts  with  antibiotic  activity.  It  is  much  more  difficult  to  separate  the
compounds responsible for that activity and identify them.
4.4.2 P. xylostella feeding on cabbage
4.4.2.1 Gut microbiota
Only two strains have been isolated from the diamondback moth larvae by culture-
dependent methods: S. keddieii and R. terrigena in our experiments. A previous study
identified on average 208 operational taxonomic units from seven P. xyllostella larvae
midguts [147]. Surprisingly only 25 operational taxonomic units had frequency higher
than  0.05%,  demonstrating  that  the  majority  of  isolates  present  in  the  guts  of
diamondback  moth  larvae  were  extremely  rare.  The  authors  do  not  discuss  the
composition of the P. xylostella microbiomes on the species level, but their dataset can
be  retrieved  through  Sequence  Read  Archive
(http://www.ncbi.nlm.nih.gov/Traces/sra/).  An  analysis  of  the  dataset  revealed  no
sequences with high degree of similarity to either  S. keddieii or  R. terrigena, but the
rarefaction curves of the dataset did not reach plateau, indicating that the sequencing
depth  was  insufficient  to  discover  all  sequences  present  in  each  sample.  Another
possible explanation is that the strains are not present at all, since the microbiota is
variable or transient.
4.4.2.2 Cabbage extract
The cabbage extract was the only plant extract tested that had no antibiotic activity
when tested against the bacteria from the  P. xylostella guts and corresponding type
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strains. Very few studies describe antibacterial activity in cabbage, and those that do
only find weak activity [204], suggesting that it is rooted only in anecdotal evidence of
traditional medicine. 
Overall  these experiments  have shown that  not  all  plant  extract  have antibacterial
activity.  They have also shown that the presence of antibiotic  resistance in the gut
bacteria  of  insects  feeding  on  a  certain  plant  is  not  always  an  indication  of  the
antibacterial properties of that plant species.
4.4.3 Cinnabar moth feeding on ragwort
4.4.3.1 Gut microbiota
Out of  five species of  bacteria  isolated from cinnabar  moth guts,  two belonged to
genus Staphylococcus: S. epidermidis and S. warneri. Both of these isolates are typical
members  of  human  skin  microbiota.  It  is  not  uncommon  for  bacteria  considered
typically human to be found in insects. Staphylococcus species have been described as
members of the gut microbiota of Termitidae family of termites and the presence of
Staphylococcus species was specific to that group of Australian higher termites [205].
The  role  of  the  Staphylococcus species  in  the  termite  gut  is  probably  cellulose
degradation [206].
4.4.3.2 Ragwort extract
Ragwort contains high concentrations of pyrrolizidine alkaloids, which are responsible
for its toxicity to cattle and horses. Because of the toxicity of pyrrolizidine alkaloids to
generalist herbivores, the compounds are thought to be a feeding deterrent, however
it was also suggested they protect the plants against microbial attack (see review by
Joosten and van Veen, 2011 [207]). In our experiments ragwort extract was one of the
most antibacterial plant extracts tested against insect gut bacteria, but the pyrrolizidine
alkaloids were not detected in the plant extract. There are no data about antibacterial
activities of pyrrolizidine alkaloids, but they have a moderate antifungal activity against
plant  pathogens  [208].  These  data  suggest  that  pyrrolizidine  alkaloids  are  not  the
compounds responsible for the antibiotic activity in the ragwort extract.
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Due to time constrains we were not able to pursue the ragwort extract further, but it is
probably one of the more interesting extracts investigated. The antibacterial activity of
the extract was not due to the presence of toxic pyrrolizidine alkaloids and it would be
interesting to identify these compounds since their antibacterial activity was relatively
high. Our experiments demonstrate that not only medicinal but also toxic plants can be
a source of antibacterial compounds.
4.4.4 Rosemary beetle feeding on lavender
4.4.4.1 Gut microbiota
The rosemary beetle microbiome was another example of an insect gut community
with  members  typically  associated  with  human  microbiota:  S.  epidermidis and  P.
agglomerans.  As  discussed before  it  is  not  uncommon for  insects  to harbour  such
bacteria  in their  guts.  P.  agglomerans is  a  prominent  member  of  the desert  locust
Schistocerca  gregaria [209]  and  produces  compounds  that  lead  to  the  swarming
behaviour  of  the  locusts  and  are  necessary  for  the  synthesis  of  an
aggregation/cohesion pheromone. It is also know to detoxify some phytochemicals as
discussed earlier in this chapter.
4.4.4.2 Antibiotic resistance
There  were  only  two  differences  in  the  antibiotic  susceptibility  profiles  of  the  gut
isolates and corresponding type strains, which was the least of all microbiomes tested.
It indicates that either the lavender leaves that the beetles were feeding on were not
toxic  enough for  the  gut  bacteria  to develop  resistance,  or  that  a  member  of  the
microbiome detoxified the extract.
4.4.4.3 Lavender extract
After  HPLC fractionation  each  collected  fraction  was  assayed for  antibiotic  activity.
Unusually  many fractions  were active  against  the bacteria  tested.  Individually  each
fraction was weakly active and together they contributed to the mild antibiotic activity
of the plant extract. Weakly active lavender extract is consistent with mild evolutionary
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pressure on the rosemary beetle gut bacteria to develop resistance mechanisms. 
These data are not consistent with the antimicrobial activity of lavender essential oil.
Lavender essential oil is a potent antimicrobial, active against both bacteria and fungi,
but there is no consensus on which component of the essential oil is responsible for
the  activity  [210].  Even  though  the  scientific  evidence  indicates  lavender  has
antibacterial  properties,  problems  around  standardization  of  the  oil  and  the
purification  of  the  active  components  hamper  the  development  of  lavender
preparations into a therapeutically useful agent. 
4.4.5 Death’s head hawkmoth feeding on potato leaves
4.4.5.1 Gut microbiota
Death’s head hawkmoth gut community was a mixture of environmental strains and
strains associated with human microbiota, similar to other insect species described in
this chapter. Surprisingly,  the death’s head hawkmoth larvae harboured strains that
were most different from the type strains when the antibiotic susceptibility profiles
were compared. 
The E. asburiae type strain is a clinical isolate and it was the only type strain tested that
was more resistant  than the gut  strain  to every antibiotic  in  the panel.  This  result
suggests the A. atropos gut is not a niche with an extremely selective environment, as
the gut isolated E. asburiae was not as antibiotic-resistant as the type strain. 
4.4.5.2 Potato leaf extract
The  potato leaf extract was weakly antibiotic. Potato leaves, similarly to ragwort, are
toxic  to many herbivores,  but  they lack the strong antibacterial  activity  of  ragwort
extract. Potato leaves have not been previously investigated for antibacterial activity, as
other potato waste products have been. Potato tubers unsuitable for sale have been
investigated as a source of antibacterial activity [211], and had a mild level of antibiotic
properties which have been attributed to phenolic compounds in the extracts. 
In summary, potato waste products are an attractive source to investigate potential
bioactivity. However we have shown the level of antibiotic activity is relatively low and
154
we have not pursued the purification of the active fraction of the extract.
4.4.6 Beet armyworm feeding on Madagascar periwinkle
4.4.6.1 Gut microbiota
There is little similarity between the bacterial species isolated from beet armyworm
larvae in our experiments and previously reported studies. Previous studies identified
Ochrobactrum sp.  and  Myroides odoratus as  the main culturable  strains  from beet
armyworm guts [212].  Rhizobium pusense, isolated in our experiments, is related to
Ochrobactrum strains. It is possible that these strains are consistently present in the
beet armyworm guts.
The beet  armyworm microbiota was shown to be involved in the production of  N-
acylamino acids [212], which can be isolated from insects’ oral  secretions and have
been indicated in eliciting plant defences. One of such N-acylamino acids, microbially-
produced volicitin (N-(17-hydroxylinolenoyl)-L-glutamine) induces damaged leaves to
produce volatile compounds attracting parasitic wasps that infect the armyworm larvae
[213]. 
Two species of  Bacillus have been isolated from the beet armyworm guts. Bacilli are
abundant in soil and commonly isolated from the insect gut. It has been proposed that
Bacillus species opportunistically invade insect guts [214]. The transition from soil to
the nutrient-rich insect gut facilitates filamentous growth.
4.4.6.2 Madagascar periwinkle extract
Madagascar  periwinkle  is  probably  the most  widely  studied plant  described in  this
chapter.  C. roseus produces terpenoid indole alkaloids used in cancer therapy, but its
antibacterial activity is less documented. Extracts of leaves, stems, flowers and roots
have been demonstrated to have antibacterial  activity [215]  and some of  the main
alkaloids  present  in  Madagascar  periwinkle  have  been  investigated  for  antibiotic
activity  [199].  The  most  active  alkaloid  from  C.  roseus was  vindoline,  but  the MIC
established for it was much higher than in our study. 
Additionally,  Madagascar  periwinkle  seeds  contain  antibacterial  proteins  CRCI  and
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CRCII (Catharanthus roseus cystatin I and II) [216]. These proteins are thiol protease
inhibitors and exhibit antibacterial activity against Escherichia coli and Staphylococcus
aureus,  but  were  ineffective  against Bacillus  subtilis.  At  25  µg/mL  the  zones  of
inhibition were 11-14 mm in diameter. The authors hypothesise that the cystatins are
at least  partially  responsible for the medicinal  properties of  C. roseus in traditional
preparations.
Our  investigation  is  the  first  attempt  to  link  the  antibacterial  properties  of  the
Madagascar  periwinkle  extract  to  the  metabolites  present  in  the  plant.  We  have
discovered that the main indole alkaloids have mild antibiotic activity against a wide
range  of  bacteria.  Vindoline  had  the  highest  antibacterial  activity,  especially  when
tested against bacteria with permeable cell membrane. In general the compounds had
MIC values an order of magnitude higher than most commonly used antibiotics, but
they would be worth investigating further to determine their targets and modes of
action. Indole alkaloids from Madagascar periwinkle are already well-studied and that
body of knowledge makes them attractive leads in antibiotic discovery.
4.4.7 General comments about bacterial species isolated from the insect
guts
We isolated a variety of bacterial strains from the guts of the insects investigated. A
majority of  the bacterial  isolates were common soil  and water strains, but we also
identified  a  number  of  strains  with  clinical  significance  in  human  health.  Such
composition of insect gut microbiomes is not unusual and has been described before
(for  example  Staphylococcus  species  in  termites  [206]  and Enterococcus  species  in
greater wax moths [150]).  As insects are sometimes vectors of  human disease,  the
presence  of  pathogens  in  the  healthy  insect  microbiota  is  an  important  factor  to
further investigate.
Surprisingly we have not identified any obligatorily  anaerobic  bacteria in the insect
guts. The oxygen levels in the herbivorous insects’ guts are low [187], especially in the
midgut  and  hindgut.  The  oxygen  level  depends  partially  on  the  insect  food  and
increases when the insects feed on artificial food. The presence of oxygen in the guts of
herbivorous insects  can  lead  to the formation  of  reactive  oxygen species  from the
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ingested  plant  material.  Additionally  the  autoxidation  of  plant  phenolics  is  greatly
reduced by the lack of oxygen, even in the highly alkaline guts of some insects. The
depletion  of  oxygen from the insect  guts  is  abolished by boiling,  suggesting  either
endogenous insect enzymes or microbial  activity are responsible.  It  is  possible that
both  processes  are  involved  and  both  the  host  insect  and  the  native  microbiota
together sustain the gut as a suitable niche.
4.4.8 General comments about antibiotic resistance
When the antibiotic resistance profiles of the gut-isolated strains and the type strains
are compared, there are three possible outcomes. Firstly, no differences between the
antibiotic resistance levels can be detected. Secondly, the gut-isolated strain can be
more resistant than the type strain.  Finally,  the type strain can be more antibiotic-
resistant than the gut strain. Initially it was hypothesised no differences and higher
resistance of  the gut-isolated strains would be the most common outcomes of  the
antibiotic  susceptibility  testing.  We  expected  the  gut  strains  to  develop  antibiotic
resistance in response to the strong selective pressures in the insect gut.
We discovered that equally often as no difference in antibiotic resistance or the gut-
isolated strain being more antibiotic-resistant,  the type strain had a higher level  of
resistance to the antibiotics tested. We expected to see a few differences like that, but
the  high  prevalence  of  this  outcome  of  the  antibiotic  susceptibility  tests  was
unexpected. It is possible the elevated antibiotic resistance of some type strains is due
to their origin as clinical isolates. Bacteria first cultured in hospital settings are likely to
have been exposed to antibiotics and to have elevated levels of antibiotic resistance or
tolerance.  However,  this  is  only  one  possibility  and  it  does  not  explain  all  the
unexpected differences in antibiotic resistance levels between the type strains and the
gut-isolated strains.
In  some cases a type strain was more resistant than the gut-isolated strain to one
antibiotic and less resistant than other, which can be explained by the fitness cost of
maintaining multiple resistance genes. Mutations resulting in antibiotic resistance are
commonly associated with a reduction in growth rate, but that is not always the case
(see review MacLean et al., 2010 [136]). 
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Notably,  the  type  strains  from  culture  collections  were  used  as  a  comparison  for
antibiotic resistance. For bacteria and other fast-evolving organisms the type strains
are deposited in culture collections in aid of taxonomic identification, not as a standard
specimen of the species. A more systematic, but much more time consuming, approach
to creating the antibiotic resistance profiles would be to combine culture-dependent
and -independent methods. The gut resistome can be probed with targeted molecular
biology methods, such as PCR and qPCR of known resistance genes, and a number of
isolates  of  the  same  species,  not  just  the  type  strain,  can  be  assayed  in  a  broth
microdilution assay for  resistance to a panel of antibiotic. Such an approach would
place each insect gut-isolated strain in a wider ecological context, but ultimately would
not aid the identification of antibacterial activity in the plant extracts, which was one of
the goals of the chapter.
4.4.9 General  comments  about  the  bacterial  susceptibility  to  plant
extracts
Medicinal and toxic plants were chosen for assessment of antibacterial activity in this
study,  based  on  anecdotal  evidence  and,  where  available,  scientific  literature.
Interestingly, there has never been a systematic study to assess whether plants used in
traditional medicine are more likely to contain valuable bioactive compounds [177].
The use of certain plants in traditional medicine is not indicative of their efficacy. Such
data  can  only  be  provided  when  standardized  and  chemically  characterized  plant
preparations are tested in vitro and in animal models, and their efficacy is confirmed in
clinical studies [179].
Even when a plant with confirmed medicinal activity is chosen, often the role of origin
and variety is underestimated.  E. dalrympleana was chosen because the stick insects
in JIC Insectary were feeding on this species of eucalyptus. However, E. dalrympleana is
a species of eucalyptus grown for timber and there is no indication of its medicinal
properties. It is not normally used for essential oil production. It is likely that higher
levels of antibiotic activity would be detected from a different species of eucalyptus.
Similarly,  different  Madagascar  periwinkle  cultivars  have  different  indole  alkaloid
contents [217] and probably display different levels of antibiotic activity. 
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It  was  hypothesised  that  the  type  strains  would  be  more  susceptible  to  the  plant
extracts  than  the  strains  from  the  insect  gut  that  have  been  exposed  to  the
constituents of the extracts. Surprisingly it is not always true. Most of the type strains
that  exhibited  unexpected  plant  extract  susceptibility  also  had  some  unusual
differences  in  antibiotic  resistance  levels.  For  example,  Burkholderia  fungorum
identified  in  the  guts  of  the  cinnabar  moth  larvae  feeding  on  ragwort  was  more
susceptible  to  ciprofloxacin  and  kanamycin  than  the  type  strain.  Apart  from  the
elevated antibiotic resistance, the B. fungorum type strain was also more resistant to
ragwort  leaf  extract.  Similarly,  Bacillus  vietnamensis type  strain  was more resistant
then the  B.  vietnamensis isolated  from the  guts  of  beet  armyworms to  ampicillin,
chloramphenicol, ciprofloxacin, kanamycin and rifampicin, as well as periwinkle root
extract.  It  is  possible  that  the  unexpected  antibiotic  resistance  and  plant  extract
susceptibility are correlated or linked, but it is impossible to hypothesise more on the
nature of this phenomenon only form the data collected.
4.4.10 General comments about the fractionation
Equally  important  to  the  choice  of  source  plant  was  the  choice  of  fractionation
method. In one of our initial methods the crude extract was fractionated on normal
phase HPLC, but the performance was unsatisfactory as the waxy components were
binding too tightly  to the matrix,  requiring long wash cycles.  To improve the HPLC
efficiency,  the plant extracts were partitioned with organic solvents and SPE before
fractionation. SPE is not as efficient in separating compounds as HPLC, but the variety
of matrices is larger. Two- or three-dimensional fractionation is possible, for example
using ion exchange matrices, size exclusion and silica- or polymer-based matrices that
separate  compounds  based  on  their  hydrophobicity.  In  the  case  of  plant  extracts
tested, size-exclusion chromatography produced peaks that were too broad and ion-
exchange matrices introduced formic acid and ammonium hydroxide,  which change
sample pH and prevent the growth of bacteria. Eventually all experiments including ion
exchange SPE included pH controls to avoid false positive results.
The HPLC fractionation was performed on a C18 matrix,  which is normally used to
separate mixtures of mostly hydrophobic compounds. Many plant extract components
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with antibacterial activity overlapped eluting early in the gradient, suggesting that a
different matrix would be more suitable (such as silica matrices). Additionally multiple
injections had to be made to obtain enough fractionated plant extract for antibacterial
activity testing. The efficiency of HPLC decreases the more extract is loaded onto the
column. Multiple small injections are favoured if the efficiency of the fractionation is
required, making preparative HPLC a slow technique.
The  phytochemicals  with antibacterial  activity  separated  in  the fractionations  were
often sticky when dried on a paper disc or evaporated to a viscous mass in tubes. They
also eluted early in water/methanol HPLC gradients,  indicating that the compounds
were hydrophilic, and were difficult to separate into single peaks, suggesting that they
might  have  been  similar  to  each  other.  It  is  possible  that  the  compounds  were
polyphenols or heavily glycosylated compounds, as these groups of compounds are
hydrophilic and can exist as close variants of similar molecules. 
4.4.11 Summary
Using  six  different  plant-insect  pairs  we  have  shown that  insect  guts  contain  both
environmental bacterial strains and strains typically associated with the human body. In
general we found only a small number of culturable bacterial strains (two – six) from
the insects’ guts, but metagenomic analysis of stick insect gut showed that a larger
number of species are likely to be present (20 – 50). We demonstrated that bacteria
from  the  insect  guts  are  antibiotic-resistant  (compared  to  their  type-strains  from
culture collections), as had been predicted from literature observations. However we
also  found  that  some  species  showed  no  difference  in  susceptibility  to  antibiotics
between  the  gut-isolated  and  the  type  strains;  this  was  not  unexpected.  More
surprisingly we found several instances where the type strain was more resistant to
antibiotics than the gut-isolated strain. In some cases this can be rationalised by the
fact that the origin of the type strain was a clinical isolate, but in other cases such
rationalisation was not  possible.  Taken together these data suggest that comparing
antibiotic susceptibilities in gut-isolated and type strain is  not necessarily  a reliable
comparison and that the differences in the antibiotic resistance between gut-isolated
strains and type strains cannot be used as a reliable indication of antibacterial activity
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in the food plant.
We confirmed the extracts of several of the plant species used have antibiotic activity,
but  that  some  plants,  such  as  cabbage,  lack  obvious  antibacterial  activity.  The
susceptibility of the bacterial strains to the plant extracts can be used as a guide for
identifying plant extract fractions with antibiotic activity. It was possible to fractionate
the extracts and to identify fractions of plant extracts with antibacterial activity, but it
was likely that they contained multiple compounds and that further separation was
challenging. However in the case of Madagascar periwinkle we were able to identify
the  compounds  in  both  the  root  and  leaf  extract  with  antibiotic  activity  and  we
established the minimal  inhibitory concentrations of  these and related compounds.
Even  though  these  metabolites  only  exhibit  a  mild  antibacterial  activity  they  are
potentially interesting lead compounds to follow. 
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5 Developing Galleria mellonella (Greater wax moth) larvae into
a  laboratory  model:  acute  toxicity  trials,  antibiotic
susceptibility testing and replacement of native gut bacteria
with human faecal microbiota 
I  would  like  to  thank  Dr  Lindsay  Hall  and  Dr  Melissa  Lawson  for  their  advice  and
technical assistance in the gut community replacement experiments.
All data in this chapter was generated by me and I produced all figures and tables on
my own.
5.1 Abstract
The aim of this  chapter was to assess how suitable  Galleria mellonella is  for  acute
systemic toxicity testing,  antibiotic efficacy screening and as a simple model of  the
human gut.  Developing such tests allows bridging a gap between  in vitro tests and
experiments in murine models, which is important as in vitro tests alone do not supply
sufficient  data  and  the  in  vivo tests  are  expensive  and are  not  statistically  robust.
However only limited data are available on how the larvae perform in laboratory tests
and how the results compare to data obtained in mice. We developed an acute toxicity
test and compared the insect LD50 values to values available in safety datasheets. For
antibiotic  efficacy  tests  we  used  established  protocols  to  compare  the  dosage
recommended for human use to doses effective in the wax moth larvae. Additionally
we obtained preliminary data on the prospect of replacing native  G. mellonella gut
microbiota with human gut bacteria. Our results showed that greater wax moth larvae
are suitable for such studies.  The insects are a useful  resource for obtaining better
preliminary results before testing hypotheses in mammalian models, reducing the need
of extensive use of laboratory mammals.
162
5.2 Introduction
5.2.1 Animal testing
The Organisation for Economic Co-operation and Development (OECD) and especially
European Union (EU) support minimal use of laboratory animals in research, a trend
strongly backed by consumers. The European Citizens’ Initiative “STOP VIVISECTION”, a
EU-wide petition to completely abolish the use of laboratory animals, was one of few
Citizens’ Initiatives to have gained enough signatures to be considered by the European
Commission [218]. The initiative supports the elimination of all animal testing by 2020,
quoting  ethical  objections,  statistical  data  indicating  that  animal  models  are  not
capable of predicting human response and obstruction in the development of new,
more  efficient  methods  [petition  no  longer  available  online].  The  European
Commission rejected the Initiative citing existing animal welfare directives that favour
alternative testing approaches and ban the marketing of cosmetics and products tested
on animals [219]. The Commission stressed that a complete ban on laboratory animal
use in Europe would be premature for the techniques currently validated and would
drive  biomedical  research  out  of  Europe.  A  remark  was  made about  the  Directive
2010/63/EU, which describes the three R’s of animal research -  the requirement to
replace, reduce and refine the use of animals wherever possible (replacing for non-
animal methods, reducing the numbers of animals, refining the method to minimise
pain,  suffering  or  distress  experienced by  the  animal,  or  to  increase  their  welfare)
[224].
An  example  of  how  concerns  about  animal  testing  have  been  addressed  is  the
implementation of The Globally Harmonized System of Classification and Labelling of
Chemicals (GHS). The main goal  for implementing GHS was to reduce the need for
animal testing by avoiding duplicative testing.
5.2.2 Acute toxicity testing
Acute  toxicity  data  are  required  under  The  Globally  Harmonized  System  of
Classification and Labelling of Chemicals (GHS). Currently the recommended  tests for
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novel substances are three in vivo procedures in rats or mice [220]. The OECD reviews
the  testing  guidelines  to  provide  up-to-date  and  evidence-based  advice.  Three
currently used acute toxicity tests are: Test No. 420: Acute Oral Toxicity - Fixed Dose
Procedure [221], Test No. 423: Acute Oral toxicity - Acute Toxic Class Method [222], and
Test No. 425: Acute Oral Toxicity: Up-and-Down Procedure [223]. 
GHS classification of hazards distinguishes six classes for acute toxicity ranging from
GHS class 1 (most toxic, at or below 5 mg/kg body weight) to GHS class 5 (toxic at 2000
mg/kg body weight) and unclassified (not toxic above 2000 mg kg body weight). Testing
above 2000 mg/kg body weight is discouraged due to solubility issues and unnecessary
suffering of the test animals (see review by Hartung, 2008 [224]). High concentrations
of  test  compounds in  animal  tissues are often not  physiologically  relevant  and the
detrimental effects can be due to tissues being oversaturated, not the toxicity of the
compound to the target tissue. 
The European Union Reference Laboratory for Alternatives to Animal Testing (EURL-
ECVAM)  publishes  recommendations  for  achieving  the  three  R  objective,  while
maintaining or improving human and environmental protection. A document on acute
systemic toxicity was published recently [225]. Instead of proposing a new test as an
alternative to current OECD guidelines, it outlined reasons to remove the need for such
testing, and stressed the inadequate understanding of pathways leading to systemic
toxicity. The document recommended exploring chemoinformatic methods and in vitro
procedures for specific toxicity mechanisms and a transition from in vivo experiments
towards pathway-based assessment of toxicological risks. 
5.2.3 Acute toxicity testing in alternative organisms
Apart from in vitro approaches to test specific pathways leading to toxicity, a number of
alternative  in  vivo tests  have  been  developed  to  test  systemic  toxicity.  Pathway
conservation  in  metazoans  allows  extrapolation  of  the  results  between  different
species  [226].  However,  genetic,  proteomic  and  physiological  differences  between
species have to be well-defined and quantified to permit an adequate extrapolation of
pathway effects, dose-response values and kinetic parameters from a test to  in vivo
human response.
164
Non-murine  in vivo tests often adopt insect species,  as their use in research is not
covered by the Directive 2010/63/EU [219]. European honey bee (Apis mellifera) larvae
are used to assess the environmental risk of chemicals (mostly pesticides) for the brood
(eggs, larvae and pupae) [227]. The test is based on a single-dose feeding procedure,
translating  well  into  the  most  likely  route  of  exposure  of  the  test  chemical  (oral
exposure)  and  assessing  if  the  chemical  acts  as  a  feeding  deterrent.  Another  test
utilizes silkworm (Bombyx mori), which can be fed leaves spiked with toxic compounds
[40].  The  test  is  reproducible  and  robust,  but  silkworms  are  highly  susceptible  to
infection  and  have  a  non-standardized  diet  (mulberry  leaves).  A  more  systematic
approach is  the  use of  greater  wax  moth (Galleria  mellonella)  which  permits  both
feeding studies and injections of the test compound directly into the body cavity.
5.2.4 Acute toxicity testing in Galleria mellonella
Galleria  mellonella is  normally  used  in  feeding  studies  assessing  the  toxicity  of
environmentally hazardous chemicals.  For example the effects of  dietary transgenic
pollen were assessed in  G. mellonella  [228]. The pollen from Bt-toxin (Cry1A(b) and
Cry1F)  producing plants caused mortality to G. mellonella larvae, but Cry1F was much
more effective than Cry 1A(b), without affecting honey bee larvae. Bt toxins can be
used for G. mellonella control in beehives, as transgenic pollen is collected by the bees
and brought back to the hive parasitized by wax moth larvae. Similarly the effects of an
insecticide azadirachtin and its fragments were assessed on galleria larvae [229]. While
the fragments were able to kill larvae in feeding studies at concentrations under 0.15
mg/g,  azadirachtin  was  only  lethal  by  injection.  Neem  tree  products,  from  which
azadirachtin was isolated, are used for insect control. This study highlights how wax
moth larvae can be used in toxicity assays in two ways through feeding studies and via
an injection.
Only recently G. mellonella larvae were used in de novo toxicity testing. The toxicity of
ionic  liquids has  been assayed [41].  Ionic  liquids  are  low temperature  molten salts
which are used as alternative to volatile organic solvents. They are commonly labelled
“ecologically friendly”, even though the class is diverse and exhibits a wide range of
toxicities. In the study the systemic toxicity was correlated to the length of alkyl chains
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of the 1-alkyl-3-methylimidazolium ionic liquids tested. The salts were toxic under 100
µg/g, apart from the shortest two-carbon alkyl chain salt (1-ethyl-3- methylimidazolium
chloride)  which  had  a  LD50 of  nearly  8000  µg/g,  presenting  a  negligible  toxicity.
Interestingly, even though their rising popularity as an alternative to volatile organic
compounds, 1-alkyl-3-methylimidazolium ionic liquids lack toxicity data.
5.2.5 Antibiotic efficacy testing in Galleria mellonella
Toxicity  testing  in  Galleria  mellonella is  an  extrapolation  from  antibiotic  efficacy
studies, which are an increasingly popular procedure in microbiology [230]. Antibiotic
efficacy studies establish a dose of an antibiotic necessary to clear a bacterial infection.
One of necessary controls in antibiotic efficacy testing is to ensure that the antibiotic
itself is not toxic to the insects. Apart from establishing a safe dose for efficacy testing a
LD50 dose can be measured.
The greater wax moth larvae have been used for virulence and antimicrobial efficacy
studies.  They  were  first  used   to  assess  antibiotic  efficacy  against  Acinetobacter
baumannii [231]. Cefotaxime, tetracycline, gentamicin and meropenem were assayed
against  a  systemic  A.  baumannii infection.  Gentamicin  and  meropenem,  which  A.
baumannii is  susceptible  to,  significantly  prolonged  the  survival  of  infected  larvae,
while  the  survival  of  untreated  larvae  and  larvae  treated  with  cefotaxime  and
tetracycline, which the bacteria are resistant to, was less than 25% in 5 days. The model
quickly gained interest with a number of academic groups using it as a standard testing
model.  G. mellonella larvae have been used to investigate emerging pathogens [232,
233] and novel  treatments for  persisting pathogens [234].  Most studies up to date
were collated by Cook and McArthur [230]. 
There are many benefits to using Galleria larvae in antibiotic efficacy studies. Many
larvae can be used in each experiment making pharmacokinetic and pharmacodynamic
data easy to obtain. Pharmacokinetic data obtained in G. mellonella, such as antibiotic
clearance time, elimination half-time of the drug and maximum drug concentration,
directly  correlates  to  human  data  [233].  Numerous  studies  confirm  that  microbial
pathogenicity  and  virulence  determinants  are  the  same  in  humans,  mice  and  wax
moths [231, 234]. The insects can be bred quickly (at 37°C the full life cycle lasts about
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6 weeks) at low cost and without the need for specialized equipment. Galleria larvae
are large, reaching 250-300 mm length at fifth instar, enough for an intraperitoneal
injection of the test compound. Additionally, the insect immune system is functionally
and structurally similar to the mammalian innate immune system [240], as discussed in
the Introduction (see Chapter 1).
In virulence and antibiotic efficacy testing  G. mellonella is  an valuable system, that
allows rapid testing using an accessible  method at  low cost.  The wax moth larvae
cannot fully replace mammals in pre-clinical trials, but they can improve the quality of
data collected and lessen the financial burden by providing more reliable and robust
data.
5.2.6 Replacement of gut microbiota
G.  mellonella is  used  in  place of  mice  and rats  in  virulence and antibiotic  efficacy
studies  because  bacteria  behave  similarly  in  insect  models  and  more  complex
mammalian  models.  Interestingly,  the  wax  moth  gut  microbiome  is  dominated  by
Enterococcus  species,  which  are  often  associated  with  human  gut  microbiome.
Enterococcus  faecalis (syn.  Streptococcus  faecalis)  was  identified  in  the  guts  of  G.
mellonella [149, 235],  to be later re-classified as  Enterococcus faecium [158]. More
recent studies indicate that a variety of related Enterococcus strains co-exist in the wax
moth  gut  [150]  (see  also  Chapter  3).  However  the  Enterococcus  species  are  non-
obligate symbionts and it  is  possible to grow Galleria  with little  or  no gut  bacteria
[170]. It is possible to surface-sterilize eggs and hatch larvae on sterile food, as well as
clear the digestive tract of bacteria using antibiotics.
Based on the inessential  presence of Enterococcus species in  G. mellonella gut and
their  association  with  human  microbiota,  we  hypothesised  that  the  native  gut
community can be replaced with a human-derived community. Development of wax
moth larvae into a model of the human gut would allow performing preliminary studies
before testing hypotheses in mice or humans, increasing the number of samples per
experiment,  as  well  as  conducting  long-term  studies  that  would  be  prohibitively
expensive in mice. 
Mice with non-native microbiota are used in research on the role of microbiota on
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human diseases, such as cancer, diabetes, inflammatory bowel disease, and obesity
[236].  The  use  of  humanized  gnotobiotic  mice  allows  investigation  of  microbiota
perturbations in human-like system. The mice can be created by inoculating germ-free
mice, or mice treated with a cocktail of antibiotics, with a human microbiota sample
[237]. Additionally the animals can carry mutations simulating human physiology or a
particular disease. All phyla and over 80% of genus-level taxa from the human faecal
samples are recovered in the guts of humanized gnotobiotic mice, but often repeated
inoculations are required. The mice are the best model for a number of studies, but
they are expensive, especially when the germ-free mice are used as special housing is
required. 
Development of Galleria mellonella into an analogous model would provide a cheaper
alternative to testing in mice and comply with the three R’s of laboratory animal use:
replacement, reduction and refinement. Testing hypotheses in a simpler humanized
animal model cannot fully replace experiments in mammals, but would minimize the
need  of  using  big  cohorts  of  mice  by  providing  a  more  statistically  robust  model
suitable for larger and longer studies.
5.2.7 Aims and objectives
Initially the objective of this study was to assess antibiotic efficacy testing against four
different bacterial  strains and demonstrate whether LD50 values obtained in greater
wax  moth  larvae  correlate  with  current  toxicological  data  obtained  in  mammalian
models.  The  objective  of  the  antibiotic  efficacy  experiments  was  to  confirm  that
antibiotics  treat  bacterial  infections  in  G.  mellonella at  the  same  efficacy  as
recommended for humans. The aim of the toxicity screens was to develop an in vivo
acute toxicity assay in galleria. With the success of antibiotic efficacy and acute toxicity
testing the scope of this chapter was extended to include the replacement of native gut
microbiota with a community derived from the human gut. The aim of the native gut
microbiota  replacement  experiments  was  to  assess  if  the  gut  microbiome  in  G.
mellonella can  be  easily  replaced  with  other  community,  with  an  ultimate  goal  of
developing the wax moths as a model for human gut.
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5.3 Results
5.3.1 Antibiotic efficacy testing
5.3.1.1 Bacteria and antibiotics tested
The efficacy of four antibiotics: ampicillin, ciprofloxacin, tetracycline and rifampicin, in
Galleria mellonella larvae was assessed against four bacterial pathogens: Gram-positive
Mycobacterium smegmatis and Staphylococcus aureus, and Gram-negative Escherichia
coli  and  Pseudomonas aerugionosa.  For each bacterial strain there was at least one
antibiotic that is indicated in the treatment of an infection caused by that strain, and at
least one that  is  predicted not  to clear  the infection to confirm that the antibiotic
action, not the insect immunity, is responsible for the recovery.
Initially the appropriate infective dose of bacteria was determined for each bacterial
species.  Groups  of  five  larvae  were  injected  as  shown in  Figure  5-1  with bacterial
cultures at a quantified dose. Mortality was recorded daily for five days. An infective
dose was one that caused immune response observed as darkening of the cuticle and
60-80% lethality within 48 h, but not 100% lethality within 24 h.  This was determined
to be 5x106 cfu in 10 µl for E. coli, M. smegmatis and S. aureus, and 5x104 cfu in 10 µl
for P. aerugionosa. 
For  antibiotic  efficacy  testing  the  larvae  were  injected  with  the  infective  dose  of
bacteria  and incubated for  2  h  to  allow the bacterial  cells  to  multiply  and excrete
virulence  factors.  A  2  hour  incubation  period  is  a  standard  treatment  in  antibiotic
efficacy testing [234, 238, 239]. After the incubation the larvae were treated with the
lowest  dose  of  antibiotic  by  injection  at  5  mg/kg  body  weight.  The  ability  of  the
antibiotic to cure the larva from the bacterial infection was scored daily for five days.
The larvae survived when the antibiotic successfully cleared the infection. When high
mortality due to an infection was observed, new larvae were injected with an infective
dose of bacteria as before and treated with a higher dose of an antibiotic: 25, 50 and
200 mg/kg body weight. Therapeutic dose of an antibiotic was determined when the
antibiotic  rescued  the  mortality  caused  by  the  bacterial  infection.  When  even  the
highest dose of the antibiotic did not clear the infection.
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Figure 5.1:  Intraperitoneal injection procedure in G. mellonella. a) Fifth instar larvae ready for
injections. Larvae with signs of immune response, demonstrated by melanisation (highlighted
by arrows), should be discarded. b)  Preparation of the larva for an injection: the larva is held
between thumb and middle finger and stabilized with index finger. c) The needle is inserted
into the last left proleg of the larva.
5.3.1.2 Results of the testing
The results of antibiotic efficacy testing in G. mellonella larvae are summarized in Table
5-1. There are four possible outcomes of the antibiotic testing: 1) predicted dose of an
antibiotic clears a bacterial infection, 2) a dose different from the predicted dose clears
an  infection,  3)  antibiotic  predicted  to  be  ineffective  is  ineffective,  4)  antibiotic
predicted to be ineffective clears the bacterial infection. In most cases the antibiotics
performed as predicted, either treating an infection within the dose predicted or being
ineffective against a resistant strain.
It  was  found  that  ciprofloxacin,  tetracycline  and  rifampicin  performed  as  expected
against E. coli infections. Both ciprofloxacin and tetracycline worked within the ranges
prescribed  for  humans  (10-15  mg/kg  body  weight/day  and  25-50  mg/kg  body
weight/day  respectively).  Rifampicin  was,  as  predicted,  not  effective  as
Enterobacteriaceae are intrinsically resistant to rifampicin. Ampicillin was expected to
clear the infection at 50-200 mg/kg body weight, but it failed to treat the infection in
Galleria. 
Pseudomonas  aerugionosa was  resistant  to  all  antibiotics  used.  P.  aeruginosa is
intrinsically  resistant  to ampicillin,  tetracycline  and rifampicin,  and these antibiotics
were  tested  as  a  negative  control.  The  strain  was  expected  to  be  sensitive  to
ciprofloxacin, which is active against Gram-negative pathogens, but when tested in the
wax moth larvae P. aeruginosa was resistant to ciprofloxacin. 
Mycobacterium smegmatis was also resistant to all antibiotics used. Mycobacteria are
intrinsically  resistant  to  a  range  of  antibiotics  and  ampicillin,  ciprofloxacin,  and
tetracycline were predicted to produce a resistant phenotype. Surprisingly rifampicin
did not work, even though it is a standard treatment against mycobacterial infections. 
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Table 5.1: Predicted and determined antibiotic susceptibility profiles of bacteria in the antibiotic
efficacy test.
Staphylococcus aureus
Pseudom
onas aeruginosa
M
icrobacterium
 sm
egm
atis
Escherichia coli
50 - 200
resistant
resistant
50 - 200
predicted am
picillin
Therapeutic dose [m
g/kg body w
eight]
200
resistant
resistant
resistant
test result
10 – 15 
10 – 15 
resistant
10 – 15 
predicted
ciprofloxacin
200
resistant
resistant
25
test result
resistant
resistant
resistant
25 – 50 
predicted
tetracycline50
resistant
resistant
25
test result
10 – 20 
resistant
10 – 20 
resistant
predicted rifam
picin25
resistant
resistant
resistant
test result
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All antibiotics used were effective against Staphylococcus aureus.  Ampicillin worked at
the high end of the spectrum normally prescribed for human use: 50-200 mg/kg body
weight/day. Ciprofloxacin only cleared the infection at a concentration nearly 20 times
higher than the dose recommended for human use. Tetracycline was predicted to be
ineffective  but  it  cleared  the  S.  aureus infection  at  50  mg/kg/body  weight.  The
tetracycline susceptibility could have been caused by the loss of tetracycline resistance
determinant from the S. aureus strain tested. Rifampicin, which is a standard treatment
for methicillin-resistant S. aureus (MRSA), was effective at a low concentration.
These antibiotic efficacy studies were based on existing literature [232]. G. mellonella
larvae have been previously  used to  study  bacterial  virulence and susceptibility  to
antibiotics and our study confirmed that the larvae are a suitable host for antibiotic
efficacy  studies.  Additionally  we  determined  that  the  antibiotic  therapeutic  dose
established in G. mellonella matches the doses recommended for use in people.
5.3.2 Acute toxicity testing
5.3.2.1 Compounds tested
17 compounds were provided by Inspiralis Ltd to test for their toxicity in G. mellonella
larvae. All compounds were made up in 50% DMSO, except where indicated in Table 5-
2. The compounds were tested blind – they were supplied in numbered tubes and only
after the test procedure was completed were the numbers linked to compound names.
The aim of this approach was to avoid bias, i.e. assigning lower toxic doses to known
toxic compounds and higher ones to safer compounds.
Insects (5-10 larvae) were injected with 10 µl  compound into the hindmost proleg.
Intraperitoneal injection was used in the procedures to strictly control the amount of
toxic compound or bacterial  pathogen that the larvae were exposed to. Alternative
approaches,  not  applied  in  this  study,  use  feeding  procedures  [240]  or  contact
exposure [241]. The quantification of exposure to a compound is less precise for such
procedures, but it is sometimes a more appropriate method when a route of exposure
is known. For example pesticide toxicity in insects testing normally employs feeding
studies [229] as it is the normal route of exposure that the study tries to mimic.
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Insects were injected with low doses (5 mg/kg body weight) of the compounds first
and the mortality was recorded daily for five days. When no mortality was observed
new groups of larvae were injected with compounds at 50 mg/kg body weight and the
mortality was recorded daily for five days again. When mortality was observed in 60%
or more of  the larvae,  the compound was re-tested at that same concentration to
confirm the toxicity. When mortality below 60% was observed, the compounds were
tested subsequently at 125, 300 and 2000 mg/kg body weight. Each compound was
assigned an LD50 value and a GHS class (Table 5-2) and the values were compared to
toxicity data available in the MSDS pages.
No  compounds  were  tested  above  2000  mg/kg  body  weight  in  line  with  OECD
guidelines [242]. Such high compound concentrations introduce solubility issues and
are discouraged in the guidelines as unnecessary and unethical. Generally, compounds
with no indication of toxicity at 2000 mg/kg body weight are considered non-toxic.
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Table  5.2: The identity and toxicity of compounds in the trial. LD50 values determined in the
test  were  compared  to  values  available  in  material  safety  data  sheets  provided  with  the
compounds.  Blank space indicates the data are not available.   GHS class refers to international
toxicity classification, where the most toxic compounds are designated 1 and the least toxic
compounds are designated 5.
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5.3.2.2 Comparison of G. mellonella results and available toxicity data
For most compounds the toxicity determined in this experiment correlates well with
toxicity  reported  in  the  MSDS  pages  available  for  each  of  the  compounds.  The
compounds with lowest LD50s in mammals were the most toxic for galleria larvae (Table
5-2). The most toxic compounds had the lowest LD50 values: the value for doxorubicin
fell  within the range established by experiments in mammals (5.5 mg/kg in galleria
versus 1.2 and 16 mg/kg in mice and rats respectively) and for amsacrine the value was
lower (40 mg/kg via intraperitoneal injection versus 100 mg/kg in rats and 243 mg/kg
in mice via oral exposure). Similar close correlation between LD50 values established in
G.  mellonella and  LD50 values  from  MSDS  pages  was  also  observed  for  etoposide,
ciprofloxacin, norfloxacin, carbenicillin, chloramphenicol, kanamycin and streptomycin.
Kanamycin  did  not  cause  larval  mortality,  however,  when  the  larvae  pupated,  the
cocoons and pupas were malformed and fragile. This effect was not observed with any
other compound. The values obtained for novobiocin and chloroquine were four to ten
times smaller  than the mammalian  LD50,  but  the only  data available  are  from oral
exposure,  making  the  values  difficult  to  compare.  A  number  of  values  obtained
correlate  badly  with  LD50 values  available  from  the  MSDS  pages.  Sodium  chloride,
tetracycline, glutamic acid, glucose, 50% DMSO and ATP were toxic to G. mellonella at
100-125 mg/kg body weight, even though the mammalian LD50s are over 2000 mg/kg
(apart from intraperitoneal tetracycline injections, which are toxic at 318 mg/kg body
weight in rats). It was hypothesised that the mortality in larvae injected with these
compounds was due to DMSO toxicity.
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Table  5.3:  LD50  values  determined  in  the  test  were  compared  to  values  available  in  the
literature.  Blank space indicates the data are not available in the literature. 
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5.3.2.3 DMSO toxicity issues
To test whether some of the mortality observed should be attributed to DMSO toxicity,
a  second  screen  was  conducted.  Five  compounds  were  re-tested  above  their
determined  G.  mellonella toxic  dose  using  PBS  buffer,  rather  than  DMSO,  as  an
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injection  medium:  ciprofloxacin,  sodium  chloride,  tetracycline,  glucose  and
streptomycin. Each compound was tested at 300 and 2000 mg/kg body weight as it is
already  known from the  previous  experiment  that  these  compounds  are  not  toxic
below these concentrations. Groups of five larvae were injected with each dose. There
was  no  mortality  in  the  groups  injected  with  ciprofloxacin,  sodium  chloride,
tetracycline or glucose (Table 5-3), but all larvae injected with streptomycin at 2000
mg/kg body weight died. The values obtained correlate better with the mammalian
LD50 values than the initial screen, confirming some of the mortality observed in the
test was associated with DMSO toxicity.
5.3.2.4 Negative controls used in the screening
At each stage of the testing three control groups, containing five to ten larvae each,
were used: the first group was untreated, the second had the cuticle pierced with a
sterilized Hamilton needle, and the third group was injected with 10 µl injection media
(50% DMSO or PBS buffer). The untreated larvae were used to monitor the general
health of the G. mellonella colony and any background mortality, for example due to
viral infections. Mortality in the group of larvae with a pierced cuticle would indicate
that  the injection  procedure  was  not  performed correctly  and was  harmful  to  the
larvae. The mortality in the group injected with the pure injection media shows either
toxicity of the medium or incorrect volume injected. Apart from the DMSO toxicity
discussed above, there was no mortality in these control  groups, suggesting the  G.
mellonella colony was healthy and the injection procedure did not  inflict  excessive
damage on the insects.
5.3.3 Native gut microbiota replacement
5.3.3.1 Hypothesis
We hypothesised that native gut microbiota of  G. mellonella could be replaced with
other bacteria, for example human gut bacteria, enabling a number of studies of the
interactions between members of human microbiota and the impact of antibiotics on
the gut microbiome. A feeding experiment was conducted to test this hypothesis.  G.
mellonella larvae were feeding on artificial food mixed with human faecal slurry from a
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healthy newborn baby, and larvae in the control group were feeding on just artificial
food. The faecal slurry was rich in Bifidobacteria and we hypothesised Bifidobacteria
would  partially  or  fully  colonize  G.  mellonella gastrointestinal  tract.  Insects  were
collected  before  the  start  of  the  feeding  procedure  to  determine  the  baseline
composition of the gut bacteria, and on day three, four and seven of the experiment.
Three dissected larval guts were pooled for each sample to obtain enough bacterial
cells and DNA for downstream analysis. Unlike previous experiments where no bacteria
were found in G. mellonella guts (see Chapter 3), bacteria were present in all samples. 
5.3.3.2 Bacterial counts in the larval guts
Before the beginning the treatment, the amount of bacteria cultured from the guts
varied  between  less  than  10  and  nearly  50,000  cfu/mg  gut  contents  (Figure  5-2).
Throughout the experiment there was no difference in the amount of bacteria isolated
from  treated  and  untreated  groups.  The  amount  of  colony  forming  units  varied
between samples, reaching as little as 1 cfu/mg gut contents in control group on day
four of the treatment and as much as 84,000 cfu/mg in the treated group on day seven.
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5.3.3.3 Composition of the gut communities
The bacteria cultured from the larval guts were identified by 16S sequencing. In both
groups  the  two  isolates  were  present:  Enterococcus  gallinarum and  Enterococcus
xiangfangensis. 58.3% of the isolates from the treated group were  E. gallinarum and
41.7% were E. xiangfangensis. In the control group, feeding on just the artificial food
without  the  faecal  slurry,  50.0%  isolates  were  E.  gallinarum,  45.0%  were  E.
xiangfangensis and  the  remaining  5%  were  represented  by  Staphylococcus
saprophyticus. All three strains belong to the order Firmicutes and can be isolated from
animal and human microbiota. Apart from the presence of S. saprophyticus, there was
no difference between the slurry fed group and control group. The microbiota from
insects treated with faecal slurry was not enriched in Bifidobacteria from the faecal
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Figure 5.2:  Bacterial counts in the guts of G. mellonella feeding on faecal slurry. Samples from
the larvae feeding on the faecal slurry are marked with crosses and the samples from control
groups are marked with circels. 12 larvae (pooled into four groups of three) were dissected
prior to the feeding experiments. The remaining larvae were divided into two groups and fed
on autoclaved artificial media with or without faecal slurry. On day three, four and seven each
group was sampled by dissecting the guts of nine larvae (pooled into three groups of three).
Two  isolates  were  identified  in  all  samples:  Enterococcus  gallinarum  and  Enterococcus
xiangfangensis. Staphylococcus saprophyticus was identified as one of the strains present in
control group on day four.
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slurry.
The experiment was not continued in this project. Instead,  it  was used to design a
more extensive study developing  G. mellonella larvae into a model of the baby gut.
Among the questions investigated are: the difference between species isolated from
the  gut  and  faecal  samples,  whether  it  is  possible  to  replace  native  G.  mellonella
microbiome and with which strains.
5.4 Discussion
5.4.1 Acute toxicity can be assessed in greater wax moth larvae
Acute toxicity of 17 compounds has been assessed in G. mellonella larvae. There was
good correlation between the LD50 values obtained in the test and reported LD50s from
safety  documentation  supplied  with  the  compounds.  Such  correlation  suggests  G.
mellonella larvae could be used in de novo acute toxicity testing providing statistically
robust preliminary data before testing in mammalian models. G. mellonella larvae can
be used as a cheap and quick way of testing compounds, however they are not free of
limitations.
The first limitation of the larvae is the limitation that applies to all other toxicity testing
systems: the toxicity cannot be tested in humans and it is not known how experimental
LD50 values correlate to human values or even if the mechanism of toxicity is the same.
There are numerous mechanisms of systemic toxicity and they are poorly understood.
In  some  cases  the  cause  of  toxicity  is  alike  in  different  systems.  For  example,
doxurubicin  is  a  DNA  intercalator  and  poisons  different  organisms  at  low  doses.
However, differences in insect and mammal physiology can lead to opposing responses
to compounds.  Insecticidal Bt toxin is only toxic to certain groups of insects based on
the alkaline conditions in their guts, while remaining insoluble and harmless in acidic
mammalian digestive tract [25].
The second limitation is specific to the use of DMSO as an injection medium in the
procedure.  Due  to  DMSO  toxicity  the  initial  test  lost  its  sensitivity  for  accurately
estimating LD50 values for mildly- or non-toxic compounds (GHS class 3 and above).
50% DMSO was lethal to wax moths above 100 mg/kg body weight when used as an
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injection medium. The test could not correctly assign LD50 to mildly toxic compounds
(for example antibiotics ciprofloxacin and chloramphenicol) and non-toxic compounds
(glutamic  acid,  glucose,  sodium chloride)  because of  the side effects  of  the DMSO
injection. Decreasing the amount of DMSO per injection, maintains the solubility of the
compounds tested without compromising the test procedure. Alternatively the solvent
effects  can  be  subtracted  from  the  compound  effects  using  statistical  methods.
Restricting  background  mortality  (mortality  in  untreated  control  groups)  not  only
lowers the experimental noise but also aligns better with the guidelines on the use of
laboratory animals.
Overall our experiments have shown that Galleria larvae can be reliably used in acute
toxicity  testing,  providing  more  data  cheaper  and  quicker  than  traditional  testing
systems. Testing in G. mellonella is unlikely to fully replace toxicity testing in mammals,
but it is a convenient step between in vitro tests and testing in mammals, adding more
complexity to the former and statistical robustness to the latter. 
5.4.2 Recommended  human  doses  of  antibiotics  cure  bacterial
infections in G. mellonella larvae
Our experiment confirmed antibiotic efficacy testing can be done in G. mellonella and
the therapeutic doses recommended for human use can be translated to doses in the
wax moth larvae. In most cases the exact dose recommended for clinical treatment of a
systemic infection can be calculated for larval body weight and can clear an infection.
Such close correlation is possible because often the mechanisms of microbial virulence
are  not  host-specific.  Previous  studies  have  shown  that  fungal  pathogen  Candida
albicans uses the same repertoire of effectors, involved in fungal virulence and yeast-
to-hypha  transition,  against  insects  and  mammals  [243].  Similarly,  the  bacterial
pathogen  Pseudomonas  aeruginosa employs  a  similar  set  of  virulence  genes  to
overcome the immune system of wax moth larvae and mice [244] and the larvae can
be used to identify virulence factors required for an infection in mammals. 
Antibiotic efficacy testing in G. mellonella does not have the same limitations as toxicity
testing. Unlike toxicity mechanisms, the mechanistic basis of antibiotic action is the
same  in  insects  and  mammals.  Even  though  insects  are  only  distantly  related  to
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